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ABSTRACT 
Cryptosporidium is an enteric parasite that has a global impact on the health and 
survival of millions of people and animals worldwide. The resistant oocyst stage of the 
organism's life cycle is excreted in the faeces of infected animals and humans and can 
contaminate sources of drinking water. Cryptosporidium currently represents the major 
public health concern of water utilities in developed nations as the oocysts produced by 
Cryptosporidium are extremely hardy, easily spread via water, resistant to chlorine and are 
difficult to inactivate or remove from water intended for consumption without the use of 
filtration. 
Recent developments in the in vitro cultivation have revealed that C. parvum can 
complete  its  life  cycle  in  media  devoid  of  host  cells,  which  highlights  the  paucity  of 
knowledge about the developmental biology of this parasite. This finding supports other 
biological and phylogenetic analysis suggesting that Cryptosporidium has a closer affinity 
with gregarines than with the coccidia. This thesis investigates the growth and propagation 
of Cryptosporidium in cell free environments. 
A  current  limitation  of  host  cell-free  cultivation  is  the  difficulty  involved  in 
visualising the life-cycle stages as they are very small in size and morphologically difficult 
to identify and dispersed throughout the media. This is in contrast to conventional cell 
culture methods for Cryptosporidium, where it is possible to focus on the host cells and 
view  the  foci  of  infection  on  the  host  cells.  Three  specific  and  three  non-specific 
techniques for visualising C. parvum life-cycle stages in cell-free culture were compared; 
antibody staining using anti-sporozoite and anti-oocyst wall antibodies (Sporo-Glo™ and 
Crypto  Cel),  fluorescent  in-situ  hybridization  (FISH)  using  a  Cryptosporidium  specific 
rRNA  oligonucleotide  probe  and  the  non-specific  dyes;  texas  red,  carboxyfluorescein 6 
 
diacetate  succinimidyl  ester  (CFSE)  and  4,6’  diamino-2-phenylindole  dihydrochloride 
(DAPI).  Results  revealed  that  a  combination  of  Sporo-Glo™  and  Crypto  Cel  staining 
resulted in easy and reliable identification of all life cycle stages. 
This thesis reports for the first time the completion of the life cycle of C. hominis in 
cell-free culture and multiplication of the parasite via qPCR. Individual life cycle stages 
were characterised using Cryptosporidium-specific antibody staining (Sporo-GloTM) and 
fluorescent  in  situ  hybridisation  (FISH)  staining  on  cultures  inoculated  with  excysted 
oocysts and purified sporozoites.  In both cultures, C. hominis successfully proliferated and 
completed  its  life  cycle,  however  development  in  cultures  inoculated  with  purified 
sporozoites lagged behind cultures inoculated with excysted oocysts. Some novel findings 
of the study include the visualisation of pairing and multiple associations between various 
developmental stages in a process similar to syzygy and the formation of Cryptosporidium 
stages (trophozoites and meronts) inside the oocysts without excystation. qPCR analysis 
revealed a 5-6-fold amplification of parasite DNA. Future studies are required to improve 
the amplification of the parasite. 
Chapter  5  describes  the  complete  development  of  all  life  cycle  stages  of 
Cryptosporidium  parvum  (cattle  genotype)  in  water.  This  is  the  first  report  in  which 
Cryptosporidium is shown to develop and complete its life cycle in water. Amplification of 
parasite numbers in water was quantified using oocyst counts and quantitative PCR (q-
PCR). Daily monitoring by microscopy revealed that some oocysts, when placed in tap or 
rain  water  and  incubated  at  4,  15,  24  and  37°C,  would  excyst,  releasing  sporozoites 
resulting in continuation of the life cycle and production of new oocysts.  Manual oocyst 
counts  and  qPCR  analysis  at  days  0,  3,  6,  9  and12,  when  compared  with  the  initial 
inoculum,  showed  a  small  but  significant  increase  in  oocyst  numbers  and  oocyst 
equivalents, respectively. 7 
 
A study was also conducted to determine if meront and merozoite life cycle stages 
derived from C. parvum oocysts incubated in rain water at 24°C were infective to neonatal 
ARC/Swiss mice. Each mouse was inoculated with approximately 25,000 meronts and 
merozoites,  meronts  were  counted  as  ‘1’  stage.  An  estimated  1.1  x10
6  oocysts  were 
recovered from 6 mice, therefore on average of 183,333 oocysts per mouse was recovered. 
This represents a 7.3 fold increase from the number of stages, which were inoculated into 
the mice. This study provided some evidence that meront and merozoite life cycle stages 
are capable of causing infection in neonatal mice. This is the first report of life cycle stages 
of Cryptosporidium other than the oocyst causing infection, however further research is 
required to confirm this. 
The  finding  of  this  thesis  will  greatly  assist  in  our  understanding  of  the 
developmental biology of Cryptosporidium, its position within the Apicomplexa and its 
relationship to gregarine protozoa. 
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1.1 GENERAL INTRODUCTION 
 
Cryptosporidium is a genus of protozoan parasites, which develop endogenously 
and extracellularly in the gastrointestinal or respiratory tracts of mammals, birds, reptiles, 
amphibians and fish causing diarrhoeal disease. This parasite is currently recognized as the 
most common non-viral cause of diarrhoea in humans worldwide. Cryptosporidiosis is a 
self-limiting  disease  in  immunocompetent  hosts;  however,  disease  is  more  severe  and 
potentially  fatal  in  neonatal  and  immuno-suppressed  individuals,  especially  those  with 
acquired immunodeficiency syndrome (AIDS). 
  Although species of Cryptosporidium were first described in the early 1900’s, it 
was near the end of that century before they were widely recognized as a pathogen of 
domesticated livestock and poultry, companion animals, and wildlife, and a threat to public 
health. The discovery of the environmentally resistant oocyst stage that transmitted the 
infection  from  host  to  host  via  contaminated  faeces  led  to  the  recognition  that 
contaminated drinking and recreational water was a major source of transmission.  
A  large  number  of  chemotherapeutic  agents  have  been  tested  against 
Cryptosporidium  and  currently,  nitazoxanide  (NTZ)  is  approved  for  treatment  of 
cryptosporidiosis in children and immunocompetent adults in the U.S.A., however NTZ is 
not effective without an appropriate immune response and is therefore ineffective for the 
treatment of immunocompromised individuals.  
The  recent  development  of  molecular  tools  has  enabled  the  identification  of 
morphologically  indistinguishable  species  allowing  researchers  to  define  relationships 
between parasite species, potential hosts and pathways of transmission. It has also allowed 
analysis of the relationship of this parasite genus within the phylum Apicomplexa. 20 
 
  Successful in vitro cultivation of this parasite was first described in 1983, where 
asexual life cycle stages were observed. Many different cell lines, media supplements and 
conditions  were  trialed  in  an  effort  to  cultivate  Cryptosporidium  spp.  in  vitro.  Recent 
developments in in vitro cultivation have revealed that this parasite can complete its life 
cycle in media devoid of host cells, contradicting current beliefs that Cryptosporidium is 
an  obligate  intracellular  parasite.  Novel  extracellular  life  cycle  stages  have  also  been 
described, further highlighting the deficiency of our knowledge about the biology of this 
parasite.  
 
1.2 HISTORICAL TIME-LINE 
 
Cryptosporidium developmental stages were first discovered in the gastric glands 
of laboratory mice by Ernest Edward Tyzzer (1907, 1910). The species, which was given 
the name Cryptosporidium muris, was later found to infect the gastric glands of several 
other mammals, but not humans. Tyzzer identified a second species in 1912, which was 
found  to  infect  the  small  intestine  of  laboratory  mice  and  was  named  C.  parvum. 
Differentiation of the two species, C. muris and C. parvum, was based on differences in 
oocyst morphology and infection site. C. muris has large ovoid oocysts (6 - 8 µm) and 
infects the epithelial cells of the gastric glands in the stomach, whereas, C. parvum has 
smaller  oocysts  measuring  4.5  -  5.0  µm  and  infects  the  epithelial  cells  of  the  small 
intestine. In 1955, a new species was reported infecting the terminal one-third of the small 
intestine in turkeys and was named C. meleagridis based on cytology and measurements of 
oocysts and other life cycle stages (Slavin, 1955). 21 
 
The  medical,  veterinary  and  economic  importance  of  Cryptosporidium  was  not 
recognized until the 1970’s, more than half a century after Ernest Edward Tyzzer first 
discovered it. In 1971 it was found to be associated with bovine diarrhea (Panciera et 
al.,1971) and 1976 saw the first two reports of cryptosporidiosis in immuno-compromised 
human patients (Miesel et al., 1976). Six years later, the U.S. Centers for Disease Control 
reported 21 men in six cities with concurrent cryptosporidiosis and AIDS (Goldfarb et al., 
1982). Cryptosporidium was first reported in reptiles by Brownstein et al., in 1977 and 
subsequently numerous reports world-wide have revealed Cryptosporidium infections to be 
associated  with  acute  and  clinical  disease  characterised  by  diarrhoea  in  humans  and 
various domestic and wild animal species including birds (O’Donoghue, 1995; Fayer et al., 
2000; Xiao, 2010). 
 
1.3 TAXONOMY AND PHYLOGENY 
 
The genus Cryptosporidium is currently classified within the phylum Apicomplexa 
and in the order Eucoccidiidae based on the possession of similar life cycle features and 
morphological characteristics to other enteric coccidian parasites (Levine, 1988) (see Table 
1.1). 
  Despite  similarities,  Cryptosporidium  demonstrates  several  peculiarities  that 
separate it from any other coccidian. These include (1) the location of Cryptosporidium 
within the host cell, where the endogenous developmental stages are confined to the apical 
surfaces of the host cell (intracellular, but extracytoplasmic); (2) the attachment of the 
parasite  to  the  host  cell,  where  a  multi-membranous  attachment  or  feeder  organelle  is 
formed at the base of the parasitiphorous vacuole to facilitate the uptake of nutrients from 22 
 
the host cell; (3) the presence of two morpho-functional types of oocysts, thick-walled and 
thin-walled, with the latter responsible for the initiation of the auto-infective cycle in the 
infected host; (4) the small size of the oocyst (5.0 x 4.5 µm for C. parvum) which lacks 
morphological  structures such as  sporocyst,  micropyle and polar granules  (Tzipori  and 
Widmer, 2000; Petry, 2004); (5) the insensitivity to all anti-coccidial agents tested so far 
(Blagburn  and  Soave,  1997  Cabada  and  White,  2010);  (6)  and  finally  the  recent 
observation of the presence of a novel  gamont-like extracellular stage similar to those 
found in gregarine life cycles (Hijjawi et al., 2002; Rosales et al., 2005). 
  The use of molecular tools for the characterisation of Cryptosporidium species has 
provided the opportunity for comparative phylogenetic studies, which have consistently 
placed Cryptosporidium as a clade separate from the coccidian taxa (Relman et al., 1996; 
Barta et al., 1997; Morrison and Ellis, 1997; Carreno et al., 1999; Lopez et al., 1999; Zhu 
et al., 2000a; Barta and Thompson, 2006). Furthermore, phylogenetic analyses suggest that 
it is an early-diverging apicomplexan with affinities to gregarines (Carreno et al., 1999; 
Leander  et  al.,  2003b;  Barta  and  Thompson,  2006),  which  is  supported  by  the 
identification of novel  extracellular gregarine-like life cycle stages  of  Cryptosporidium 
(Hijjawi et al., 2002; Rosales et al., 2005). 
  The  unique  biological  and  morphological  characteristics  of  Cryptosporidium 
coupled  with  molecular  phylogenetic  studies  make  it  clear  that  the  present  taxonomic 
classification within the coccidia requires revision. 
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Table 1.1. Previous taxonomic Classification of Cryptosporidium (Levine, 1988). 
Classification  Name  Biological Characteristics 
Phylum  Apicomplexa 
 
Possess an apical complex in 
some life cycle stages. 
Class  Sporozoasida 
 
Reproduces by asexual and sexual 
cycles. 
Subclass  Coccidiasina 
 
Life cycle involves merogony, 
gametogeny and sporogony 
Order  Eucoccidiida 
 
Merogony occurs. 
Suborder  Eimeriina 
 
Independent macro and 
microgamy development. 
Family  Cryptosporidiidae  Oocysts contain four naked 
sporozoites (no sporocyst); 
endogenous stages with 
attachment organelle; 
monoxenous life cycle. 
 
1.4 SIMILARITIES BETWEEN CRYPTOSPORIDIUM AND GREGARINES 
 
Following the report of the cross-reactivity of an anti-Cryptoporidium monoclonal 
antibody  with  the  monocystid  gregarine  (Bull  et  al.,  1998),  many  studies  have  been 24 
 
conducted  analysing  the  phylogenetic  relationships  between  the  gregarines  and 
Cryptosporidium (Carreno et al., 1999; Leander et al., 2003a, b; Leander and Keeling, 
2004a; Barta and Thompson, 2006; Kopečná et al., 2006; Leander et al., 2006). Biological, 
morphological  and  ultrastructural  studies  have  highlighted  similarities  between 
Cryptosporidium and the gregarines (Table 1.2) (Hijjawi et al., 2002; Hijjawi et al., 2004; 
Rosales et al., 2005; Barta and Thompson, 2006; Leander, 2007; Valigurová et al., 2007). 
Information  gained  from  these  studies  suggests  that  Cryptosporidium  is  most  closely 
related to some of the earliest diverging apicomplexan parasites, the archigregarines.  The 
similarities between these two groups of parasites is discussed below and summarized in 
Table 1.2 (see review by Hijjawi et al., 2010).  
 
1.4.1 Gregarine protozoa 
 
Gregarines  are  a  group  of  apicomplexans  which  are  distinct  from  coccidians, 
haemosporidians  and  piroplasms  and  are  thought  to  be  the  earliest  lineage  of 
apicomplexans (Leander et al., 2003a). They are a diverse group of large single-celled 
parasites that that inhabit the intestines and other extracellular spaces of invertebrates and 
lower vertebrates, which are abundant in natural water sources (Leander  et al., 2003a; 
Barta and Thompson, 2006; Leander, 2007; Valigurová et al., 2007).  
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1.4.2 Host cell interaction 
 
Gregarine and Cryptosporidian parasites are characterised by their attachment onto 
the surface of epithelial cells via specialised organelles. Gregarines attach to the host cell 
via either an epimerite or mucron and Cryptosporidium attach to the host cell the feeder 
organelle  (Valigurová  et  al.,  2007).  Cryptosporidia  have  a  unique  intracellular  but 
extracytoplasmic niche location within the host cell. This location and the attachment via 
the feeder organelle are different to all known coccidians. Furthermore, recent molecular 
and  ultrastructural  characterisation  of  the  marine  aseptate  gregarines,  Selenidium  and 
Lecadina,  provide support  for the sister  relationship between  Cryptosporidium  and the 
gregarines (Leander et al., 2003b). 
  Recent studies have found similarities with the location in the host cell, host cell 
attachments  and  the  feeding  behaviors  between  Cryptosporidium  and  some  gregarine 
species (Butaeva et al., 2006; Valigurová et al., 2007). Butaeva et al., (2006) demonstrated 
that  the  double-membrane  parasitophorous  vacuole  of  Cryptosporidium  and  the  multi-
membranous vacuole of Ditrypanocystis appear to be similarly formed (Figure 1.1). Both 
Cryptosporidium (Fig 1.1a) and Ditrypanocystis sp (Fig 1.1b) form a specialized host-
parasite interface reflecting similar modes of adaptations to parasitic survival in similar 
sites of locations in the enterocyte brush border. Valigurová et al., (2007) noted that both 
C. parvum and Gregarina steini were attached to the host cells by their apical processes: 
the epimerite, feeder organelle  and associated structures.  The feeder organelle  and the 
whole attachment site of C. muris resemble the epimeritic region of G. steini. 
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Figure  1.1.  Comparative  diagrammatic  representation  displaying  similarities  and 
dissimilarities  of  the  parasitophorous  vacuole  formation  around  Cryptosporidium  and 
Ditrypanocystis sp. within the host cell. (from: Goebel and Braendler, 1982). 
 
a.  Cryptosporidium  in  the  gut  of  suckling  mouse  possessing  a  double-membrane 
parasitophorous  vacuole  of  fused  microvilli;  feeder  organelle  is  seen  at  the  host  cell 
interphase.  
b. Ditrypanocystis sp. in the gut of an oligochaete worm possessing a multi-membranous 
parasitophorous  vacuole  of  fused  clustered  cilia  lacking  microtubules,  membranous 
channels are formed at the area of attachment.  
hc: host cell, aa: attachment area, fo: feeder organelle, mch: membranous channels, mv: 
microvilli, ci: cilia, cc: clustered cilia, pv: parasitophorous vacuole, mvi: inner membrane 
of    parasitophorous  vacuole,  mvo:  outer  membrane  of  parasitophorous  vacuole,  om: 
parasite outer membrane, im: parasite inner membrane, smt: subpellicular microtubules. 
(Butaeva et al., 2006). 
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1.4.3 Life cycle 
 
Most  Cryptosporidium  and  gregarine  species  infect  epithelial  cells  of  the  host 
gastrointestinal tract and have non-motile zygotes. Cryptosporidium and most gregarines 
have monoxenous life cycle and transmission is via oral ingestion of infective oocysts, 
whereas, other members of the apicomplexan-protozoan pathogens are usually transmitted 
by an invertebrate vector or intermediate host.  
  Cryptosporidium  and  some  gregarines  have  life  cycles  consisting  of  three 
alternating  phases  of  development:  merogony  (asexual),  gametogony  (sexual),  and 
sporogony  (asexual)  (Leander  et  al.,  2003a;  Leander,  2007)  although  this  varies 
considerably within the gregarine group (Levine, 1985; Sidall, 1995).  
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Table 1.2. Similarities between Cryptosporidium and some archigregarines species. 
Properties      Cryptosporidium  Archigregarines 
/Selenidiidae  
Location within the host cell  Occurs  in  the  intestines 
enterocyte brush border 
Occurs  in  the  intestines 
enterocyte brush border 
Extracellular development   Yes  Yes 
 
Presence  of  parasitiphorous 
vacuole 
Double-membrane   
 
Multi-membranous    for  
Ditrypanocystis species  
Presence of Apicoplast  Absent  Absent in species studied 
Syzygy-like  pairing  of 
extracellular stages 
Present  Present 
Life cycle   Monoxenous  Monoxenous 
Life cycle developmental stages   3  schizogonies  (merogony, 
gametogony, and sporogony) 
3  schizogonies  (merogony, 
gametogony, and sporogony) 
Oocyst size and layers 
 
 
2-layered wall  
7.4 x 5.6 µm  (C. muris oocysts) 
5.0 x 4.5 µm (C. parvum oocysts) 
2-layered wall  
12-18 µm (Selenidium oocysts) 
No. of sporozoites / oocyst  Four  Four 29 
 
1.4.4 Oocyst morphology 
 
Archigregarines  (Selenidium)  and  Cryptosporidium  have  4  infective  sporozoites 
within each cyst, whereas all other gregarines have 8 or more sporozoites per cyst (Leander 
et al., 2003b). Cryptosporidium oocysts are small (7.4 x 5.6 µm for C. muris and 5.0 x 4.5 
µm for C. parvum) and lack morphological structures such as sporocyst, micropyle and 
polar granules. Oocysts of Selenidium are similar in shape to Cryptosporidium, possess a 
2-layered wall, 1 µm thick, however, they are larger in size (12 - 18 µm).   
 
1.4.5 Cross reactivity of anti-Cryptosporidium antibodies 
 
Bull et al., (1998) demonstrated that an anti-Cryptosporidium monoclonal antibody 
cross-reacted with oocysts of a monocystid gregarine.  It was suggested that the cross-
reactivity was due to similar biological properties between the two parasites not shared by 
other apicomplexan parasites such as the coccidia (Carreno et al., 1999).  
 
1.4.6 Phylogenetic similarities 
 
Analysis of the complete genome of C. parvum and C. hominis identified neither a 
plastid genome nor genes with putative plastid-targeting sequences (Abrahamsen et al., 
2004; Xu et al., 2004).  Furthermore, plastid-like structures have not been revealed through 
microscopy  of  Cryptosporidium  (Riordon  et  al.,  2003).  Most  apicomplexans  including 30 
 
Plasmodium,  Toxoplasma  and  Eimeria  possess  both  plastids  and  corresponding  plastid 
genomes.  Studies  on  some  gregarine  species  also  failed  to  reveal  the  presence  of  an 
apicoplast  (Valigurova  and  Koudela,  2005;  Toso  and  Omoto,  2007a).  Recent 
ultrastructural  studies  of  the  eugregarine  Leidyana  and  the  species  Gregarina 
niphandrodes also failed to find apicoplasts (Valigurova and Koudela, 2005; Toso and 
Omoto, 2007a). These findings raise again the possibility that the plastid was lost in the 
apicomplexans  following  the  divergence  of  the  gregarines  and  Cryptosporidium,  and 
further complement the close relationship between the two. Similarities can be found when 
comparing the life cycle development of Cryptosporidium with two Mattesia species of 
gregarine (M. dispora and M. geminate) (Hijjawi et al., 2004) (Figure 1.2). The behavior 
of the sporozoites of M. dispora is similar to observations of Cryptosporidium sporozoites 
in cell free culture (Hijjawi et al., 2004); the formations of circular trophozoites which 
aggregate  together  forming  type  I  meronts  (outlined  in  boxes,  Fig  1.2  a,  b  and  c). 
Moreover, similarities in the shape of merozoites released from Meront I and Meront II are 
also obvious (outlined in circles Fig 1.2 b and c).   
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Figure  1.2.  Comparison  of  life  cycles  of  Mattesia  geminata,  Mattesia  dispora  and 
Cryptosporidium parvum. 
 
   (a)               (b)                  (c) 
(a) Mattesia geminata life cycle, Kleespies et al., 1997. (b) Mattesia dispora life cycle, 
Levine, 1970. (c) Cryptosporidium parvum life cycle in host cell free culture, Hijjawi et 
al., 2004. 
 
 
1.5 CRYPTOSPORIDIUM SPECIES 
 
The first species of Cryptosporidium to be described were C. muris (Tyzzer, 1910) 
and C. parvum (Tyzzer, 1912). For many years, following the initial discovery of these 
species, there was much confusion surrounding Cryptosporidium taxonomy and a total of 
23  species  were  described,  many  erroneously.  Initially,  the  parasite  was  commonly 
confused with other apicomplexan genera, particularly the coccidian genus Sarcocystis, 
resulting in a variety of named and un-named species being incorrectly assigned to the 32 
 
genus  (Triffitt,  1925;  Bearup,  1954;  Pande,  1972;  Anderson  et  al.,  1968;  Dubey  and 
Duszynski, 1969; Pande et al., 1972). Following this, the concept of strict host specificity 
was applied and multiple new species were named based on host occurrence (Xiao et al., 
2004) including: C. agni in sheep, C. bovis in calves (Barker and Carbonell, 1974), C. 
anserinum  in  geese  (Proctor  and  Kemp,  1974),  C.  cuniculus  in  rabbits  (Inman  and 
Takeuchi, 1979), C. garnhami in humans (Bird, 1981), and C. rhesi in monkeys (Levine, 
1980).  However,  cross  transmission  studies  demonstrated  that  isolates  from  different 
animals could be transmitted from one host species to another, which ended this practice. 
Many of these new Cryptosporidium species became a synonymous group referred to as C. 
parvum resulting in the widespread use of this name for Cryptosporidium spp. infecting a 
wide  range  of  mammals  including  humans.  However,  the  following  species;  C. 
meleagridis in turkeys (Slavin, 1955), C. wrairi in guinea pigs (Vetterling et al., 1971), 
and  C.  felis  in  cats  (Iseki,  1979)  retained  their  name  due  to  demonstrated  biological 
differences from the established species C. parvum  and C. muris. Following this, other 
Cryptosporidium species were named based on biological differences, such as C. baileyi in 
chickens (Current et al., 1986), C. serpentis in reptiles (Levine, 1980) and C. varanii in 
lizards (Pavlásek et al., 1995). More recently, it was recognised that C. parvum in fact 
consists of two distinct species; C. parvum and C. hominis (Carraway et al., 1996; Peng et 
al., 1997; Morgan-Ryan et al., 2002). 
  The  recent  application  of  molecular  characterisation  tools  has  helped  to  clarify 
confusion surrounding Cryptosporidium taxonomy and the existence of multiple species 
has been validated (Xiao, 2010). Xiao et al., (2004) have proposed a taxonomic framework 
to be used as a guide in the description of new species of Cryptosporidium in order to 
minimize confusion and the creation of invalid names for species. Several new species 
have  been  named  in  recent  years  using  multiple  parameters  that  include  morphology, 33 
 
developmental biology, host specificity, histopathology, and/or molecular biology. These 
include C. andersoni from cattle (Lindsay et al., 2000), C. canis from dogs (Fayer et al., 
2001), C. hominis from humans (Morgan-Ryan et al., 2002), C. molnari (Alvarez-Pellitero 
and Sitja-Bobadilla, 2002) and C. scophthalmi (Alvarez-Pellitero et al., 2004) from fish, C. 
suis from pigs (Ryan et al., 2004), C. bovis (Fayer et al., 2005) and C. ryanae (Fayer et al., 
2008) from cattle, C. fayeri (Ryan et al., 2008) and C. macropodum (Power and Ryan, 
2008) from marsupials, C. fragile (Jirků et al., 2008) from frogs and C. xiaoi from sheep 
(Fayer and Santin, 2009) and C. ubiquitum from  a variety of hosts (Fayer et al., 2010). 
Cryptosporidium galli in birds was  first described by Pavlásek in 1991, however, was 
recently re-described based on molecular and biological differences (Ryan et al., 2003). 
The use of molecular tools allowed the genetic analysis of previously described C. varanii 
and C. saurophilum isolates, which determined they were in fact genetically identical. As 
C. varanii (Pavlásek et al., 1995) was described prior to C. saurophilum (Koudela and 
Modry, 1998), it takes precedence over C. saurophilum (Pavlásek and Ryan, 2008). 
  Many  of  the  Cryptosporidium  species  are  morphologically  identical  but 
information on host range and other phenotypic characteristics together with molecular 
phylogenetic data is gradually being collated from different parts of the world, supporting 
the taxonomic validity of the 22 species currently recognised (Table 1.3). 
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Table 1.3. Valid species of Cryptosporidium. 
Species  Major hosts  Minor Hosts  Reference 
C. muris  Rodents, bactrian 
camels 
Humans, rock hyrax, 
mountain goats 
Tyzzer, 1907 
C. andersoni  Cattle, bactrian camels  Sheep  Lindsay et al., 2000 
C. parvum  Cattle, sheep, goats, 
humans  
Deer, mice, pigs  Tyzzer, 1912 
C. hominis  Humans, monkeys  Dugongs, sheep, 
cattle 
Morgan-Ryan et al., 2002 
C. wrairi  Guinea pig    Vetterling et al., 1971 
C. felis   Cats  Humans, cattle  Iseki, 1979 
C. canis  Dogs  Humans  Fayer et al.,  2001 
C. meleagridis  Turkeys, humans  Parrots, chickens, 
cockatiels 
Slavin, 1955 
C. fayeri  Red Kangaroo, Eastern 
Grey Kangaroo, Koala 
  Ryan et al., 2008 
C. macropodum  Eastern Grey Kangaroo, 
swamp wallaby 
  Power and Ryan, 2008 
C. ubiquitum  Sheep, deer, humans    Fayer et al. 2010 
C. baileyi  Chicken, turkeys  Cockatiels, quails, 
ostriches, ducks 
Current et al., 1986 
C. galli  Finches, chicken, 
capercalles, grosbeaks 
  Ryan et al., 2003 35 
 
C. serpentis  Snakes, lizards    Tilley et al., 1990 
C. varanii  Lizards  Snakes  Pavlásek et al., 1995 
C. fragile  Frogs    Jirků et al., 2008 
C. molnari  Fish    Alvarez-Pellitero and Sitja-
Bobadilla, 2002 
C. scophthalmi  Fish    Alvarez-Pellitero et al., 2004 
C. suis  Pigs    Ryan et al., 2004 
C. bovis  Cattle, sheep    Fayer et al., 2005 
C. ryanae  Cattle    Fayer et al., 2008 
C. xiaoi  Sheep    Fayer and Santin, 2009 
 
 
1.5.1 Cryptosporidium genotypes 
 
Previously, mammals found to be infected with Cryptosporidium were reported to 
have C. parvum or C. parvum-like parasites based solely on microscopic descriptions. As 
such,  over  150  mammals  have  been  identified  as  hosts  of  C.  parvum  without  careful 
morphometric  measurements  or  genetic  data.  However,  with  recent  molecular 
characterisation,  it  has  been  shown  that  there  is  extensive  host  adaptation  in 
Cryptosporidium evolution and many mammals or groups of mammals have host-adapted 
Cryptosporidium  genotypes.  Some  of  these  genotypes  have  been  delineated  as  distinct 
species and include C. hominis (previously termed human genotype or genotype 1), C. 
parvum (also termed bovine genotype or genotype 2), C. canis (dog genotype) and C. suis 36 
 
(pig genotype I), C. ryanae (deer-like genotype), C. fayeri (marsupial genotype I), and C. 
macropodum  (marsupial  genotype  II).  There  are  currently  more  than  50  recognised 
Cryptosporidium  genotypes,  some  of  which  probably  represent  individual  species, 
however, more data is required to name them (Sulaiman et al., 2002; Xiao et al., 2004; 
Xiao and Fayer, 2008; Xiao, 2010). 
 
1.5.2 Species infecting humans 
 
Cryptosporidium hominis and C. parvum are the two species responsible for the 
majority  of  infections  in  humans  (Xiao  et  al.,  2004).  C.  meleagridis  has  been  widely 
reported in humans (Pedraza-Diaz et al., 2000, 2001a; Xiao et al., 2001; Chalmers et al., 
2002;Gatei  et  al.,  2006;  Leoni  et  al.,  2006)  and  is  now  recognised  as  the  third  most 
common species infecting humans (Xiao et al., 2004). C. felis (Pieniazek et al., 1999; 
Morgan et al., 2000; Pedraza-Diaz et al., 2001b; Xiao et al., 2001; Caccio et al., 2002; 
Gatei et al., 2006; Leoni et al., 2006), C. canis (Pieniazek et al., 1999; Pedraza-Diaz et al., 
2001b; Xiao et al., 2001, 2007; Gatei et al., 2006; Leoni et al., 2006), C. muris (Guyot et 
al., 2001; Tinagtip and Jongwutiwes, 2002; Gatei et al., 2006), C. suis (Xiao et al., 2002; 
Cama et al., 2003; Leoni et al., 2006), C. andersoni (Leoni et al., 2006) and C. ubiquitum 
(Ong et al., 2002; Leoni et al., 2006; Soba et al., 2006; Fayer et al., 2010)  have also been 
reported infecting humans. 
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1.6  MAINTENANCE  AND  AMPLIFICATION  OF  CRYPTOSPORIDIUM  IN  THE 
LABORATORY 
 
A  major  hurdle  for  research  laboratories  to  facilitate  biological,  pathological, 
immunological and molecular and drug evaluation studies on Cryptosporidium has been 
the  inability  to  continuously  propagate  Cryptosporidium  in  vitro.  This  limitation  is 
reflected in the lack of access to life cycle stages other than oocysts and sporozoites, and 
the need for animals to generate oocysts for research (Tzipori and Widmer, 2008). In the 
laboratory, Cryptosporidium can be amplified in two ways: in vivo, in animal models, and 
in vitro using different cell lines, however both of these methods have their limitations. 
 
1.6.1 Animal models for parasite propagation and oocyst production 
 
Presently,  there  are  no  methods  allowing  the  indefinite  storage  of  infectious 
material and isolates have to be continuously passaged through animals, usually calves or 
mice for C. parvum and piglets and gerbils for C. hominis (Tzipori and Widmer, 2008). 
Experimental infections with Cryptosporidium have been successfully established 
in  a  variety  of  domestic  and  laboratory  animals,  particularly  neonatal  and  immuno-
suppressed or immuno-deficient animals (O’Donoghue, 1995).    
  Reports of experimental infections in domestic animals include: calves (Tzipori et 
al.,  1983;  Fayer  et  al.,  1985),  lambs  (Tzipori  et  al.,  1981a,  1982a;  Anderson  1982; 
Snodgrass et al., 1984), goat kids (Tzipori et al., 1982b) and piglets (Moon and Bemrick, 
1981; Tzipori et al., 1981b, 1994). Small animal models such as neonatal mice support the 38 
 
infection of C. parvum (Sherwood et al., 1982; Ernest et al., 1986).  These infections were 
reported to be C. parvum, however, recent recognition that C. parvum in fact consists of 
two distinct species; C. parvum and C. hominis (Carraway et al., 1996; Peng et al., 1997; 
Morgan-Ryan et al., 2002) outdate these studies and it is now unclear which species or 
genotype these animal models were infected with. Cryptosporidium parvum is a common 
species infecting many hoofed mammals and C. hominis mainly infects humans, however, 
C. hominis does infect other mammalian species under laboratory conditions including 
calves (Akiyoshi et al., 2002), piglets (Akiyoshi et al., 2002), and gerbils (Baishanbo et al., 
2005). Techniques for purifying oocysts from the faeces and gastrointestinal tracts of the 
infected animals for further in vitro cultivation, molecular and biochemical studies has 
been successfully established (Waldman et al., 1986; Arrowood and Sterling et al., 1987; 
Current, 1990; Meloni and Thompson, 1996). 
  Infectivity in mice is generally considered to be the ‘gold standard’ for measuring 
C. parvum infectivity (Rochelle et al., 2002). The neonatal mouse model has a long history 
of successful application to testing infectivity and is popular due to its sensitivity (Finch et 
al., 1993), relative ease of manipulation, and the feasibility of using a large number of 
animals (Tzipori and Widmer, 2008). The drawbacks of the use of animal models include 
ethical concerns, the methods are expensive and labor intensive, they do not support the 
infection  of  all  species  and  genotypes  and  they  are  not  suited  for  high-throughput 
applications and for routine monitoring of oocyst infectivity in water monitoring facilities 
(Rochelle et al., 2002; Tzipori and Widmer, 2008). 
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1.6.2 In vitro cultivation 
 
The establishment of a reliable, reproducible in vitro culture system for propagating 
large numbers of Cryptosporidium stages will enhance research studies on this parasite. 
The ability to maintain the life cycle of Cryptosporidium in cell culture will enable detailed 
investigations on life cycle stages and the developmental biology of this parasite. In vitro 
cultivation will also aid in the investigation of pathogenicty of different strains and species 
as  well  as  provide  the  basis  for  other  research  such  as  drug  screening,  molecular, 
immunological and viability studies. 
  There  are  many  factors  that  affect  the  development  and  proliferation  of 
Cryptosporidium in in vitro culture. These include: the excystation protocol, age and strain 
of  the  parasite,  stage  and  size  of  inoculum,  host  cell  type  and  maturity  and  culture 
conditions such as pH, medium supplements and atmosphere (Hijjawi et al., 2003).  
  Since  the  1980’s,  many  different  in  vitro  cultivation  techniques  have  been 
developed to study the infectivity of Cryptosporidium utilizing over 20 different cell lines, 
various growth conditions, and a variety of assay formats (Arrowood, 2002; Rochelle et 
al.,  2002;  Hijjawi,  2003).  Complete  development  of  C.  parvum  has  been  reported  in 
several cell lines with the production of some oocysts (Current and Long, 1983; Buraud et 
al., 1991; Rasmussen et al., 1993; Eggleston et al., 1994; Upton et al., 1994a, 1997;Yang 
et al., 1996; Villacorta et al., 1996; Arrowood, 2002). A major limitation of these studies, 
however, is their failure for long term propagation, low yields of oocysts and/or their lack 
of reproducibility. 
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Despite the shortcomings of in vitro cell culture, several studies comparing the use 
of  epithelial  cell  monolayers  with  the  neonatal  mouse  model  demonstrate  comparable 
results between the two techniques (Upton et al., 1994b; Rochelle et al., 2002; Jenkins et 
al., 2003; Joachim et al., 2003). These results support the view that cell culture can replace 
the neonatal mouse model for certain studies. Cell culture based assays are more suited to 
high throughput testing and the ability to detect waterborne C. hominis and C. parvum 
oocysts with the same assay is advantageous (Tzipori and Widmer, 2008). 
  Recent advances in in vitro cultivation of Cryptosporidium include the successful 
long-term maintenance and propagation of C. hominis and C. parvum (Hijjawi et al., 2001, 
2003), C. andersoni (Hijjawi et al., 2002, 2003) and C. hominis (Hijjawi et al., 2003) in 
HCT-8 cells using modified culture procedures. This modified culture system supported 
the complete life cycle including both sexual and asexual stages. All previously known life 
cycle stages of Cryptosporidium were identified including trophozoites, meront I, meront 
II,  merozoites,  microgamonts,  macrogamonts,  thin  and  thick-walled  oocysts  and 
sporozoites.  In  addition,  previously  undescribed  extracellular  stages  were  observed 
(Hijjawi et al., 2002, 2003).  
  More recently, the ability to culture C. parvum without the need for host cells was 
reported (Hijjawi et al., 2004). This system described the completion of the life cycle in 
RPMI  1640  media  (Fig  1.3)  with  the  presence  of  all  developmental  phases  including 
merogony, gametogony and sporogony. This landmark discovery challenges current beliefs 
that Cryptosporidium is an obligate intracellular parasite. 
  Girouard et al., (2006) recently attempted to propagate Cryptosporidium spp. in 
cell  free  culture  without  success.  The  authors  concluded  that  cell  free  cultivation  of 
Cryptosporidium is not a universal phenomenon, or is not readily accomplished. Despite 41 
 
the authors stating the methodology of Hijjawi et al., (2004) was followed, there were 
some discrepancies and unclear explanations which may have affected the outcome. In 
addition,  the  ability  to  identify  the  life  cycle  stages  without  the  aid  of  fluorescent 
antibodies takes considerable expertise and practice. 
In a recent study, Karanis et al., (2008) observed merozoites as well as sporozoites 
following excystation treatment of oocysts. The authors also tried propagating the treated 
oocysts in cell free media according to Hijjawi et al., (2004) with limited success, but 
failed to establish a long-term cell free culture longer than 48 hours. It was suggested that 
perhaps this organism required several media manipulations to become adapted to axenic 
culture conditions and that media manipulation may ultimately enable the development, 
propagation and establishment of Cryptosporidium spp. in axenic in vitro cultures (Karanis 
et  al.,  2008).  More  recently,  multiplication  C.  parvum  DNA  from  cell  cultures  in  the 
absence of host cells has been reported (Zhang et al., 2009). The findings in these studies, 
and of Hijjawi  et  al., (2004), indicate a natural  ability of  Cryptosporidium to  develop 
outside of its host cells and demonstrates that perhaps endogenous development in the host 
intestine is not obligate for this parasite to complete its life cycle (Karanis et al., 2008). A 
limitiation of these studies however, is the failure of long term propagation, low yields of 
oocysts and/or their lack of reproducibility. 
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Figure 1.3. Diagram of the cell-free life cycle of Cryptosporidium parvum (from Hijjawi 
et al., 2004). 
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1.7 CRYPTOSPORIDIUM LIFE CYCLE AND DEVELOPMENTAL STAGES 
 
1.7.1 Life cycle 
 
The  complex,  monoxenous  life  cycle  of  Cryptosporidium  consists  of  several 
developmental stages involving both sexual and asexual cycles which are demonstrated in 
Figure 1.4. The primary site of infection with  C. hominis and C. parvum is the small 
intestine, with the ileum above the ceacal junction being favored in some animals such 
mice and calves (Fayer, 2008). Other species favour the gastric mucosa such as C. muris 
(Tyzzer, 1910), C. serpentis (Tilley et al., 1990), C. andersoni (Lindsay et al., 2000), C. 
fragile  (Jirků  et  al.,  2008)  and  C.  molnari  (Alverez-Pellittero  et  al.,  2002). 
Cryptosporidium baileyi in chickens favours the respiratory tree and cloaca (Current et al., 
1986). 
 
1.7.1.1 The environmental stage / infective stage 
The infective sporulated oocyst, the only documented exogenous life cycle stage, is 
excreted from the body of an infected host in the faeces. The oocysts possess a tough 
trilaminar wall which is extremely resistant to chemical and mechanical disruption and 
maintains the viability of the internal sporozoites under adverse environmental conditions 
(Fayer and Unger, 1986; Fayer, 2008). 
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1.7.1.2 Excystation 
Once inside the body, oocysts excyst, releasing infective sporozoites through the 
suture  in  the  oocyst  wall  (Reduker  et  al.,  1985;  Reduker  and  Speer,  1985;  Fayer  and 
Unger, 1986) commencing the endogenous phase of the life cycle. Excystation  can be 
triggered by various factors including reducing conditions, carbon dioxide, temperature, 
pancreatic enzymes and bile salts (Robertson et al., 1993; Fayer and Leek, 1984; Reduker 
and Speer, 1985; Gold et al., 2001; Fayer, 2008). However, All of the conditions listed are 
not obligate as it has been demonstrated under experimental conditions, that sporozoites 
can excyst from oocysts in warm aqueous solutions alone, possibly enabling autoinfection 
and infection in extra-intestinal sites (Fayer, 2008) and very good excystation rates can be 
achieved after only pre-treatment with acid solution.  
 
1.7.1.3 Cell invasion 
The motile sporozoites approach a potential host cell anterior end first and actively 
invade  the  cell  (Fayer  et  al.,  1997;  Tzipori  and  Widmer,  2000;  Wetzel  et  al.,  2005). 
Following the adherence of the anterior end of the sporozoite to the luminal surface of an 
epithelial cell in the microvilli, each sporozoite matures into a trophozoite.  
  Trophozoites undergo asexual proliferation by merogony to form meronts, marking 
the  beginning  of  the  asexual  part  of  the  life  cycle  (Fayer  et  al.,  1997).  Two  types  of 
meronts have been described in the Cryptosporidium life cycle (Current and Reese, 1986). 
Type I meronts develop six or eight nuclei, each incorporated into a merozoite, which are 
released from  the  parasitophorous  vacuole once mature. The mature type  I merozoites 
infect other host cells and either recycle as type I meronts and merozoites, or develop into 45 
 
a  type  II  meront  which  produces  four  merozoites  (Current,  1990;  Current  and  Garcia, 
1991, Fayer et al., 1997; Tzipori and Widmer, 2000). Following the release of mature type 
II  merozoites,  a  new  host  cell  is  invaded  and  the  sexual  phase  in  the  life  cycle 
(gametogeny)  is  initiated.  Type  II  merozoites  either  enlarge  and  develop  into  a  uni-
nucleate macrogamont or undergo cellular fission forming a multi-nucleated microgamont 
containing 14-16 non-flagellated microgametes.  
  Microgametes are released from ruptured microgamonts; they penetrate host cells 
containing macrogamonts and subsequently fertilize the macrogamont forming a zygote 
(Current,  1990;  Current  and  Garcia,  1991;  Fayer  et  al.,  1997).  The  zygote  undergoes 
sporogony,  during  which  both  thin-walled  and  thick-walled  oocysts  are  formed,  each 
containing four potentially infective sporozoites. Thin walled oocysts remain within the 
host leading to autoinfection and persistent infections, thick walled oocysts are shed in the 
faeces (Current, 1991; Tzipori and Widmer, 2000). 
 
1.7.2 Developmental stages in the life cycle 
 
In  comparison  to  most  other  enteric  protozoa,  the  developmental  stages  of 
Cryptosporidium  are  small  (1-6  µm).  Among  the  coccidia,  Cryptosporidium  has  the 
smallest oocyst (5.0 x 4.5 µm for C. parvum). Recent advances in the in vitro cultivation of 
Cryptosporidium  have  revealed  that  this  parasite  can  complete  its  life  cycle  in  media 
devoid of host cells (Hijjawi et al., 2004) (Fig 1.3) (see section 1.6.2), which contradicts 
current beliefs that Cryptosporidium is an obligate intracellular parasite (Fig 1.4).  
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Figure 1.4. Diagrammatic representation of the Cryptosporidium life cycle (Barta and 
Thompson, 2006). 
 
 
 
1.7.2.1 Oocysts 
Oocysts  are  spherical  to  ovoid  in  shape,  fully  sporulated  containing  four 
sporozoites  and  a  residuum.  The  oocyst  residuum  contains  a  large  lipid  body  and  a 
crystalline protein body alongside amylopectin granules (Harris et al., 2004). The oocyst 
wall is smooth, measures approximately 50 nm in thickness, is composed of two electron 
dense layers separated by an electron-lucent space (Fayer et al., 1990; Harris and Petry, 
1999) and is extremely resistant to chemical and mechanical disruption. The oocysts of 47 
 
Cryptosporidium are unique in having a suture at one end, which dissolves during the 
excystation process. Cryptosporidium lacks sporocysts and other morphological structures 
such  as  a  micropyle  and  polar  granules,  which  are  often  observed  in  other  coccidian 
oocysts (Arrowood, 2002). Amylopectin found in the residuum has been identified as the 
carbohydrate storage in different life cycle stages of a number of apicomplexans (Alvarez-
Pellitero et al., 1997; Speer et al., 1998, 1999; Medina et al., 2001) and is used as an 
energy reserve for excystation and invasion of host cells (Vetterling and Doran, 1969). 
 
1.7.2.2 Sporozoites 
Sporozoites of Cryptosporidium have a characteristic crescent shape, with a slightly 
pointed anterior end and a rounded posterior end containing a prominent nucleus (Hijjawi, 
2003). Sporozoites lie parallel to each other within the oocyst and upon excystation escape 
through a slit-like opening created upon dissolution of the unique suture in the oocyst wall 
(Reduker et al., 1985; Dubey et al., 1990). Excysted sporozoites move by flexing and 
gliding, and eventually penetrate the host cell (Current and Reese, 1986). 
 
1.7.2.3 Trophozoites 
Trophozoites are circular to oval shaped, uni-nuclear stages which represent the 
transitional stage between sporozoites and merozoites. Traditional belief is that individual 
trophozoites  undergo  multiple  mitotic  divisions,  resulting  in  the  formation  of  type  I 
meronts. However, observations in cell and cell free culture have revealed trophozoites 
forming aggregates of two or more, and occasionally as many as 20 trophozoites, prior to 
mitotic divisions, resulting in meront stages of variable sizes (Hijjawi et al., 2002, 2004; 
Thompson et al., 2005). 48 
 
1.7.2.4 Meronts 
Two different types of meronts have been described (type I and type II) (Current 
and Reese, 1986; Hijjawi et al., 2001). The development of type I meronts occurs as a 
result  of  mitotic  division  of  trophozoites  and  aggregates  of  trophozoites,  as  well  as 
aggregates of ‘recycled’ merozoites released from type I meronts and they appear as grape 
like clusters, variable in size (Hijjawi et al., 2001, 2002, 2004). Initial descriptions of type 
I meronts state that each develops six or eight merozoites, and four merozoites from type II 
meronts (Current, 1990; Current and Garcia, 1991, Fayer et al., 1997; Tzipori and Widmer, 
2000). The number of merozoites produced has been used as a means of differentiating 
between type I and type II meronts (Thompson et al., 2005). However, recent observations 
demonstrate that the number of merozoites produced by each meront (type I and type II) is 
variable,  depending  on  the  initial  size  of  the  meront,  and  is  an  unreliable  means  of 
differentiating between meront types (Hijjawi et al., 2004). Merozoites released from type 
I  meronts  are  actively  motile,  circular  to  oval  in  shape  and  are  small  in  size.  These 
merozoites enlarge and clump together to forming a rosette-like shape. Type II meronts 
produce two different types of merozoites, broadly spindle shaped with pointed ends or 
rounded in shape (Hijjawi et al., 2001, 2002, 2004; Thompson et al., 2005).  
 
1.7.2.5 Merozoites 
Merozoites have a central nucleus and are motile, displaying gliding and flexing 
movements.  Type  I merozoites  are small in  size and are very  active;  however type  II 
merozoites  are  larger  and  are  more  sluggish.  Type  I  merozoites  are  either  recycled, 
clustering together to produce more type I meronts and hence amplifying the number of 
type I merozoites; or give rise to type II meronts. Type II merozoites differentiate into 
micro- and macrogamonts (Hijjawi et al., 2001, 2002, 2004; Thompson et al., 2005). 49 
 
1.7.2.6 Microgamonts 
Microgamonts  become  multi-nucleate  and  each  nucleus  is  incorporated  into  a 
microgamete (Fayer et al., 1997). Microgametes appear to bud from the surface of the 
microgamont and appear as bullet shaped and display a jerky, gliding movement (Current 
and Reese, 1986). Hijjawi et al., (2004) described microgamonts in cell free culture as 
circular in shape and dark in appearance. 
 
1.7.2.7 Macrogamonts 
Macrogamonts are typically large in size (4 x 4µm – 5 x 4µm) and possess a large 
peripheral  nucleus.  Microgametes  have  been  observed  adhering  to  the  surface  of 
macrogamonts  and  have  also  been  reported  being  visualised  within  a  microgamont, 
representing the fertilisation process (Hijjawi et al., 2004; Thompson et al., 2005). Once 
fertilisation is complete, a zygote (or unsporulated oocyst) is formed, which then matures 
into a sporulated oocyst containing four sporozoites. 
 
1.7.2.8 Novel extracellular stages 
In a study by Hijjawi et al., (2002), the presence of previously undescribed  C. 
parvum  and  C.  andersoni  extracellular  stages  were  observed  in  in  vitro  cell  culture. 
Cryptosporidium andersoni extracellular stages were also observed in cattle faeces and 
were isolated using laser microdissection and subsequently genotyped. This was the first 
report  of  an  extracellular  developmental  stage  in  the  life  cycle  of  Cryptosporidium, 
contradicting current beliefs that this parasite is an obligate intracellular organism. These 
extracellular  stages  were  described  as  gregarine-like  due  to  their  similarities  to  stages 
found  in  the  life  cycle  of  gregarines  (Manwell,  1977;  Levine,  1985)  and  have  been 50 
 
subsequently reported by Rosales et al., (2005). The presence of these stages in the life 
cycle  of  Cryptosporidium  provides  additional  evidence  for  the  closer  relationship  to 
gregarine  protozoa  than  coccidia.  The  origin  and  fate  of  these  stages  in  the 
Cryptosporidium life cycle is unclear. 
 
1.8 CRYPTOSPORIDIUM METABOLISM 
 
The complete C. parvum genome (Abrahamsen et al., 2004) and partial C. hominis 
genome (Xu et al., 2004) have been sequenced, facilitating a better understanding of the 
metabolic  activities  of  this  parasite  and  revealing  many  unexpected  and  unique 
biochemical  activities.  The  genome  of  this  parasite  is  highly  compact  and  encodes  a 
streamlined metabolism in which a great number of conventional pathways are completely 
lost  or  simplified.  Cryptosporidium  parvum  has  evolved  to  maximize  the  number  of 
biosynthetic molecules that are salvaged from the host and has retained the capacity for 
biosynthesis of only those metabolites that are unavailable, or require too much energy to 
transport (Abrahamsen et al., 2004).  
  In  contrast  to  other  apicomplexans,  C.  parvum  lacks  both  mitochondrion  and 
apicoplast genomes. Nuclear genes for DNA replication and translation are also absent 
(Zhu et al., 2000b; Abrahamsen et al., 2004). A number of putative mitochondrial proteins 
were identified, however, the parasite lacks a tricarboxylic acid (TCA) cycle and much of 
the oxidative phosphorylation pathway, indicating it does not rely on complete oxidation 
and  respiratory  chains  for  synthesizing  adenosine  triphosphate  (ATP).  A  complete 
glycolytic  pathway  is  present,  however,  atypical  enzymes  are  used  to  maximize  ATP 
conversion (Abrahamsen et al., 2004). Cryptosporidium parvum is unable to synthesise 51 
 
most basic metabolites, including amino acids, fatty acids and nucleotides, and instead 
relies  on  scavenging  from  the  host  to  meet  its  basic  metabolic  requirements  via  an 
extensive collection of amino acid and sugar transporters and salvage pathways. Genome 
analysis (Abrahamsen et al., 2004) confirmed previous hypotheses that this parasite relies 
solely on cytosolic glycolysis to fulfill its energy needs (Denton et al., 1996; Entrala and 
Mascaro, 1997). Cryptosporidium parvum can utilise amylopectin during the glycolysis 
(Thompson  et  al.,  2005)  and  also  possesses  an  alternative  oxidase  (AOX)  pathway 
(Roberts et al., 2004; Suzuki et al., 2004). 
 
1.9 SURVIVAL OF CRYPTOSPORIDIUM IN THE ENVIRONMENT 
 
The robust nature of Cryptosporidium has long been recognised and oocysts are 
capable of surviving in the environment for long periods. In general, aged oocysts are more 
susceptible  to  environmental  pressures  (Carey  et  al.,  2004).  Many  studies  have  been 
conducted to assess the survival of Cryptosporidium under environmental conditions and 
the  effects  of  temperature  and  desiccation  on  the  survival  of  oocysts  has  been  well 
documented. Throughout these studies, various techniques have been applied to assess the 
viability and/or infectivity of Cryptosporidium oocysts, these include: infectivity of animal 
models, in vitro excystation, inclusion/exclusion of vital dyes and cell culture. Each of 
these  methodologies  have  varying  sensitivities,  furthermore,  different  strains  of 
Cryptosporidium  and  oocysts  of  varying  age  have  been  used  throughout  these  studies 
resulting in differing and sometimes conflicting results. 
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1.9.1 Application of laboratory techniques to assess survival of oocysts 
 
1.9.1.1 Animal infectivity models 
The  neonatal  mouse  model  is  the  most  direct  method  to  assess  viability  and 
infectivity and has been widely used in the assessment of oocyst inactivation of C. parvum 
(Fayer and Nerad, 1996; Bukhari et al., 1998; Fayer et al., 1998; Rochelle et al., 2002; 
Carey et al., 2004). This method is considered the ‘gold standard’ for the assessment of 
Cryptosporidium oocyst infectivity; however, it is expensive to perform.  
 
1.9.1.2 In vitro excystation 
Oocyst viability can be assessed through in vitro excystation, whereby oocysts are 
exposed to conditions representing those found within the gut. These conditions include 
exposure to appropriate temperatures, pH levels, bile salts and pancreatic enzymes. After 
the treatment, the ratio of sporozoites to completely or partially excysted oocysts can be 
estimated by microscopy (Carey et al., 2004). This technique is useful for estimating the 
proportion of potentially viable and infectious oocysts within a sample, however it has 
been found to overestimate infectivity (Black et al., 1996; Bukhari et al., 1998).  
 
1.9.1.3 Fluorogenic dyes 
Some studies have used vital dye staining to determine oocyst survival (Robertson 
et al., 1992; Chauret et al., 1998; Freire-Santos et al., 2000; Walker et al., 2001; Nichols et 
al., 2004). This method assesses viability by the inclusion or exclusion of two fluorogenic 
dyes, 4',6-diamidino-2-phenylindole (DAPI) and Propidium Iodide (PI). Dead oocysts will 53 
 
either include PI (PI
+) or are observed as non-refractive empty oocysts and viable oocysts 
will include DAPI (DAPI
+) and exclude PI (PI
-) (Robertson et al., 1993). Campbell et al., 
(1992) and Robertson et al., (1993) found DAPI and PI determination of oocysts viability 
correlated well with in vitro excystation, however, this method has also been found to 
overestimate infectivity (Black et al., 1996; Bukhari et al., 1998). Furthermore, research 
has also demonstrated that permeability of oocysts to DAPI is a dynamic state which may 
be either increased or decreased by selected treatments (Robertson et al., 1992; Rose et al., 
1992). 
 
1.9.1.4 Mammalian cell culture 
  Another technique for assessing oocyst infectivity is the cell culture assay for both 
C. parvum and C. hominis (Current and Haynes, 1984; Upton et al., 1994b; Di Giovanni et 
al., 1999) Evaluation of this technique using human ileocecal adenocarcinoma (HCT-8) 
cells has shown it to be equivalent to the gold standard neonatal mouse infectivity assay 
(Rochelle et al., 2002; Slifko et al., 2002). However, a study by Neumann et al., (2000) 
showed  that  excystation  followed  by  cell  culture  is  a  poor  indicator  of  C.  parvum 
infectivity because a population of oocysts that did not excyst was still capable of initiating 
infection in mice. The intensive labor required for the growth and maintenance of the cell 
monolayer  and  prolonged  incubation  period  represent  significant  disadvantages, 
particularly in confirming a potential waterborne outbreak (Carey et al., 2004).  
  A range of methods have been applied for the analysis of cell culture infection, 
these include; PCR (Rochelle et al., 1997a; LeChevallier et al., 2000), reverse transcription 
PCR (RT-PCR) (Di Giovanni et al., 1999; Rochelle et al., 1997b), immunofluorescence 54 
 
microscopy (Slifko et al., 1997), colourometric in situ hybridisation (Rochelle et al., 2002) 
and real-time PCR (MacDonald et al., 2002; Keegan et al., 2003). 
 
1.9.1.5 Reverse transcription PCR (RT-PCR) 
RT-PCR  involves  first  the  production  of  cDNA  from  the  mRNA  template  by 
reverse transcription, followed by amplification of a specific fragment of cDNA by PCR. 
As  only  viable  organisms  can  produce  mRNA,  this  method  selectively  detects  viable 
organisms (Carey et al., 2004).  
  An RT-PCR assay used by Widmer et al., (1999a) detected a gradual decline in ß-
tubulin mRNA levels over a 20-week period for oocysts stored at room temperature. These 
results correlated with a loss of oocyst viability in a neonatal mouse infectivity assay. A 
study by Jenkins et al., (2000) showed RT-PCR directed to C. parvum aminoglucosidase 
mRNA was useful for discriminating between viable and non-viable oocysts. There was a 
positive  relationship  between  mouse  infectivity  and  the  RT-PCR  signal.  Stinear  et  al., 
(1996) and Rochelle et al., (1997b) both successfully amplified heat shock protein (hsp70) 
mRNA in an RT-PCR to detect viable C. parvum oocysts. Fontaine and Guillot (2003), 
developed a real-time RT-PCR for the detection and quantification of C. parvum oocysts 
using  18S  rRNA,  this  study  determined  that  18S  rRNA  may  not  be  associated  with 
viability after heat treatment (see section 1.9.1.6). 
 
1.9.1.6 Fluorescent in situ hybridisation (FISH) 
The FISH technique employs fluorescently labeled oligonucleotide probes targeted 
to specific sequences of ribosomal RNA (rRNA) (O’Donoghue, 1995; Lindquist, 1997). 55 
 
Regions  of  rRNA  evolve  at  different  rates  and  target  sequences  range  from  highly 
conserved to highly variable (Amman et al., 1995) allowing the degree of specificity of a 
probe to be designed. The use of rRNA as an indicator of viability has been mostly studied 
in bacteria (Amann et al., 1995; McKillip et al., 1998) and has been identified as ideal 
targets for fluorescently labeled probes for the following reasons; a denaturation step is not 
required during the procedure as the target region is often at least partially single stranded, 
rRNA has a short half-life and should only be present in a high copy number in viable or 
recently viable cells (Amman et al., 1995; Vesey et al., 1995, 1998).  
  There are varied opinions in the literature on the use of FISH for assessing viability 
of Cryptosporidium. Studies have shown that the ribosomal genes of Cryptosporidium are 
present  in  low  numbers  and  are  dispersed  on  several  chromosomes.  Cryptosporidium 
parvum has only 5 rDNA units, which are present on at least 3 chromosomes (Le Blancq et 
al., 1997; Widmer et al., 1999b). Furthermore, a study on the stability of Cryptosporidium 
18S rRNA and rDNA showed rRNA molecules were quite stable for at least 1 hour after 
post  lysis  heat  treatment  and  rRNA  was  still  present  even  after  4  hours  of  treatment 
suggesting  that  18S  rRNA  may  not  be  associated  with  viability  after  heat  treatment 
(Fontaine and Guillot, 2003).   
  Vesey  et  al.,  (1995)  conducted  the  first  study  utilizing  the  FISH  technique  for 
assessing Cryptosporidium viability and reported that oocysts that contained fluorescing 
sporozoites after hybridisation with the probes were considered viable and oocysts that did 
not fluoresce, dead. Later, Vessey et al., (1998) compared oocyst viability using FISH with 
a  specific  C.  parvum  probe  with  in  vitro  excystation  and  reported  that  percentage 
viabilities determined by the two methods showed a significantly high correlation (r
2= 
0.998,  P  <0.05).  Other  studies  have  shown  this  technique  to  be  a  highly  specific  and 
sensitive  assay  for  the  detection  of  viable  Cryptosporidium  oocysts  in  faecal  and 56 
 
environmental samples (Jenkins et al., 2003; Surl et al., 2003; Graczyk et al., 2003; Lemos 
et al., 2005; Bednarska et al., 2007) 
  In contrast, a study by Smith et al., (2004) established that the determination of 
viability  using  rRNA  targeted  FISH  probes  is  not  straightforward.  FISH  fluorescence 
signals  were  visually  detected  for  up  to  96  hours  after  oocysts  had  been  heat  killed, 
demonstrating  that  FISH  may  overestimate  viability  of  oocysts  recently  rendered 
nonviable. Additionally, results indicated that nonviable, but permeabilised oocysts may 
continue  to  show  strong  FISH  positive  results  for  up  to  4  days,  hence  there  is  some 
question as to the accuracy of FISH for determination of C. parvum viability (Smith et al., 
2004). 
 
1.9.2 Oocyst survival in the terrestrial environment 
 
Once oocysts are excreted, they can be released into the terrestrial environment 
from  faeces  by  physical  processes  such  as  rainfall  events  (Davies  et  al.,  2004).  After 
dispersal from the faecal matrix, inactivation may be dependent on the physical, chemical 
and biological properties of the soil environment (Ferguson et al., 2003). Oocysts on the 
soil surface are subject to high temperatures and desiccation, which can be lethal, however, 
within the soil column, oocysts are to a large extent protected from inactivation depending 
on soil temperature and soil texture. Oocysts within the soil column are tied away from 
host ingestion until rainfall events can mobilize them (King and Monis, 2006). 
  Extreme temperatures may be reached on the soil surface or within faecal material, 
which adversely affects oocyst viability and infectivity (Fayer, 1994; Harp et al., 1996; 57 
 
King et al., 2005; Moriarty et al., 2005) (see section 1.9.4). Oocyst survival on the soil 
surface is also greatly limited due to the process of desiccation (King and Monis, 2006). 
Reports show that desiccation is lethal to oocysts with only 3 and 5% remaining viable 
after being air dried at room temperature for 2 and 4 h respectively (Robertson et al., 1992; 
Deng and Cliver, 1999).  
  Temperature was identified as the critical factor affecting oocyst survival within the 
soil matrix (Jenkins et al., 2002; Davies et al., 2005), indicating that oocysts at 4°C within 
the soil profile may remain infectious for very long periods, perhaps years, regardless of 
soil texture. Although it is unclear how soil texture is able to influence oocyst viability, it 
was identified as being important for oocyst survival in studies by Jenkins et al., (2002) 
and Davies et al., (2005). Soil moisture was found not to be influential on oocyst survival 
(Jenkins et al., 2002; Kato et al., 2004; Davies et al., 2005), however, Nasser et al., (2007) 
suggested oocysts in a loam soil can become susceptible to dehydration.  
  Vegetated surfaces and buffered strips have been identified as very effective in 
retaining  oocyst  and  reducing  Cryptosporidium  in  surface  runoff  into  drinking  and 
irrigation water supplies (Davies et al., 2004; Tate et al., 2004; Trask et al., 2004; Atwill et 
al., 2006). 
 
1.9.3 Oocyst survival in environmental waters 
 
Water-borne Cryptosporidium oocysts, including seawater, are able to survive at a 
range of temperatures (Robertson et al., 1992; Chauret et al., 1998; Fayer et al., 1998a, 
1998b; Freire-Santos et al., 1999, 2000; Jenkins et al., 2000) and studies have shown that 58 
 
oocysts incubated in water in the laboratory at temperatures ranging from 0 to 20°C can 
maintain high levels of infectivity for up to 6 months (Fayer et al., 1998; Pokorny et al., 
2002; Jenkins et al., 2003; Nichols et al., 2004; King et al., 2005). Temperatures of 20°C 
and above, however, correspond with decreased oocyst infectivity (Fayer et al., 1998a; 
Nichols et al., 2004; King et al., 2005). The ability of Cryptosporidium to initiate infection 
has been linked to finite carbohydrate energy reserves in the form of amylopectin, which 
are  consumed  in  direct  response  to  ambient  environmental  temperatures  (Fayer  et  al., 
1998). A recent study by King et al., (2005) employed assaying for ATP production in 
oocysts and cell culture-PCR assays to demonstrate that temperature inactivation at higher 
temperatures  is  a  function  of  increased  metabolic  activity  of  oocysts,  resulting  in  a 
depletion of energy stores. 
  Oocyst survival in seawater has been investigated with significant reductions in 
oocyst  viability identified using DAPI/PI vital  dyes  (Robertson  and Gjerde, 2004) and 
significant reductions in infectivity to neonatal BALB/C mice were observed when oocysts 
were subjected to concentrations of 20ppt and higher (Fayer et al., 1998b). Salinity, time 
and salinity-time interactions have been described as important factors affecting infection 
intensity in neonatal CD-1 mice (Freire-Santos et al., 1999). Strong synergistic interactions 
between salinity and temperature were identified by Fayer et al., (1998b), with oocysts 
held at 20°C remaining infectious for 12 weeks at salinities of 0 and 10 ppt, 4 weeks at 20 
ppt and 2 weeks at 30 ppt. These findings demonstrate that although salinity can have a 
pronounced  effect  on  oocyst  infectivity,  oocysts  could  survive  long  enough  in  marine 
waters to be removed by filter feeders (see section 1.9.5) or marine animals (Robertson et 
al., 1992; Fayer et al., 1998b; Friere-Santos et al., 1999; Tamburrini and Pozio, 1999).  
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1.9.4 Oocyst survival at extreme temperatures 
 
Extreme temperatures adversely affect oocyst viability and infectivity and oocysts 
are particularly susceptible to heat shock (Fayer, 1994; Harp et al., 1996; King et al., 2005; 
Moriarty et al., 2005). Oocysts may encounter such conditions within deposited faecal 
material. A study by Li et al., (2005) demonstrated bovine faecal material, when exposed 
to  ambient  temperatures  of  mid-20  to  30°C  under  direct  exposure  to  solar  radiation, 
exhibited temperature peaks over 40°C and up to 70°C (Li et al., 2005). In the same study, 
a thermocycler was used to emulate diurnal cycles found in bovine faeces and it was found 
that oocysts lost infectivity within the first diurnal cycle (Li et al., 2005). 
  Freezing oocysts at temperatures below -20°C for greater than 24 hours renders 
them non-viable (Robertson et al., 1992; Fayer and Nerad, 1996). However, oocysts were 
able to remain viable and infectious after being frozen at -10°C for up to 168 h, -15°C for 
up to 24 h and at -20°C for up to 8 h (Fayer and Nerad, 1996). This demonstrates the 
ability of oocysts to remain viable within ice cubes, which are typically frozen between -
15°C and -20°C (Carey et al., 2004). Kato et al., (2002) found that 99% of oocysts that 
were frozen at -10°C in soils became inactivated within 50 days. Robertson and Gjerde 
(2004), reported that oocysts did not persist in a Norwegian terrestrial environment over 
winter and they postulated that the sheer forces generated during the freeze-thaw cycles 
disintegrated the parasites. Fayer and Nerad (1996), postulated that oocysts may be able to 
survive for weeks or perhaps months in soils where temperatures were just below freezing, 
but were insulated by a cover of snow; this prediction was supported in a study by Jenkins 
et al., (1996), in which oocysts were found to remain viable for 39 days in field soil.  
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1.9.5 Biotic antagonism and predation 
 
The level of heterotrophic bacteria in natural waters was found to influence oocyst 
survival  (Heisz  et  al.,  1997).  A  study  by  Zuckerman  et  al.,  (1997),  demonstrated 
degradation  of  oocysts  in  the  presence  of  Serratia  marcescens,  a  bacterium  with  high 
chitinolytic activity. Survival of oocysts was  found to be greater in membrane filtered 
water  than  in  unfiltered  water  (Chauret  et  al.,  1998),  suggesting  that  oocysts  were 
adversely affected by other organisms.  
  Rotifers, ciliates, amoebae, gastrotrichs and platyhelminths have been reported to 
ingest oocysts (Fayer et al., 2000b; Harvey, 2004; Huamanchay et al., 2004; Stott et al., 
2001, 2003; Gómez-Couso et al., 2006a), however, there is minimal information on the 
effect that predation has on either the removal of oocysts from the environment, or on 
oocyst infectivity (Fayer et al., 2000; King and Monis, 2006).  
  Under experimental conditions, Méndez–Hermida et al., (2006) demonstrated that 
the brine shrimp Artemia is capable of ingesting the oocysts of Cryptosporidium. This 
microcrustacean is the most common live food used in larviculture of fish and shellfish 
(Méndez–Hermida  et  al.,  2006).  A  further  study  by  Méndez–Hermida  et  al.,  (2007) 
demonstrated that Cryptosporidium oocysts incubated with Artemia franciscana remained 
viable and therefore potentially infectious to respective hosts. These results demonstrate 
that Artemia may act as a vehicle of infection for Cryptosporidium. 
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1.9.6 Biofilms 
 
The transport of Cryptosporidium oocysts in the environment can be influenced by 
interactions  with  surface  attached  microbial  communities  (biofilms).  Biofilms  are 
ubiquitous and constitute the dominant mode of microbial life in most aquatic ecosystems 
where they can form on rocks, plants and sediments and are also prevalent in waste water 
treatment  systems  (Searcy  et  al.,  2006;  Battin  et  al.,  2007).  Wherever  free-swimming 
microbial cells encounter surfaces, they can switch from a planktonic lifestyle to form 
sessile communities (Battin et al., 2007), that are encased in a heterogeneous matrix of 
extracellular  polymeric  substances  (EPS)  composed  of  polysaccharides,  proteins,  lipids 
and  nucleic  acids  (Costerton  et  al.,  1995;  Flemming,  1995).  There  is  little  published 
literature  addressing  the  interaction  of  oocysts  with  biofilms  (Angles  et  al.,  2007), 
however, those studies which have been conducted, illustrate that Cryptosporidium oocysts 
are readily incorporated into biofilms and they are able to persist and subsequently detach 
from biofilms (Rogers and Keevil, 1995; Keevil, 2003; Searcy et al., 2006).  
  Searcy  et  al.,  (2006)  demonstrated  biofilms  formed  from  monocultures  of  the 
bacterium  Psuedomomas  aeruginosa,  gave  a  greater  surface  deposition  of  C.  parvum 
oocysts  than  did  clean  surfaces.  Although  the  use  of  monoculture  biofilms  does  not 
represent complex biofilms communities, it does illustrate that biofilms can promote the 
attachment of oocysts to surfaces (Angles et al., 2007). A study using a mixed population 
of  microorganisms  isolated  from  reservoir  water  showed  that  the  majority  of  oocysts 
introduced into a laboratory scale  reactor  attached in  clusters in  the denser regions  of 
biofilms (Rogers and Keevil, 1995), with a substantial proportion of oocysts remaining 
viable for at least 15 days (Rogers et al., unpublished). Other research has shown that C. 62 
 
parvum oocysts adhere to potable water biofilms (Keevil, 2003). High concentrations of 
oocysts  in  these  biofilms  were  maintained  over  several  months  and  many  were  DAPI 
positive indicating viable sporozoites. Recovery of oocysts from the biofilms after several 
months revealed oocysts were still able to excyst and were infective to an animal model 
(Keevil, 2003). The author’s hypothesized that biofilms can act as a sponge, concentrating 
low numbers  of oocysts in  properly treated  water and  a sudden sloughing of biofilms 
containing a bolus of oocysts may be of appropriate dose to cause infection. The trapping 
of Cryptosporidium in biofilms can serve as an environmental reservoir of disease and 
deposited  pathogens  may  be  released  back  to  the  water  by  detachment  or  biofilm 
sloughing.  
 
1.10 TRANSMISSION OF CRYPTOSPORIDIUM 
 
Cryptosporidium infections are acquired by the ingestion or inhalation of materials 
contaminated  with  infectious  oocysts.  Routes  of  transmission  can  involve:  direct  or 
indirect contact from person to person, animal to animal, or animal to human; through the 
ingestion of contaminated food or water; or, via vectors such as arthropods or even birds 
may play a role as mechanical agents of transmission (Thompson et al., 2005).  
  Faeces deposited on the ground are subject to rain and wind, as well as mechanical 
transport hosts, which can transport oocysts across or through soil.  Contamination of soil 
and  surface  water  with  oocysts  can  ultimately  lead  to  contamination  of  fresh  foods, 
drinking  water  and  recreational  water  and  contamination  of  seawater  may  result  in 
contaminated seafood such as oysters, clams and mussels. 63 
 
1.10.1 Mechanical transport hosts 
 
Due to contact with potentially contaminated faecal material, birds, beetles, flies, 
cockroaches and perhaps other invertebrates have the ability to spread and disseminate 
oocysts of Cryptosporidium to otheruncontaminated areas mechanically (Graczyk et al., 
1996a, 1997, 1999a, b, 2005; Smith et al., 1993, 1998; Mathieson and Ditrich, 1999) 
  Wild filth flies trapped in a barn, where a calf had cryptosporidiosis and house flies 
exposed under laboratory conditions to cattle faeces containing C. parvum oocysts, were 
found to harbor oocysts in their excreta and on their external surfaces (Graczyk et al., 
1999a,  b).  Oocysts  have  been  recovered  from  the  intestinal  tract  of  synanthropic  flies 
(Graczyk  et  al., 2003)  and from  flies  collected from  a cattle farm and a land fill  site 
(Szostakowska et al., 2004).  
  After ingestion of C. parvum oocysts, dung beetles were found to excrete some 
intact oocysts, although most were destroyed by digestion. Oocysts were also recovered 
from the external surfaces of beetles, suggesting they may be capable of disseminating 
oocysts in the environment (Mathieson and Ditrich, 1999). Cockroaches collected from a 
household where a child had cryptosporidiosis, were found to have what appeared to be 
oocysts of C. parvum in their intestinal tracts, suggesting the cockroaches played a role in 
dissemination (Zerpa and Huicho, 1994). 
 
Following the isolation of Cryptosporidium oocysts of unknown species from gulls 
in the United Kingdom, it was postulated that birds could disseminate oocysts over wide 
areas (Smith et al., 1993). Subsequently, it was demonstrated that infectiveoocysts were 64 
 
passed through the intestinal tract for nearly 1 week following the ingestion of C. parvum 
oocysts by Canada geese (Graczyk et al., 1997a, 1998). Viable C. parvum oocysts were 
collected from the faeces of Canada geese in fields where they rested along their migratory 
path  (Graczyk  et  al.,  1998)  and  Zhou  et  al.,  (2004),  also  detected  the  presence  of  C. 
hominis and C. parvum in the faeces of Canada geese by PCR analysis. However it was 
hypothesized the presence of these species in the geese was due to mechanical transport 
not infection (Graczyk et al., 1997a, 1998; Zhou et al., 2004) 
 
1.10.2 Foodborne transmission 
 
There have been few reports of food related outbreaks of cryptosporidiosis, as they 
are difficult to document and are also greatly under-reported because individual and small 
group outbreaks are less likely to be recognised (Fayer et al., 2004). 
  As water supplies directly affect the food industry, contaminated irrigation waters 
used in agricultural and food industry practices can potentially contaminate foods. Cool, 
moist  vegetables provide an optimal environment  for survival  of  Cryptosporidium  and 
oocysts have been found on the surface of raw vegetables from the market place (Ortega et 
al., 1991; Monge and Chinchilla, 1996; Robertson and Gjerde, 2001). Vegetables may also 
become contaminated from fertilizers, transport hosts (birds, flies etc.), by soiled hands of 
farm workers, produce handlers, or food workers and from contaminated surfaces where 
vegetables are packed, stored, sold or prepared (Fayer et al., 2000; Slifko et al., 2000). 
  In  1993,  an  outbreak  in  Maine  (U.S.A.)  in  which  160  people  developed 
cryptosporidiosis, was associated with consumption of apple cider (Millard et al., 1994). 65 
 
During this outbreak, C. parvum oocysts were isolated directly from apple cider and from a 
stool specimen of a calf residing on the farm that supplied the apples. A cryptosporidiosis 
outbreak involving 50 school-children was attributed to milk produced by a local small 
scale  farmer  using  a  faulty  pasteurizer  (Gelleti  et  al.,  1997).  In  2002,  another 
cryptosporidiosis outbreak in Australia was linked to unpasteurised cow milk (Harper et 
al., 2002). Foodborne outbreaks have been attributed to contamination from food handlers 
who had been in direct contact with infected persons, or had been infected themselves, 
however no genotyping was undertaken to confirm the source (Besser-Wiek et al., 1996; 
Quinn et al., 1997; Quiroz et al., 2000). 
  Large quantities of oocysts find their way into the ocean from precipitation events 
or  through  their  discharge  of  treated  and  untreated  waste  products,  resulting  in 
contamination of marine waters. These oocysts may be removed by filter feeders or infect 
marine animals (Robertson et al., 1992; Fayer et al., 1998b; Friere-Santos et al., 1999; 
Tamburrini and Pozio, 1999; Robertson, 2007; Srisuphanant et al., 2009). Shellfish filter 
large volumes of water and are able to concentrate viable oocysts from their environment 
and have been suggested as reservoirs for zoonotic transmission, posing a threat to human 
health as well as marine wildlife that may feed on these shell fish (Fayer et al., 1999; 
Tamburrini and Pozio, 1999; King and Monis, 2006; Robertson, 2007; Srisuphanant et al., 
2009).  This  is  supported  by  the  identification  of  Cryptosporidium  species  in  marine 
mammals (Fayer et al., 2004; Applebee et al., 2005; Hughes-Hank et al., 2005), several 
species of fish (Sitja-Bobadilla et al., 2005; Ryan et al., 2003) and additionally, infective 
oocysts have been detected and recovered from filter feeding shellfish, such as oysters, 
clams and mussels worldwide (Fayer et al., 1998b, 2002; Friere-Santos et al., 2000b, 2001; 
Gomez-Couso et al., 2003, 2004, 2006; Giangaspero et al., 2005; MacRae et al., 2005; Li 
et al., 2006; Srisuphanant et al., 2009). 66 
 
  Some  molecular  studies  have  been  undertaken  for  species  classification  of 
Cryptosporidium oocysts detected in naturally contaminated marine bivalves. Generally, 
C. parvum was found to be the predominant species detected (Gomez-Bautista et al., 2000; 
Fayer et al., 2002, 2003; Gomez-Couso et al., 2004; Giangaspero et al., 2005; Traversa et 
al., 2005;Miller et al., 2005; Li et al., 2005; Gomez-Couso et al., 2006; Graczyk et al., 
2007). Other species detected include C. hominis (Lowery et al., 2001; Fayer et al., 2002, 
2003; Gomez-Couso et al., 2004), C. meleagridis (Fayer et al., 2003), C. baileyi (Fayer et 
al., 2002), C. felis (Miller et al., 2005) and C. andersoni (Miller et al., 2005). 
 
1.10.3 Waterborne transmission 
 
Cryptosporidium has a high potential for waterborne transmission for many reasons 
including:  its  worldwide  distribution,  environmentally  robust  oocysts,  ability  to  cause 
infection at a low dose, its prevalence in water sources and resistance to conventional 
water treatments (see section 1.8) and the parasite is recognized as a serious public health 
issue world-wide (Rose, 1997; Fayer, 2000, 2004; Carey et al., 2004).   
At least 325 water-associated outbreaks of parasitic protozoan disease have been 
reported. North American and European outbreaks accounted for 93% of all reports and 
nearly two-thirds of outbreaks occurred in North America. Over 30% of all outbreaks were 
documented  from  Europe,  with  the  UK  accounting  for  24%  of  outbreaks,  worldwide. 
Cryptosporidium accounts for 50.8% of outbreaks (165) (Karanis et al., 2007). 
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1.10.3.1 Transmission via drinking water 
Cryptosporidium  oocysts  have  been  found  in  untreated  wastewater,  filtered 
secondarily  treated  waste  water,  activated  sludge  effluent,  combined  sewer  overflows, 
ground water, surface  water and treated drinking water (LeChevallier  et  al., 1991a, b; 
Wallis  et  al.,  1996;  LeChevallier  and  Norton,  1996;  Rose  et  al.,  1997;  Smith,  1998; 
Gennaccaro et al., 2003; Ryan et al., 2005; Karanis et al., 2007).  
  In  the  UK,  USA  and  Canada,  a  significant  number  of  outbreaks  have  been 
associated with contaminated ground water (wells and springs not properly protected from 
sewage  and  runoff  or  wells  located  adjacent  to  rivers  and  streams)  and  many  of  the 
documented outbreaks associated with contaminated surface water were linked to human 
sewage discharge and runoff, which occurred during heavy rainfall events (Rose et al., 
2002; Karanis et al., 2007). 
Cryptosporidium parvum is one of several common Cryptosporidium species found 
in water, but it is difficult to determine the source of C. parvum oocysts in water and 
although  cattle  have  often  been  implicated  as  sources  of  waterborne  outbreaks,  the 
application  of  genotyping  tools  has  often  identified  human  effluent  as  the  source 
(Thompson et al., 2005). Nevertheless, the high prevalence of C. andersoni oocysts in 
surface  water  and  wastewater  indicates  that  cattle  are  an  important  source  of 
Cryptosporidium contamination. The finding of C. baileyi, C. muris and Cryptosporidium 
wildlife  genotypes  in  water  indicates  that  wildlife  also  contribute  to  Cryptosporidium 
oocyst contamination in water (Xiao et al., 2000; Jellison et al., 2002; Ward et al., 2002; 
Xiao, 2010). Cryptosporidium hominis is also frequently seen in surface water in some 
areas (Xiao et al., 2004). 68 
 
  The  largest  water-borne  disease  outbreak  ever  documented  in  humans  for  any 
pathogen was the cryptosporidiosis outbreak in Milwaukee in 1993, where approximately 
one  quarter  of  the  population  (403,000  people)  were  reported  suffering  from  watery 
diarrhea. There were 90 deaths associated with this outbreak and it cost over 90 million US 
dollars  (MacKenzie  et  al.,  1994).  In  1998,  the  Sydney  water  Authority  detected  high 
numbers of Cryptosporidium oocysts in water supplies; this contamination event cost the 
industry an estimated AU$75M and led to a re-evaluation of procedures and optimisation 
of water treatment processes (Cox et al., 2002). 
 
1.10.3.2 Transmission via recreational water 
Swimming is a very popular recreational activity worldwide and the majority of 
recreational water outbreaks have been linked to swimming pools, with others documented 
at water parks, water slides and fountains (Fayer et al., 2000; Rose et al., 2002, Causer et 
al., 2006; Karanis et al., 2007). The most common cause of recreational water outbreaks is 
a faecal accident (Rose et al., 2002; Karanis et al., 2007). In public pools, the combination 
of frequent faecal contamination, oocyst resistance to chlorine, low infectious dose and 
high bather densities facilitate transmission and the likelihood of transmission increases 
when recreational waters are used by diapered children, toddlers and incontinent persons 
(Fayer et al., 2000; Fayer, 2004). 
 
1.11 ENVIRONMENTAL DETECTION OF CRYPTOSPORIDIUM 
 
Microbial  contamination  of  public  water  supplies  is  of  significant  concern,  as 69 
 
numerous  waterborne  outbreaks,  including  Cryptosporidium,  have  been  reported 
worldwide (see section 1.10.3). Detection and enumeration of Cryptosporidium oocysts in 
water supplies is important for the prevention of future cryptosporidiosis outbreaks (Carey 
et al., 2006).  
  Standardised  large  volume  filtration  and  enumeration  methods  have  been 
developed and are now part of standard water testing in the UK and USA. Although in 
Australia  no  routine  monitoring  of  distribution  systems  is  recommended,  many  water 
authorities  routinely  test  for  the  presence  of  Cryptosporidium  oocysts  in  water.  These 
procedures  are  labor  intensive,  time  consuming  and  require  extensive  laboratory 
experience for interpretation of results. Variable recoveries have been demonstrated and 
oocyst  viability  and  infectivity  are  not  reliably  determined,  further,  the  species  of 
Cryptosporidium present or host species of origin is not identified using these methods 
(Smith and Rose, 1998; Carey et al., 2004, 2006). 
 
1.11.1 USEPA Method 1622 
 
The USEPA Method 1622 was developed and validated in 1999 to analyse raw and 
treated waters for the presence of C. parvum oocysts (Fig 1.5). This method first requires 
the concentration of water samples by filtration (section 1.11.2), materials remaining on 
the filter membrane (including oocysts) are eluted and the eluate is centrifuged to pellet the 
oocysts. The oocysts are then subjected to immunomagnetic separation (IMS) (see section 
1.11.3) to remove oocysts from concentrated debris, followed by staining with fluorescent 
monoclonal  antibody  and  4'-6-diamidino-2-phenyldole  (DAPI).  The  sample  is  then 
examined using fluorescence and differential interference contrast (DIC) microscopy  to 70 
 
quantitate oocysts present and DAPI staining is used to determine the presence of four 
nuclei (sporozoites) within the oocyst (section 1.11.4) (USEPA, 1999).  
 
Figure 1.5. Flow diagram of method 1622 used to detect Cryptosporidium oocysts. 
 
IMS = immunomagnetic separation; DIC = differential interference contrast; and DAPI = 
4'-6-diamidino-2-phenylindole. 
Collect 10 – 100 L water samples1 
Filter water sample through sampling capsule 
(Envirocheck™, FiltaMax™), or use CaCl2 
floculation - oocysts and extraneous matter 
retained on filter 
Particles eluted through wrist action agitation. 
Eluting solutions consist of: 
-Laureth-12      - Antifoam A 
-1 M Tris, pH 7.4    - Deionized water 
-0.5 M EDTA, 2 M Na, pH 8.0 
Sample concentrated by centrifugation  
(1000-1100 x g for 15 min) to obtain pellet 
Dynal IMS used to purify oocysts from extraneous 
materials of water concentrates  
Oocysts detected by immunofluorescent assay 
Sporulated oocysts confirmed by DIC microscopy 
(size, shape, etc.) and staining with DAPI 71 
 
1.11.2 Concentration 
 
Environmental water samples contain low oocyst numbers, therefore, concentration 
and purification of large volumes of water is required for their detection. Concentration of 
oocysts is non-specific and will simultaneously concentrate extraneous material, which can 
interfere  with  subsequent  detection  and  identification  by  obstructing  filters,  trapping 
parasites  during  floatation,  disrupting  gradient  formation  and  inhibiting  PCR  reactions 
(Smith et al., 1995, 1998; Zarlenga and Trout, 2004; Carey et al., 2004, 2006). 
  Common concentration methods include calcium carbonate flocculation (Vessey et 
al., 1993), cartridge filtration and membrane filtration (Carey  et al., 2004). Membrane 
filtration  is  the  most  widely  accepted  concentration  technique  and  is  used  in  water 
treatment  facilities  implementing  the  EPA  1622  method  and  also  Drinking  Water 
Inspectorate (DWI) requirements in the United Kingdom. Commercially available filters 
include  Envirocheck™  (Pall  Corporation),  FiltaMax™  (IDEX  laboratories)  and 
CrypTest™  (Krackeler  Scientific  Inc).  Karanis  and  Kimura  evaluated  the  three 
flocculation  methods;  Calcium  carbonate,  ferric  sulphate  and  aluminium  sulphate 
comparing their recovery efficiency with ferric sulphate proving very successful even for 
purification  of  very  low  spike  levels  in  tap  water.  In  addition,  in  vitro  excystation 
experiments  did  not  show  a  significant  reduction  in  oocyst  viability  following  ferric 
sulphate  flocculation  in  comparison  to  calcium  carbonate  flocculation  (Karanis  and 
Kimura, 2002). 
  Water samples are passed through a capsule containing the membrane filter at a 
flow rate of 2.0 L per minute. The resulting sample in the capsule is eluted using buffers 
containing  detergents  and  surfactants  (USEPA,  1999).  The  addition  of  detergents  and 72 
 
surfactants to the elution buffer improves the recovery efficiency by reducing the non-
covalent interactions between negatively charged oocyst surfaces and other particulates 
(Smith and Rose, 1990). A study by Feng et al., (2003), determined that a certain level of 
particulate  matter  (~10  nephelometric  turbidity  units)  of  the  correct  size  can  actually 
increase C. parvum oocyst recovery from water by acting as a carrier. 
 
1.11.3 Purification 
 
Parasite concentration is followed by a purification step prior to using  sensitive 
detection  methods.  Purification  techniques  include  density  gradient 
flotation/centrifugation, which takes advantage of differential densities between oocysts 
and debris, and immunomagnetic separation (IMS), which is a more refined procedure that 
uses parasite specific antibodies coupled to magnetic particles (Zarlenga and Trout, 2004). 
Immunomagnetic  separation  (IMS)  is  now  almost  exclusively  used  in  water  testing 
laboratories  and  is  an  essential  part  of  the  EPA  1622  method  and  Drinking  Water 
Inspectorate (DWI) requirements.  
  Immunomagnetic separation utilises Cryptosporidium oocyst wall antibodies bound 
to magnetic particles to selectively bind oocysts, regardless of viability. A strong magnetic 
field is then applied to separate the captured oocyst-bead complex from the concentrated 
water  sample.  The  water  concentrate  is  removed  and  the  oocyst-bead  complex  is 
dissociated, resulting in a clean suspension of oocysts (Carey et al., 2004; Zarlenga and 
Trout, 2004). IMS allows for efficient separation from debris, better microscopic results 
for immunofluorescence assays (IFA), reduces the occurrence of false positives (Connell et 73 
 
al., 2000) and larger equivalent volumes of water concentrates can be analysed (Carey et 
al., 2004).  
 
1.11.4 Detection 
 
The final process of the EPA 1622 method involves an IFA in conjunction with 
Differential  Interference  Contrast  (DIC)  microscopy  and  DAPI  staining  to  enumerate 
oocysts  in  the  sample  and  determine  their  viability.  IFA  uses  fluorescently  labeled 
antibodies to detect specific antigens on the oocyst wall, thereby significantly improving 
detection  and  differentiation  from  unstained  background  debris  (Carey  et  al.,  2004; 
Zarlenga and Trout, 2004). Qualitative analysis is performed by checking for objects that 
meet the size (4-6 µm), shape (round to ovoid) and fluorescent characteristics (bright apple 
green) of Cryptosporidium oocysts. DIC microscopy is used to confirm morphology and 
DAPI staining to determine the presence of four nuclei (sporozoites) within the oocyst (see 
also section 1.11.1). 
  IFA  methods  are  subject  to  variation  in  sensitivity,  reproducibility  and 
interpretation  of results,  in  addition  this  method cannot  assess viability  (Clancy et  al., 
1994;  Carey  et  al.,  2004).  These  antibodies  also  react  with  other  species  of 
Cryptosporidium  which  are  not  infective  to  humans  (Graczyk  et  al.,  1996b).  Some 
commercially available anti-Cryptosporidium monoclonal antibodies have been shown to 
cross-react with some yeasts and algae (Clancy et al., 1994; Rodgers et al., 1995) and 
Monocystis species (Bull et al., 1998). The inability of this method to determine viability 
and infectivity, and the limitations of DAPI staining has been addressed by combining cell 
culture with immunofluorescent detection (Slifko et al., 1999). IFA microscopy methods 74 
 
are laborious, time consuming, dependent on operator experience and require a fluorescent 
microscope (Carey et al., 2004). 
 
1.11.4.1 Flow cytometry 
Another detection method for Cryptosporidium oocysts in water samples is flow 
cytometry. Cell-sorting flow cytometers are able to efficiently separate Cryptosporidium 
oocysts from background materials (Vesey et al., 1993a, b). Water concentrates are stained 
with  an  appropriate  fluorescent-labeled  anti-Cryptosporidium  monoclonal  antibody  and 
subsequently passed through a fluorescent activated cell sorter (FACS). Particles with the 
fluorescence  and  light-scattering  characteristics  of  oocysts  are  sorted  from  the  sample 
stream and are collected on a microscope slide or membrane filter, which can then be 
examined by fluorescence microcopy to confirm the presence of Cryptosporidium (Carey 
et al., 2004; Zarlenga and Trout, 2004). Flow cytometry is a rapid method which allows for 
high throughput (typically 10,000 oocysts counted) as compared to microscopic analysis 
(typically 100-200 oocysts counted) (Kato and Bowman, 2002), however large numbers of 
oocysts are required to be present in the original sample (Carey et al., 2004). 
  Other  organisms  and  particles  of  similar  size  may  cross-react  with  the  anti-
Cryptosporidium  monoclonal  antibody  and  have  similar  fluorescence  characteristics 
resulting in false-positive results (Rodgers et al., 1995; Bull et al., 1998). Auto-fluorescent 
algae of similar size to oocysts may also lead to incorrect conclusions if FACS is used 
directly to produce oocyst counts, however, confirmation by fluorescence microcopy can 
be performed more easily and reliably than direct microscopy of unsorted samples (Vesey 
et al., 1994; Carey et al., 2004; Zarlenga and Trout, 2004). 75 
 
 
1.11.4.2 Molecular techniques 
The limitation of the above mentioned techniques are their inability to determine 
species of Cryptosporidium oocysts detected. Molecular techniques, such as the PCR, are 
capable  of  differentiating  between  human  and  animal  species  and  genotypes  of 
Cryptosporidium.  PCR  based  procedures  have  proven  to  have  greater  specificity, 
sensitivity  and  reproducibility  than  conventional  diagnostics  relying  on  microscopy 
(Morgan and Thompson, 1998; Carey et al., 2004). These procedures are cost effective, 
easy to interpret and amenable to quantitation and large sample throughput (Carey et al., 
2004; Thompson et al., 2005). Disadvantages of this technique include the presence of 
inhibitors in environmental samples, the possibility of sample contamination, the efficient 
release  and  precipitation  of  DNA  from  oocysts  and  its  inability  to  assess  viability. 
Inhibitors of concern in environmental samples include phenolic compounds, humic acids 
and heavy metals, all of which can adversely affect the PCR efficiency (Tsi and Rochelle, 
2001).  The  robust  nature  of  the  oocyst  wall  requires  more  rigorous  treatments  for 
disruption and some studies have addressed this issue (Sluter et al., 1997; Kostrzynska et 
al., 1999). 
 
1.11.4.2.1 Quantification of Cryptosporidium oocysts by PCR 
Quantitative-PCR  (qPCR)  methods  (see  section  1.9.1.5),  have  been  developed 
offering  quantification  of  Cryptosporidium  oocysts,  greater  reproducibility,  enhanced 
sensitivity,  reduced  variation,  higher  throughput  with  a  reduced  turn-around  time  and 
minimal amplicon contamination (Carey et al., 2004; Thompson et al., 2005). Specific 
probes have been applied to qPCR methods to produce multiplex PCR and melting-curve 76 
 
analysis  to  allow  discrimination  between  species  and  genotypes  of  Cryptosporidium 
(Tanriverdi et al., 2002; Amar et al., 2004), however, these methods are limited in their 
application as only four channels are available on most qPCR machines, resulting in the 
possible detection of only a few species. 
 
1.11.5 Determination of Cryptosporidium viability and infectivity 
 
When  assessing  the  potential  threat  of  C.  parvum  and  C.  hominis  from 
environmental samples, it is important that oocyst viability and infectivity be determined. 
The  EPA  1622  method  utilises  DAPI  staining  to  assess  for  the  presence  of  four 
sporozoites,  which  is  a  sign  of  potential  oocyst  viability,  however  this  method  has 
limitations which are discussed in section 1.9.1.3. Other methods of determining oocyst 
viability and/or infectivity include techniques such as animal infectivity models (section 
1.9.1.1), in vitro excystation (section 1.9.1.2), mammalian cell culture (section 1.9.1.4), 
cell-culture PCR, RT-PCR (section 1.9.1.5) and fluorescent in situ hybridisation (section 
1.9.1.6). 
 
1.12 DISINFECTION OF CRYPTOSPORIDIUM OOCYSTS IN WATER 
 
Water disinfection is conducted with the aim of destroying the viability/infectivity 
of  potentially  infective  organisms  present,  which  is  accomplished  with  chemical  or 
physical disinfectants and the most common of these is chlorine (Betancourt and Rose, 
2004). Chlorine is effective against many microorganisms, however, Cryptosporidium is 77 
 
one of the most resistant organisms in water and chlorination, even at high concentrations, 
shows little or no impact on oocyst viability (Korich et al., 1990; Gyürék et al., 1997; 
Carpenter et al., 1999).  
  Inactivation research is now focused on alternative disinfectants such as chlorine 
dioxide, ozone and ultraviolet (UV) radiation. Ozone and UV light have shown efficacy in 
rendering  oocysts  non-infectious  and  have  applicability  for  disinfection  of 
Cryptosporidium oocysts in water treatment facilities (Rose et al., 1997; Rennecker et al., 
1999; Clancy et al., 2000; Kanjo et al., 2000; Shin et al., 2001; Erickson and Ortega, 
2006). Both these methods have many similar advantages and disadvantages (Peeters et al., 
1989;  Betancourt  and  Rose,  2004).  Chlorine  dioxide  has  been  shown  to  inactivate  C. 
parvum  oocysts  given  sufficient  concentration  and  contact  time  (Peeters  et  al.,  1989; 
Korich et al., 1990; Ruffell et al., 2000). Chlorine dioxide and ozone treatments, however, 
may lead to the formation of undesirable chemical by-products (Singer, 1990; Tate et al., 
1990; von Gunten and Hoigné, 1994; von Gunten, 2003a, b; Meunier et al., 2006). The 
advantages of UV light are: it is a physical process that does not rely on the addition of 
chemicals; it has been shown to be highly effective on protozoa; it requires relatively short 
contact  times;  no  UV  disinfection  by-products  have  been  currently  identified. 
Disadvantages include: differences in output of various UV lamps, reactor design and scale 
up issues; inability to measure lamp dose in practice; interference by turbidity; and no 
lasting residual disinfection effect (Betancourt and Rose, 2004).  
  Experimental studies have shown that sequential treatment of water with multiple 
chemicals such as chlorine and monochloramine or ozone followed by monochloramine or 
free chlorine can achieve greater levels of inactivation than exposure to a single chemical 
(Dreidger, et al.,2000, 2001; Rennecker, et al., 2000; Li et al., 2001; Biswas et al., 2003; 
Erickson and Ortega, 2006).   78 
 
1.13 AIMS AND OBJECTIVES 
 
Recent developments in in vitro cultivation have revealed that Cryptosporidium can 
complete its life cycle in media devoid of host cells (Hijjawi et al, 2004), contradicting 
current beliefs that Cryptosporidium is an obligate intracellular parasite which highlights 
the deficiency of our knowledge about the biology of this parasite. 
  As the oocyst is believed to be the only stage in the life cycle capable of surviving 
in  the  environment,  current  detection  methods  for  Cryptosporidium  within  the  water 
industry,  and  studies  conducted  to  assess  the  survival  of  Cryptosporidium  under 
environmental conditions, only look for the presence of oocysts. Preliminary work in our 
laboratory demonstrated the presence of life cycle stages appearing in samples which had 
been stored in sterile water and PBS for long periods of time. The aim of the present study 
was to improve the detection of life cycle stages in cell-free culture and determine if C. 
parvum could complete its life cycle in water as this has direct relevance to EPA approved 
environmental detection methods for this parasite. 
  The ability of life cycle stages to survive in water and their observation in faecal 
specimens (Hijjawi et al., 2002; Hijjawi and Estcourt, unpublished data) demonstrates that 
oocysts are possibly not the only environmental stage of Cryptosporidium and this is an 
aspect that previous survival experiments of  Cryptosporidium in the environment have 
failed to address.  
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The specific aims of this thesis were to: 
1.  Compare  fluorescent  staining  techniques  to  improve  the  detection  of  life  cycle 
stages in cell-free culture. 
2.  Develop and validate cell-free culture of C. hominis. 
3.  Investigate the fate of  oocysts placed into water under laboratory  conditions  at 
different temperatures. 
4.  Determine if C. parvum would complete its life cycle and amplify in water under 
laboratory conditions at different temperatures. 
5.  Determine the infectivity of non-oocyst life cycle stages of C. parvum to neonatal 
mice. 
 
The hypotheses for this thesis are: 
1.  Fluorescent staining techniques can be used to improve the detection of life cycle 
stages in cell-free culture 
2.  A cell-free culture system can be established for C. hominis. 
3.  The  fate  of  oocysts  placed  into  water  under  laboratory  conditions  at  different 
temperatures will vary depending on different environmental conditions. 
4.  Cryptosporidium parvum can complete its life cycle and amplify in water under 
laboratory conditions at different temperatures. 
5.  Non-oocyst life cycle stages of Cryptosporidium parvum are infectious to neonatal 
mice. 
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CHAPTER 2: 
GENERAL MATERIALS AND METHODS 81 
 
2.1 CRYPTOSPORIDIUM ISOLATES 
 
The C. parvum cattle genotype (Swiss cattle C26) was used for most experiments 
throughout this thesis. This cattle derived isolate was originally obtained from a naturally 
infected calf from the Institute of Parasitology, University of Zurich and has subsequently 
been passaged through mice at Murdoch University since 1995 as described by Meloni and 
Thompson (1996).  
 
2.2 PURIFICATION OF CRYPTOSPORIDIUM OOCYSTS 
 
Cryptosporidium  parvum  oocysts  were  obtained  by  infecting  4-5  day  old 
ARC/Swiss mice intra-gastrically with 100,000-120,000 oocysts from isolate C26 using 
methods described by Meloni and Thompson, (1996) and Lumb et al., (1998). On day 7 
post-infection, mice were euthanised (CO2 inhalation) and the duodenum, jejunum, ileum, 
caecum, colon and rectum removed. The pooled gastrointestinal tracts were dissected into 
small segments using surgical scissors, before being disrupted and homogenised using a 
mechanical blade. The samples were then placed in 1 x Phosphate buffered saline  (~ 
4ml/mouse), homogenised further using a bar mix and sputasol (5mg/ml) was added before 
placing on a rotary mixer at room temperature for 90-120 minutes. The suspension was 
then  centrifuged  at  2,000  x  g  for  8  minutes  and  the  supernatant  was  removed  to 
approximately 1 ml above the pellet. 40 ml of 1 x PBS and 10 ml of ether was added, 
followed by vigorous mixing for approximately 1 minute, then centrifugation at 2,000 x g 
for 8 minutes. Samples were removed from the centrifuge and were vigorously mixed for 82 
 
approximately 30 seconds followed by another centrifugation at 2,000 x g for 8 minutes. 
The supernatant was  removed and the pellet  resuspended in  2 ml of PBS. For further 
purification  of  the  oocysts,  the  2  ml  suspension  was  layered  onto  a  ficoll  gradient 
(4%/2%/1%/0.5% ficoll prepared in PBS containing 16% sodium diatrizoate). Gradients 
were  centrifuged  at  1,000  g  for  40  minutes  at  4°C.  Oocysts  were  collected  from  the 
PBS/0.5% ficoll interface and washed with sterile PBS and antibiotics (10,000 U penicillin 
G  and  0.01  g  streptomycin)  stored  at  4°C.  Oocysts  were  counted  on  a  Neubauer 
haemocytometer. 
 
2.3 OOCYST COUNTS 
 
Duplicate  10  µL  aliquots  of  each  sample  were  loaded  onto  a  haemocytometer 
chamber  and  oocysts  were  counted  in  five  grids  on  the  haemocytometer  using  400  x 
magnification. The calculation; (number of counted oocysts x 2,000) x total volume (mL) 
of oocyst suspension was used to give an estimation of the total number of oocysts present. 
 
2.4 CELL-FREE CULTIVATION OF CRYPTOSPORIDIUM 
 
2.4.1 Bleaching of Oocysts 
 
Purified  Cryptosporidium  oocysts  were  bleached  prior  to  use  by  placing  the 
required amount of oocysts into a 10 ml centrifuge tube and adding 10 ml of 0.25% sodium 83 
 
hypochlorite (bleach) (Scott Scientific, Western Australia) in sterile PBS before mixing by 
inverting the tube gently. The oocysts were incubated at room temperature for 30 minutes 
and subsequently centrifuged at 2,000 g for 8 minutes, then the supernatant was removed 
to just above the pellet, followed by a wash in 10 ml of sterile PBS, centrifugation at 2,000 
g for 8 minutes and removal of the supernatant. 
 
2.4.2 Excystation of oocysts 
 
Bleached  oocysts  were  excysted  by  placing  in  9  ml  of  freshly  prepared,  filter 
sterilized  (0.22  µm  filter)  excystation  medium  composed  of  acidic  water  (pH  2.5-3) 
containing 0.5% trypsin/EDTA and incubated in a water bath at 37°C for 20 minutes with 
mixing every 5 minutes. The excystation suspension was then centrifuged at 2,000 g for 8 
minutes, the supernatant removed and the oocysts were suspended in the required volume 
of sterile rain water. 
  Following excystation, an excystation count was routinely performed to determine 
the percentage of oocysts that had excysted. The treated oocysts, or an aliquot thereof, 
were incubated at 37°C in a water bath for at least 2 hours. Samples were then centrifuged 
at 2,000 x g for 8 minutes, the supernatant removed down to approximately 50 µl and a 10 
µl aliquot was placed onto a microscope slide. Under 1000 x magnification, at least 100 
oocysts  were  screened  and  counted  as  either  un-excysted  (still  fully  sporulated),  or 
excysted  (empty  shell)/excysting.  With  the  ratio  of  excysted/excysting:  un-excysted,  a 
percentage excystation rate was determined. For example a count of 72 excysted/excysting 
and 28 un-excysted oocysts means the excystation rate was 72%. 84 
 
2.4.3 Media and water preparation 
 
2.4.3.1 Rain water collection and preparation 
Rain  water  was  collected  during  rainfall  into  a  20  L  plastic  bucket.  In  the 
laboratory,  the  collected  water  was  funneled  into  a  cylinder  and  the  water  was 
subsequently passed through a triple layer of gauze into a plastic container to remove any 
large particles of dirt, pollen and other matter that may be present. The rain water was then 
filtered through a 0.22 µm vacuum filter into a sterile schott bottle. If the rain water was 
particularly dirty it was re-filtered through another 0.22 µm vacuum filter into a fresh, 
sterile schott bottle. The sterile rain water was then stored at 4°C until required. 
 
2.4.3.2 Tap water collection and preparation 
Water was collected from the tap into a plastic container. The tap water was then 
filtered through a 0.22 µm vacuum filter into a sterile schott bottle. Collection of tap water 
was conducted immediately prior to inoculation with Cryptosporidium oocysts. 
 
2.4.3.3 Maintenance medium preparation 
100  ml  maintenance  media  (RPMI-1640)  was  prepared  with  the  following 
ingredients. 0.03 g l-glutamine, 0.3 g sodium bicarbonate, 0.02 g bovine bile salts, 0.1 g 
glucose, 25 µg folic acid, 100 µg 4-aminobenzoic acid, 50 µg calcium pantothenate, 875 
µg  ascorbic  acid,  1%  fetal  calf  serum  (FCS),  10,000  U  penicillin  G  and  0.01  g 
streptomycin and the pH was adjusted to 7.4 as previously described (Hijjawi et al., 2000). 
Media was filtered through 0.22 µm vacuum filter to ensure sterility. 85 
 
2.4.4 Culture plate inoculation and maintenance 
 
Each well on the culture plate containing 1 ml of the relevant media type (tap 
water, rain water or maintenance media), was inoculated with 10 µl of the pre-treated 
oocyst suspension containing approximately 15,000 oocysts. The oocyst suspension was 
mixed thoroughly to ensure each 10 µl aliquot contained the same number of oocysts. 
Plates were incubated at the relevant temperatures: 4°C, in a fridge; 15°C, in a refrigerated 
incubator; 24°C, on a bench top; and 37°C with 5% CO2, in an incubator. 
 
2.4.5 Culture flask inoculation and maintenance 
 
Culture flasks (25 cm
2) containing 10 mL maintenance media were inoculated with 
1-2 x 10
6 pre-treated oocysts and incubated at 37°C with 5 % CO2 for the period required. 
If the incubation period exceeded 14 days, the sample was removed and centrifuged at 
2,000 g for 8 minutes. The supernatant was discarded and the pellet resuspended in 10 mL 
fresh maintenance media and placed into a new culture flask. 
 
2.4.6 Preparation of parasites from culture plates for further analysis 
 
Culture  well  contents  were  mixed  vigorously  using  a  pipette  before  being 
transferred to individual sterile 2.0 ml eppendorf tubes. 80µl of 1:250 trypsin/EDTA was 
added to each well and plates were incubated at room temperature for 30 minutes followed 86 
 
by  three  washes  with  200  µl  of  1  x  PBS.  Each  washing  was  pooled  into  the  2.0  ml 
eppendorf tube containing the original sample.  
  Tubes containing samples for DNA extraction followed by Q-PCR analysis were 
centrifuged at 10,000 g for 5 minutes, the supernatant was removed and the pellet washed 
with 1 mL 1x PCR buffer (50 mM KCl, 10 mM Tris-HCl, pH 8.3) and centrifuged at 
10,000 g for 5 minutes. The supernatant was again removed and the pellet resuspended in 
30 µL 1x PCR buffer by vortex mixing. Samples were stored at -20°C until all samples had 
been collected. 
  Tubes containing samples for oocyst counts were centrifuged at 2,000 x g for 8 
minutes; the supernatant was removed down to the 0.5 ml mark, followed by mixing to 
resuspend the pelleted oocysts. 
  Tubes containing samples for examination by fluorescent staining methods were 
centrifuged at 2,000 g for 8 minutes. The supernatant was removed down to approximately 
50 µL and life cycle stages were resuspended. Samples were then subject to methodologies 
for fluorescent staining. 
 
2.5 MICROSCOPY AND IMAGING 
 
Cultures were examined regularly using an inverted light microscope (Olympus 
IMT-2) at magnifications ranging from 100X–400X. Cultures were screened using this 
microscope to check for the presence of life cycle stages and also to check for evidence of 
contamination. Once samples were screened from the culture wells, the contents of three or 
more  culture  wells  (from  the  same  incubation  conditions)  were  collected  and  pooled. 87 
 
Samples were centrifuged at 2,000 g for 8 minutes, the supernatant was removed to the 1 
ml mark and the Cryptosporidium oocysts were resuspended. A drop of the liquid was 
placed onto a microscope slide with a cover slip over top. Samples were subsequently 
examined  under  high  power  using  nomarski  phase-contrast  on  an  Olympus  BX51 
microscope to check for the presence of C. parvum life cycle stages. Images were captured 
using an Olympus DP70 camera and associated imaging software. 
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CHAPTER 3: 
COMPARISON OF VARIOUS STAINING 
METHODS FOR THE DETECTION OF 
CRYPTOSPORIDIUM IN CELL-FREE CULTURE 
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3.1 INTRODUCTION 
 
Recent developments in in vitro cultivation have revealed that Cryptosporidium can 
complete its life cycle in media devoid of host cells (Hijjawi et al., 2004). This finding 
supports other biological and phylogenetic analysis (Bull et al., 1998; Carreno et al., 1999; 
Hijjawi et al., 2002; Hijjawi et al., 2004; Leander et al., 2003b; Rosales et al., 2005; Barta 
and  Thompson,  2006),  suggesting  that  Cryptosporidium  has  a  closer  affinity  with 
gregarines  than  with  the  coccidia.  A  recent  study  has  reported  the  failure  of 
Cryptosporidium spp. to propagate in host cell-free culture suggesting this method may 
have to be modified before easy reproducibility can be obtained (Girouard et al., 2006). 
However  this  is  most  likely  due  to  the  fact  that  the  protocol  for  cell-free  media  and 
conditions described by Hijjawi et al., (2004) was not adhered to, as this is essential. More 
recently  Karanis  et  al.,  (2008)  observed  merozoites  as  well  as  sporozoites  following 
excystation treatment of oocysts. The authors also tried propagating the treated oocysts in 
cell  free  media  according  to  Hijjawi  et  al.,  (2004)  with  limited  success,  but  failed  to 
establish a long-term cell free culture longer than 48 hours. 
  In the initial publication by Hijjawi et al., (2004), life cycle stages were visualised 
using differential interference contrast microscopy. However, life cycle stages in cell-free 
culture, are small in size, frequently clump together and are therefore difficult to identify. 
In contrast, life-cycle stages grown on cell lines such as HCT-8 are easier to visualise as 
the life-cycle stages form foci of infection on the cells and are not dispersed throughout the 
media as is the case with cell-free culture. Difficulty in the visualisation of life-cycle stages 
in cell-free culture is one of the major impediments to laboratories adopting the cell-free 
culture approach. The development of a standardised, simple and reliable method for the 90 
 
detection and visualisation of Cryptosporidium life-cycle stages is very important to prove 
the proliferation and amplification of Cryptosporidium in cell-free culture. 
  In the present study, three specific and three non-specific techniques for visualizing 
the  life-cycle  stages  of  C.  parvum  in  cell-free  culture  were  compared  to  validate  and 
facilitate  the  identification  of  life  cycle  stages  in  cell-free  culture.  These  included  the 
commercially available antibody stains Sporo-Glo™ (Waterborne™ Inc., New Orleans, 
USA)  and  Crypto  Cel  (Cellabs,  Sydney,  Australia);  fluorescent  in-situ  hybridization 
(FISH) using a Cryptosporidium specific rRNA oligonucleotide probe (Vesey et al., 1998) 
and  three  non-specific  dyes,  the  protein  dye  Texas  Red
®-X  succinimidyl  ester  (TR) 
(Invitrogen, USA), the vital dye carboxyfluorescein succinimidyl ester (CFSE) (Invitrogen, 
USA) and 4,6’ diamino-2-phenylindole dihydrochloride (DAPI) (Sigma-Aldrich, USA). 
  The  specific  aim  of  this  research  was  to  provide  more  evidence  for  cell  free 
development of the C. parvum life cycle. 
 
3.2 MATERIALS AND METHODS 
 
The  Cryptosporidium  isolate  used  in  this  procedure,  oocyst  purification,  oocyst 
treatment,  media  preparation,  cell  free  cultivation  in  culture  flasks  and  microscopic 
techniques are described in the general materials and methods (chapter 2). 
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3.2.1 Processing of life-cycle stages for staining 
 
Media containing life-cycle stages in culture flasks were mixed by pipetting to lift 
any  stages  that  were  stuck  to  the  flask  and  then  5  ml  aliquots  were  removed  and 
centrifuged at 2,000 x g for 8 minutes to concentrate life cycle stages. The supernatant was 
removed down to approximately 200 µl and the pellet was then resuspended and placed 
into a 1.5 ml centrifuge tube.  
 
3.2.2 Crypto Cel staining 
 
Crypto Cel (Cellabs, Sydney, Australia) antibody reagent (25µl) was added to a 
tube containing C. parvum life-cycle stages, mixed and incubated at 37°C for 30 minutes. 
The volume was then made up to 1.5 ml using 1 x PBS. Tubes were centrifuged at 2,000 x 
g for 8 minutes and the supernatant removed. Samples were washed again in 1 x PBS and 
the supernatant was removed to leave ~50 µl for microscopic examination. 
 
3.2.3 Sporo-Glo™ staining 
 
A working stock solution of 1 x Sporo-Glo™ (Waterborne™, New Orleans, USA) 
antibody reagent  was  prepared following manufacturer’s  instructions  and 50 µl of this 
preparation was added to the C. parvum sample followed by a 45 minute incubation at 
room temperature. Following incubation, 1 x PBS was added to make the volume up to 1.5 92 
 
ml, the tubes were centrifuged at 2,000 x g for 8 minutes and the supernatant removed. 
Samples were washed again in 1 x PBS and the supernatant was removed to leave ~50 µl 
for microscopic examination. To examine the specificity of Sporo-Glo™ staining, a range 
of bacteria including Salmonella typhimurium, Pseudomonas aeruginosa, Acinetobacter 
baumannii,  Staphylococcus  aureus,  Escherichia  coli,  Clostridium  difficile  and 
Saccharomyces cerevisiae (kindly supplied in culture by Dr Tatjana Heinrich from the 
Telethon  Institute  for  Child  Health)  was  mixed  with  C.  parvum  cell-free  cultures  and 
processed for Sporo-Glo™ staining as described above. 
 
3.2.4 Combined Sporo-Glo™ and Crypto Cel staining 
 
Sporo-Glo™  antibody  reagent  (50  µl)  was  added  to  the  C.  parvum  sample, 
followed by 15 minute incubation at  room temperature. 25 µl  of Crypto  Cel  antibody 
reagent was added and samples were mixed and incubated at 37°C for another 30 minutes. 
Samples were washed with 1 x PBS as described above. 
 
3.2.5 Fluorescent in situ hybridisation (FISH) 
 
A previously published oligonucleotide probe directed against 18S rRNA specific 
to Cryptosporidium fluorescently labeled with Cy3 was utilised in the present study; Cry1 
(5'-CGG  TTA  TCC  ATG  TAA  GTA  AAG-3')  (Vesey  et  al.,  1998).  A  second  probe 
(EUB338) complementary to a 16s rRNA region conserved for all bacteria (5'-GCT GCC 
TCC  CGT  AGG  AGT-3')  (Amann  et  al.,  1990)  labeled  with  6-FAM,was  used  as  a 93 
 
negative control in all samples. Hybridisation was conducted as previously described and 
the hybridization buffer was prepared in DEPC treated water to ensure the absence of 
residual  RNAses  (Vesey  et  al.,  1998).  Probe  concentrations  were  100  pmoles/µL. 
Escherichia coli (ATCC53323) was grown overnight in LB broth containing 10 g/L Bacto-
tryptone, 10 g/L NaCl, 5 g/L yeast in de-ionised water, centrifuged at 2,000 x g for 5 
minutes and the supernatant removed and the pellet resuspended in 5 ml of 1 x PBS. 200 µl 
aliquots  were  mixed  with  samples  taken  at  different  time  periods  to  demonstrate  the 
EUB338 probe binding to E. coli and not to Cryptosporidium life cycle stages. 
 
3.2.6 Texas Red
®-X succinimidyl ester (TR) staining 
 
A  10  mM  stock  solution  of  TR  (Invitrogen,  USA)  was  prepared  in  0.5% 
dimethylsulfoxide (DMSO) and then further diluted 1:500 with deionised water to make a 
20 µM working stock. An equal volume of 20 µM TR was added to the Cryptosporidium 
life cycle stage suspension. Samples were incubated at 37°C for 30 minutes, and washed 
twice in 1 x PBS as described above. 
 
3.2.7 Carboxyfluorescein diacetate succinimidyl ester (CFSE) staining 
 
A  10  mM  stock  solution  of  CFSE  (Invitrogen,  USA)  was  prepared  following 
manufacturer’s instructions and then further diluted 1:500 with 1 x PBS to make a 20 µM 
working stock. An equal volume of 20 µM CFSE was added to the oocyst or life cycle 94 
 
stage suspension and tubes were incubated at 37 °C for 30 minutes. Samples were washed 
in 1 x PBS, centrifuged at 2,000 x g for 8 min and the supernatant was removed. 
 
3.2.8 DAPI staining 
 
An equal volume of 100% methanol was added to the life cycle stage suspension 
and samples were incubated at room temperature for 30 minutes. Samples were then made 
up to 1.5 ml with 1 x PBS, then centrifuged at 2,000 x g for 8 min and the supernatant 
removed to approximately 50 µL. 50 µL of DAPI (Sigma-Aldrich, USA) diluted 1:1000 in 
1  x  PBS  was  added  and  incubated  at  room  temperature  for  2  min.  Samples  were 
subsequently washed as described above. Escherichia coli was grown as described above 
and mixed with cell culture samples to demonstrate the non-specificity of DAPI staining. 
 
3.2.9 Microscopy 
 
Wet mounts of stained samples were analysed using an Olympus BX51 microscope 
and appropriate fluorescence filters and DIC optics. Images were captured under 1000x 
magnification using an Olympus DP70 digital camera and associated imaging software. 
Overlay of Sporo-Glo™ and Crypto Cel images was done using Olympus DP70 associated 
imaging software.  
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3.3. RESULTS 
 
3.3.1 Sporo-Glo™ and Crypto Cel staining 
 
BothSporo-Glo™and Crypto Celare fluorescent anti-Cryptosporidium antibodies, 
which took between 45-60 min to prepare and cost AUD$1.50-2.00 per sample (Table 
3.1).Sporo-Glo™is  a  polyclonal  antibody,  which  recognised  C.  parvum  sporozoites, 
trophozoites, meronts and merozoites (Figure 3.1a-e). The oocyst wall and contents were 
observed fluorescing if the oocyst wall was compromised (e.g. partially excysted) allowing 
the antibody through the membrane to bind to internal and excysting sporozoites (Figure 
3.1a). Sporo-Glo™ was particularly useful for detecting and identifying meront stages. 
Meront I and meront II stages under interference are typically transparent and therefore 
difficult to identify, however they are easily detected using Sporo-Glo™ (Figure 3.1d-e). 
Crypto Cel bound to oocyst walls only, as this monoclonal antibody is directed against the 
oocyst wall and did not detect life cycle stages (Figure 3.1 g and j). A combination of both 
Crypto Cel and Sporo-Glo™ provided a simple method of identifying all life cycle stages 
and oocysts (Figure 3.1 h and k).  
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Figure 3.1. Cryptosporidium parvum life cycle stages derived from host-cell free culture 
stained with fluorescent antibody stains; Sporo-Glo™ and Crypto Cel. 
 
 
a-e  =  Nomarski  (left)  and  Sporo-Glo
TM  staining  (right);  a  =  excysting  oocysts;  b  = 
excysting oocyst and trophozoites, c = trophozoite clump, starting to undergo division to 
form meront I, d = meront I, e = meront II, f-k Nomarski(left) and Crypto Cel and Sporo-
Glo
TM staining right; f = empty oocysts and trophozoites; g = Crypto Cel staining of the 
same sample showing detection of oocysts, h = combination of Crypto Cel and Sporo-
Glo
TM on the same sample; i = oocysts (empty, excysting and sporulated) and meront I 
(m),  j  =  Crypto  Cel  staining  of  same  sample  showing  ooycst  staining  only,  k  = 
combination of Crypto Cel and Sporo-Glo
TM the same sample. Scale bar = 5 µm. 
 
The specificity of Sporo-Glo™ was evaluated by the addition of a range of bacteria 
and also yeast to cell-free cultures, followed by Sporo-Glo™ staining. Results revealed 
that Sporo-Glo™ was highly specific for Cryptosporidium and did not react with any of 97 
 
the bacteria or yeast tested (Figure 3.2 a-d). No life-cycle stages or structures resembling 
life-cycle stages were detected in heat-treated oocyst controls. 
 
Figure 3.2. Sporo-Glo
TM and Crypto Cel staining of Cryptosporidium parvum life cycle 
stages and other microorganisms.  
 
 Nomarski  (left)  and  Sporo-Glo
TM  staining  (right)  a  =  cultures  containing  Salmonella 
typhimurium, Pseudomonas aeruginosa and Escherichia coli mixed with C. parvum life 
cycle stages, showing specificity of Sporo-Glo
TM for Cryptosporidium. b = Crypto Cel 
staining overlay of same sample. c = Nomarski (left) and Sporo-Glo
TM staining (right); 
Acinetobacter  baumannii,  Staphylococcus  aureus  and  C.  parvum  trophozoite  and 
merozoites. d = Clostridium difficile, Saccharomyces cerevisiae and a Cryptosporidium 
parvum oocyst. 
 
3.3.2 FISH staining 
 
FISH  staining  took  approximately  110  min  to  perform  and  was  themost  time 
consuming, expensive and technically demanding of all the staining methods employed 
(Table 3.1). The Cry1 FISH probe bound to all life cycles stages of C. parvum (Figure 3.3 
a, b and d). The EUB338 probe, which is complementary to a 16S rRNA region conserved 
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for most bacteria (Amann et al., 1990), bound to the spiked E. coli but did not bind to 
Cryptosporidium (Figure 3.3 e).  
 
Figure 3.3. FISH staining of Cryptosporidium parvum life cycle stages derived from host 
cell free culture.  
 
a-b = Normaski (left) and FISH staining (right). a = sporulated oocyst with trophozoite on 
the periphery, b = meront, c = meront and merozoite stage in cell culture sample spiked 
with E. coli, d = FISH staining with Cry1 probe of cell culture sample spiked with E. coli, 
e  =  FISH  staining  with  EUB338  probe  of  cell  culture  sample  spiked  with  E.  coli 
demonstrating binding to the bacteria but not the Cryptosporidium life cycle stages, f = 
overlay of fluorescence from Cry1 probe and EUB338 probe in cell culture sample spiked 
with E. coli. 
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3.3.3 TR staining 
 
This staining method took approximately 45 minutes, was simple and inexpensive 
to use but is non-specific and will bind to any protein structures, therefore will react with 
contaminants (Table 3.1). TR staining produced bright and clear details of the morphology 
of all life cycle stages (Figure 3.4a-c), no images shown for TR staining of other structures 
or organisms.  
 
Figure 3.4. Texas red staining of Cryptosporidium parvum life cycle stages derived from 
host cell free culture. 
 
a-c = Normaski (left) and TR staining (right); a = excysting oocyst, b = trophozoites, c = 
merozoites. 
 
3.3.4 CFSE staining 
 
CFSE  staining  also  took  approximately  45  minutes,  and  like  TR  staining  was 
simple and inexpensive to use but is also non-specific (Table 3.1). All life cycle stages 
were visualised (Figure 3.5 a and b). 
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3.3.5 DAPI staining 
 
DAPI staining was the fastest and cheapest method to perform as it only took 20 
min but is also non specific (Table 3.1). DAPI was observed binding to all life cycle stages 
including trophozoites and oocysts but also bound to E. coli (Figure 3.5 c). In addition, 
only  cell  nuclei  were  observed  using  DAPI,  and  therefore  it  was  not  always  easy  to 
identify life-cycle stages.  
 
Figure 3.5. CFSE and DAPI staining of Cryptosporidium parvum life cycle stages derived 
from host cell free culture. 
 
a-b = Normaski (left) and CFSE staining (right). a = two sporulated C. parvum oocysts, 
one unsporulated oocyst and four trophozoites stained with CFSE, b = meront II stage 
stained  with  CFSE  circular  merozoite,  c  =  (left)  and  stained  with  DAPI  (right); 
trophozoites mixed with E. coli. 
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Table 3.1. Comparison of staining methods for visualisation of life cycle stages in cell free 
culture. 
  Staining 
time (min.) 
Stages 
identified 
Specificity  Cost per 
assay ($)* 
Ease of life 
cycle stage 
visualisation** 
 
Crypto Cel 
 
45 
 
Cryptosporidium 
oocyst walls 
only 
 
Specific 
 
1.50 
 
+++ 
Sporo-Glo
TM  60  All life cycle 
stages 
Specific  2  +++ 
FISH  110  All life cycle 
stages 
Specific  5.20  ++ 
Texas red  45  All life cycle 
stages 
Non-specific  0.15  +++ 
CFSE  45  All life cycle 
stages 
Non-specific  0.10  ++ 
DAPI  20  All life cycle 
stages 
Non-specific  0.07  + 
* Australian dollars. 
**+++ = easy to visualise life cycle stages, ++ = requires experience with cell culture to visualise life cycle 
stages, + = difficult to visualise life cycle stages.  
 102 
 
3.4. DISCUSSION 
 
The  present  study  evaluated  three  specific  and  three  non-specific  staining 
techniques for visualisation of both C. parvum life-cycle stages in cell-free culture. Of the 
non-specific stains used, DAPI was the quickest and cheapest to perform but stained nuclei 
only and did not provide clear visualisation of the life-cycle stages. Both TR and CFSE 
were easy to use and provided clear visualisation of the life-cycle stages. TR is a red 
fluorescent dye that binds to proteins and is used in fluorescence microscopy applications 
and in immunohistochemistry. TR is very bright and photostable, therefore produced clear 
images of life cycle stages that were easy to visualise. CFSE is cleaved by intracellular 
esterases after being transported inside the cell and reacts with amine-containing residues 
of proteins to form stable and highly fluorescent dye-protein adducts (Wang, 2000; Feng et 
al., 2006). CFSE has been widely used for the tracking of development of and division of 
transplanted  cells  and  more  recently  has  been  used  to  quantitatively  track  the  early 
invasion of epithelial cells by C. parvum and C. hominis sporozoites (Feng et al., 2006).  
This stain has also been used to track and monitor bacterial strains in aquifers (Mailloux 
and Fuller, 2003; Fuller et al., 2004) 
  A limitation of these techniques is their non-specificity and as life-cycle stages in 
cell-free  culture  can  cluster  together,  it  can  be  difficult  to  differentiate  between  some 
Cryptosporidium lifecycle stages and artifacts, particularly to the untrained eye. The use of 
specific  stains  is  therefore  recommended  for  individuals  inexperienced  with  cell-free 
culture. However, once individuals are experienced and confident at recognising life-cycle 
stages, both CFSE and TR are useful stains as they provide very and easy visualisation of 103 
 
different life cycle stages.  Also, as oocysts are pre-treated with sodium hypochlorite and 
cultured in antibiotics, it is unlikely that contaminating bacteria would be present. 
 
Immunofluorescent antibodies have proven to be useful in detecting and identifying 
oocysts and other life-cycle stages of Cryptosporidium particularly in environmental or 
clinical samples, which contain other organisms and artifacts. Of the specific stains used, 
the  commercially  available  fluorescent  polyclonal  antibody  Sporo-Glo™,  which 
recognises  Cryptosporidium  sporozoites,  life  cycle  stages  (and  oocyst  wall  if 
compromised) was the easiest to use and provided a clear means of identifying all life 
cycle  stages.  Sporo-Glo™  bound  to  the  extracellular  developmental  stages  such  as 
sporozoites and merozoites as well as to other intracellular stages (trophozoites, meronts 
and gamonts). Sporo-Glo™ is widely used by numerous researchers for evaluating the 
infection foci produced in mammalian cell monolayers inoculated with C. parvum oocysts 
as a test for viability (Schets et al., 2005; Silfko et al., 1997; 1999). Little information is 
available on the specificity of Sporo-Glo™, however in the present study, the antibody 
appeared to be highly specific for Cryptosporidium as it did not cross-react with a range of 
bacteria and yeast added to the cultures. 
  Crypto Cel is a monoclonal antibody preparation directed against the oocyst wall. 
No other life cycle stages were recognised, including the internal morphology of oocysts 
and therefore was not useful for detecting life-cycle stages. It was also not possible to 
determine if the oocyst was sporulated, excysting or empty (non-viable). A combination of 
both Sporo-Glo™ and Crypto Cel, however, allowed easy detection and differentiation of 
oocysts and life-cycle stages and therefore was the best method to observe the life cycle 
process in cell free culture. 104 
 
  FISH  staining  is  a  highly  sensitive  method,  which  uses  fluorescently  labeled 
oligonucleotide probes designed to hybridise with specific sequences of intracellular rRNA 
thus staining viable Cryptosporidium stages. FISH staining using a Cryptosporidium rRNA 
probe was also specific but was much more time-consuming than antibody staining as this 
method  requires  an  initial  permeabilisation  procedure  before  probe  hybridisation.  In 
addition, a specific buffer (Vesey et al., 1998) prepared in DEPC treated water was found 
to  be  essential  for  optimal  fluorescence.  FISH  staining  was  also  more  expensive  and 
required some expertise in the visualisation of life cycle stages. The Cry1 FISH probe used 
in the present study was subjected to GenBank blast searches to confirm its specificity and 
was  found  to  be  specific  for  C.  parvum,  C.  hominis,  mouse  genotype  I,  C.  suis,  C. 
meleagridis, C. wrairi and C. canis. The probe did not cross-react with other species of 
Cryptosporidium, coccidia or bacteria. Previous studies  have shown that  isolates of  C. 
baileyi and C. muris did not cross-react with the Cry1 probe (Vesey et al., 1998). 
  The identification of all life-cycle stages using both antibody and RNA staining 
methods  that  are  specific  for  Cryptosporidium  provides  further  proof  of  the  ability  of 
Cryptosporidium to complete its life cycle in cell-free culture. The use of a combination of 
both Sporo-Glo™ and Crypto Cel should allow easier and more reliable identification of 
life-cycle stages in cell-free culture, which will facilitate a better understanding of the life-
cycle of Cryptosporidium. 
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CHAPTER 4: 
COMPLETE DEVELOPMENT AND 
MULTIPLICATION OF CRYPTOSPORIDIUM 
HOMINIS IN CELL-FREE CULTURE 106 
 
4.1 INTRODUCTION 
 
The present study reports for the first time the completion of the life cycle of C. 
hominis in cell-free culture and multiplication of the parasite via qPCR. Individual life 
cycle stages were characterised using Cryptosporidium-specific antibody staining (Sporo-
Glo
TM) and fluorescent in situ hybridisation (FISH) staining on cultures inoculated with 
excysted  oocysts  and  purified  sporozoites.    In  both  cultures,  C.  hominis  successfully 
proliferated and completed its life cycle, however development in cultures inoculated with 
purified sporozoites lagged behind cultures inoculated with excysted oocysts. Some novel 
findings of the study include the visualisation of pairing and multiple associations between 
various  developmental  stages  in  a  process  similar  to  syzygy  and  the  formation  of 
Cryptosporidium stages (trophozoites and meronts) inside the oocysts without excystation. 
qPCR  analysis  revealed  a  5-6-fold  amplification  of  parasite  DNA.  Future  studies  are 
required  to  improve  the  amplification  of  the  parasite.  The  present  study  confirms  the 
suitability of this culturing model to support the growth and proliferation of C. hominis 
(which unlike C. parvum, cannot be readily cultured in small animal models) and will 
greatly assist in our understanding of the developmental biology of Cryptosporidium, its 
position within the Apicomplexa and its relationship to gregarine protozoa.   
In the present study, for the first time the characterisation of the life cycle stages of 
C. hominis in cell-free culture using a variety of stains and multiplication of the parasite 
using qPCR is reported. The stains used include the Cryptosporidium specific fluorescent 
antibody Sporo-Glo™ (Waterborne™ Inc., New Orleans, USA) and fluorescent  in situ 
hybridisation  (FISH)  using  a  Cryptosporidium  specific  rRNA  oligonucleotide  probe 
(Vesey  et  al.,  1998)  and  one  non-specific  dye;  the  protein  dye  Texas  Red
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(Invitrogen, USA), to provide more evidence for the development of the Cryptosporidium 
life cycle in cell-free culture.  
 
The specific aims of the experiments reported in this chapter were to: 
1.  Confirm the development and presence of C. hominis life cycle stages in cell free 
media following inoculation with oocysts treated for excystation. 
2.  Confirm the development and presence of C. hominis life cycle stages in cell free 
media following inoculation with purified sporozoites. 
3.  Determine any increase in C. hominis DNA levels over time using qPCR following 
inoculation of cell free cultures with oocysts treated for excystation. 
4.  Determine any increase in C. hominis DNA levels over time using qPCR following 
inoculation of cell free cultures with purified sporozoites. 108 
 
4.2 MATERIALS AND METHODS 
4.2.1 Cryptosporidium genotyping and purification 
 
The  C.  hominis  isolate  used  in  the  present  study  was  obtained  from  a  local 
diagnostic  laboratory  from  an  infected  human  patient  from  Western  Australia  and 
genotyped by sequence analysis of the 18S rDNA as previously described (Ryan et al., 
2003). The sample was purified using ether extraction and a Ficoll density gradient as 
previously  described  (Meloni  and  Thompson,  1996).  Purified  oocysts  were  stored  in 
phosphate buffered saline (PBS) and antibiotics (100 IU/ mL penicillin G, 0.1 µg/ mL 
streptomycin and 2.5 µg/ mL amphotericin B) at 4°C for a maximum of 2 weeks before 
use. 
 
4.2.2. Bleaching and excystation of oocysts 
 
Bleaching and excystation of oocysts was performed as described in sections 2.4.1 and 
2.4.2 in Materials and Methods. As a control, intact but heat inactivated oocysts (incubated 
at 70°C for 30 min) were included in the experimentation. 
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4.2.3. Filtration of excysted oocysts to purify sporozoites 
 
Following excystation of oocysts, the suspension was re-eluted in 5 mL of maintenance 
media and incubated at 37°C in a water bath for at least two hours to allow the full release 
of sporozoites from the oocysts. This suspension was then filtered through a syringe filter 
unit (Pall Scientific, New York, U.S.A.) containing a 2 µm Isopore™ membrane filter 
(Millipore, Massachusetts, U.S.A), to remove all oocyst shells and un-excysted oocysts, 
leaving a pure suspension of sporozoites. Following filtration, samples were checked by 
microscopy to ensure that they were oocyst-free and sporozoites were enumerated using a 
haemocytometer. As a control, intact but heat inactivated purified sporozoites (incubated at 
70°C for 30 min.) were also cultivated and stained as described below. 
 
4.2.4. Cell free cultivation 
 
Each well on a 48 well culture plate (Greiner Bio-One, CELLSTAR), contained 1.5 
mL of cell free maintenance media (RPMI-1640) containing 0.03 g l-glutamine, 0.3 g 
sodium  bicarbonate,  0.02  g  bovine  bile,  0.l  g  glucose,  25  µg  folic  acid,  100  µg  4-
aminobenzoic acid, 50 µg calcium pantothenate, 875 µg ascorbic acid, 1% fetal calf serum 
(Invitrogen), 0.36 g HEPES buffer, 10,000 U penicillin G and 0.0l g streptomycin  per 
100ml, adjusted to pH 7.4 as previously described by Hijjawi et al., (2004). Wells were 
inoculated with a 10 µl suspension of excysted C. hominis oocysts or purified sporozoites 
(~1 x  10
3/excysted oocysts or sporozoites/well) and were mixed thoroughly to ensure each 
10  µl  aliquot  contained  approximately  the  same  number  of  oocysts  or  sporozoites. 
Thelayer of coagulated newborn calf serum under the culture medium, which was included 110 
 
in the initial publication by Hijjawi et al., (2004) was not included in the present study, as 
it did not increase parasite DNA by qPCR. Cultures were incubated at 37°C, 5% CO2 for 9 
days and were inspected daily under an inverted light microscope (Olympus IMT-2) at 
magnifications ranging from 100X – 400X to check for the presence of life cycle stages.  
 
4.2.5. Preparation of parasites for staining and qPCR 
 
Samples were removed after 24 hrs, 48 hours, 3 days, 5 days, 7 days and 9 days 
post inoculation for staining and qPCR analysis. For all staining methods and for qPCR, 
each 48 well culture plate was trypsinised for 20 minutes to lift any parasites that were 
stuck to the plates and then the contents of 4 wells were removed, pooled and centrifuged 
at 2,000 x g for 8 minutes to concentrate parasites. The supernatant was removed down to 
approximately 200 µl and the pellet resuspended and placed into a 1.5 ml centrifuge tube. 
 
4.2.6. Microscopy, imaging and fluorescent staining techniques 
 
Cultures were examined daily using microscopy techniques outlined in section 2.5 
in General Materials and Methods. Fluorescent staining methods utilised in this chapter, 
Sporo-Glo
TM, Crypto Cel, FISH and TR staining techniques are all outlined in section 3.2. 
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4.2.7 DNA extraction and qPCR analysis 
 
DNA was extracted from all samples using a MoBio PowerSoil™ DNA isolation 
kit (MO BIO, Carlsbad, California, USA). This was performed in triplicate (i.e. 3 x 4 
pooled wells).  qPCR was performed in triplicate using a Cryptosporidium diagnostic locus 
unique to Cryptosporidium (Cgd3_440 which spans positions  52052 - 53389 of contig  
AAEE01000004  which  maps  to  chromosome  3)  as  previously  described  (Yang  et  al., 
2009). Heat-inactivated controls were analysed in the same manner.  A standard curve was 
constructed using 6 triplicates of genomic DNA extracted from known numbers of oocysts 
and serially diluted at a 1:9 ratio, calibrated to correspond to 1-10,000 oocysts. Statistical 
analysis was performed using SPSS 11.0 (Statistical Package for the Social Sciences) for 
Macintosh  OS  X  (SPSS  inc.  Chicago,  USA)  to  determine  if  there  was  a  statistically 
significant increase in parasite DNA compared to heat-treated controls. 
 
4.3 RESULTS 
   
   
In order to confirm the presence of various developmental stages of C. hominis in cell-free 
culture, images for individual stages that developed from initial inoculations with excysted 
oocysts  and  purified  sporozoites  were  captured  using  the  Cryptosporidium  specific 
polyclonal antibody Sporo-Glo™ and the Cry1 FISH probe. The negative control bacterial 
FISH  probe  (EUB338)  did  not  bind  to  any  of  the  life  cycle  stages  (data  not  shown). 
Parasites in different life cycle stages for cultures inoculated with excysted oocysts and 
purified  sporozoites  were  compared  using  microscopy  and  qPCR.  The  purity  of  the 112 
 
sporozoite  preparation  was  assessed  to  be  100%  (i.e.  no  oocysts)  as  determined  by 
microscopic examination and counting of sporozoites by haemocytometer. 
 
4.3.1 Life cycle stages of C. hominis in cultures inoculated with excysted oocysts 
 
The rate of excystation was variable as some oocysts excysted immediately (Figure 
4.1a) and some remained unexcysted for several days in cell-free culture. Trophozoites 
(Figure  4.1b)  appeared  24  hours  post-inoculation  of  excysted  oocysts  into  cell-free 
cultures, which were consistent with previous studies (Hijjawi et al., 2002; Hijjawi et al., 
2004).  Trophozoites  were  circular  to  oval,  uni-nuclear  stages,  which  developed  into 
meronts (Figure 4.1e). Trophozoites appeared to aggregate together in groups of two or 
more (Figure 4.1b, 4.1c), and occasionally more than 20 trophozoites,  resulting in  the 
development  of  the  meront  stage  (Figure  4.1e).  Aggregation  of  trophozoites  was  also 
observed in HCT-8 cultures (Figure 4.1d) where multiple sporozoites penetrated one cell 
and  developed  into  trophozoites  (Hijjawi  et  al.,  2002,  2004).    Trophozoites  were  also 
observed pairing laterally together in a process similar to syzygy in gregarines, which is 
defined as association of gregarine protozoa end-to-end or in lateral pairing without sexual 
fusion (Figure 4.1b, 4.1f). Interestingly, the transformation of sporozoites to trophozoites 
was also observed within unexcysted oocysts (Figure 4.1g), resulting in the formation of 
meronts inside the oocysts without excystation (Figure 4.1h).  
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Figure 4.1. Cryptosporidium hominis life-cycle stages from cell-free cultures inoculated 
with excysted oocysts.  
 
a = excystation of sporozoites, nomarski DIC (left) and stained with Sporo-GloTM (right); 
b = two C. hominis trophozoites (intermediate form between trophozoite and sporozoite 
pairing together in a process similar to syzygy and a third circular one is also attached to 
the two, nomarski DIC (left) and TR staining (right); c = pairing of multiple C. hominis 
trophozoites  and  (right)  stained  with  Sporo-GloTM;  d  =  multiple  aggregation  of 
trophozoites in HCT-8 cells similar to those observed in cell-free culture; e = development 
of a meront from trophozoites, nomarski DIC (left) and Sporo-GloTM staining (right); f = 
trophozoites pairing end to end in a process similar to syzygy, nomarski DIC (left) and TR 
staining (right); g = trophozoites forming inside an oocyst without excystation, nomarski 
DIC  (left)  and  TR  staining  (right);  h  =  aggregation  of  trophozoites  and  formation  of 
meronts inside the oocyst stage, nomarski DIC (left) and TR staining (right); i = meront I 
stage, nomarski (left), FISH staining (right); j = meront II forming a rosette-like pattern 96 
hrs post inoculation of C. hominis oocysts in cell-free culture, nomarski DIC (left) and 
FISH (right), k = merozoites released from meront II which are characterized by being 
spindle in shape with pointed ends, nomarski (left) and Sporoglo (right), l = macrogamont 
characterised by having a thick cell wall, similar in size to oocysts with one large nucleus, 114 
 
nomarski DIC (left) and FISH (right), m = zygote and the start of sporogony, nomarski 
DIC (left) and Sporo-GloTM (right). 
 
Meront stages were observed 48 to 72 hours post inoculation in cell-free culture 
and consistent with a previous study (Hijjawi et al., 2004), two morphological types of 
meronts were observed; meront I and meront II. Meront I were almost transparent grape-
like aggregates and were difficult to detect using Nomarski interference microscopy, but 
were readily detected using FISH (Figure 4.1i) and Sporo-Glo
TM (not shown). Meronts 
varied in  size according  to  the original number of trophozoites, which were originally 
aggregated together. Meront II can be differentiated from meront I by the presence of thick 
membrane around it which makes it impossible to identify its internal structure and any 
processes which occurs inside it. Some of meront II stages formed a rosette-like pattern 
(Figure 4.1j) and others were irregular in size and had different sizes and shapes  (not 
shown). Merozoites released from meront I and II varied in size and shape. Merozoites 
released  from  meront  I  appeared  to  be  actively  motile  and  mostly  circular,  however, 
merozoites released from type II meronts were bigger in size and sluggish, either broadly 
spindle-shaped with pointed ends, or rounded to polymorphic and had a thick membrane 
(Figure 4.1k).   
Sexual  stages  (microgamonts  and  macrogamonts)  were  observed  5  days  post-
inoculation in cell-free culture. As described in previous studies (Current and Reese, 1986; 
Hijjawi et al., 2004), microgamonts and macrogamonts appeared to form from type II 
merozoites.  Macrogamonts  were similar in  size to  oocysts with a large single nucleus 
(Figure 4.1l). Microgamonts, containing microgametes, occupied most of the cell around 
the  residuum  (not  shown).  Stages  resembling  zygotes/  unsporulated  oocysts  were  also 115 
 
observed with a large undifferentiated nucleus (Figure 4.1m). After day 5 a mixture of all 
C. hominis developmental stages including trophozoites, meront I and II, gametocytes and 
oocysts were observed since the development of this parasite in vitro is not synchronized. 
Only oocysts were observed in the heat-treated controls.  No progression to other life cycle 
stages was detected.  
 
4.3.2. Life cycle stages of C. hominis in cultures inoculated with purified sporozoites 
 
The  life-cycle  and  all  the  described  developmental  stages  described  earlier  in 
section 4.3.1 for C. hominis cultures inoculated with excysted oocysts was similar for those 
cultures  inoculated  with  purified  sporozoites  (Figure  4.2),  with  the  exception  that 
development of life-cycle stages appeared delayed, with the later stages appearing much 
later than for cultures inoculated with excysted oocysts. Trophozoites appeared 24 hours 
post-inoculation  of  purified  sporozoites  into  cell-free  cultures  and  appeared  to  from 
aggregates  of  two  or  more  (Figure  4.2b).  As  with  cultures  from  excysted  oocysts, 
aggregates up to 20 or more trophozoites were observed (Figure 4.2c), which resulted in 
the development of the meront I stages, which were not visualised until day 4 (Figure 4.2d) 
and meront II on day 5 (Figure 4.2e).  On day 7, sporulated oocysts were observed (Figure 
4.2f-g). Oocysts were also observed on day 8 and 9 (Figure 4.2h). No life-cycle stages or 
structures resembling life-cycle stages were detected in heat-treated purified sporozoite 
controls.  
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Figure 4.2. Cryptosporidium hominis life-cycle stages from cell-free cultures inoculated 
with filtered sporozoites. 
 
 a = purified sporozoites, b = pairing of C. hominis trophozoites, Nomarski DIC (left) and 
(right)  stained  with  Sporo-Glo
TM;  c  =  aggregation  of  trophozoites,  in  the  process  of 
developing into meronts, Nomarski DIC (left) and FISH staining (right); d = meront  I 
stage, Nomarski (left), FISH staining (right); e = meront II stage, Nomarski (left), Sporo-
Glo
TM staining (right); f = oocyst  day 7, Nomarski (left), Sporo-Glo
TM staining (right); g = 
same oocyst stained with CryptoCel
TM; h = oocyst  day 9, Nomarski (left), Sporo-Glo
TM 
staining (right). Scale bar = 5 µm. 
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4.3.3. qPCR analysis of cultures inoculated with excysted oocysts, purified sporozoites 
and heat-inactivated controls 
 
qPCR analysis  indicated an approximately 6.3-fold amplification of the parasite 
DNA for cultures inoculated with excysted oocysts over a 9 day period and a 5.9-fold 
amplification  for  cultures  inoculated  with  purified  sporozoites  over  the  same  period 
(Figure 4.3). A t-test revealed a significant (p < 0.01) increase in parasite DNA between 
days 5-9 compared to heat-treated controls.  It was also evident that, similar to the delay 
observed in microscopic analysis of cultures inoculated with purified sporozoites, qPCR 
amplification of parasite DNA also appeared delayed, with no increase in DNA until day 
three (Figure 4.3).  No amplification was seen in heat-inactivated controls (Figure 4.3). 
 
Figure 4.3. qPCR analysis of cultures inoculated with excysted oocysts, purified 
sporozoites and heat-treated controls over a nine day period. 
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4.4. DISCUSSION 
 
The present study reports for the first time the completion of the life cycle of C. 
hominis in cell-free culture and demonstration of multiplication of parasites using qPCR. 
In many previous studies, the observation of unsporulated / mature oocysts in any artificial 
culture system for Cryptosporidium provides definite proof for the completion of the life 
cycle  of  this  parasite  in  vitro  (Current  and  Reese,  1986;  Hijjawi  et  al.,  2003).  The 
completion  of  Cryptosporidium  life  cycle  by  observing  the  production  of  oocysts  was 
reported in cell-free culture (Hijjawi et al., 2004) as well in cell culture models using 
different cell lines such as Caco-2 cells, MDBK and HCT-8 cell lines (Buraud et al., 1991; 
Villacorta et al., 1996; Hijjawi et al., 2001; 2002). During the present study, the presence 
of  C.  hominis  oocysts  were  confirmed  in  cell-free  cultures  inoculated  with  purified 
sporozoites by the demonstration of oocyst wall staining using Crypto Cel (a monoclonal 
antibody preparation directed against the oocyst wall) (Figure 4.2g).  
Cryptosporidium hominis is an important species, which is restricted to humans and 
in many countries is more prevalent than C. parvum (Xiao, 2010). Being able to culture C. 
hominis in cell-free culture is of great significance since this species cannot be readily 
cultured in small animal models, unlike C. parvum which can be passaged through mice 
(Meloni  and  Thompson  1996).    A  gnotobiotic  pig  model  has  been  established  for  C. 
hominis  (Pereira  et  al.,  2002,  Widmer  et  al.,  2000)  and  C.  hominis  is  also  reportedly 
capable  of  infecting  and  proliferating  in  immunosuppressed  gerbils  (Baishanbo  et  al., 
2005); however, this is beyond the facilities of many laboratories. Thus an in vitro cell-free 
culture model will open new insights into our understanding of this human specific parasite 119 
 
and will facilitate many studies  regarding its  developmental biology, pathogenesis and 
drug susceptibility. 
The identification of all C. hominis life-cycle stages using both antibody (Sporo-
Glo
TM) and RNA (FISH) staining methods that are specific for Cryptosporidium provides 
further  proof  of  the  ability  of  Cryptosporidium  to  amplify  and  propagate  in  a  culture 
system devoid of host cells. In the present study, all life cycle stages of C. hominis with the 
exception of the oocyst stage, which is not recognised bySporo-Glo
TM, reacted strongly 
with Sporo-Glo
TM and it was easy to visualise each individual stage. Sporo-Glo
TM was 
particularly  useful  for  detecting  and  identifying  meront  I  stages  as  they  are  almost 
transparent using Nomarski interference microscopy (Figure 4.1i and 4.2d) and therefore 
very difficult to detect in cell-free culture. TR staining although non-specific was also 
included as it produced bright and clear details of the morphology of life cycle stages and 
particularly internal structures. 
qPCR analysis revealed a 6.3-fold increase in  DNA over a nine-day period for 
cultures  inoculated with  excysted oocysts and a 5.9-fold increase in  DNA for cultures 
inoculated with excysted sporozoites. This is similar to a recent study, which reported an 
estimated 5.6-fold increase in C. parvum DNA concentration over a 5-day culture period 
(Zhang  et  al.,  2009).  Both  microscopy  and  qPCR  analysis  indicated  that  cultures 
inoculated with purified sporozoites lagged behind those inoculated with excysted oocysts. 
The reason for this is unclear. It may be due to the fact that sporozoites are much less 
robust than oocysts and the stress of filtration followed by washing and centrifugation, may 
affect  their viability. When cell-free cultures  are inoculated with  excysted oocysts, the 
sporozoites can escape gradually from the oocysts shells and adapt quickly to the culture 
medium, therefore their chances for survival and initiation of their life cycle would be 
maximised. The observations in the present study are also consistent with a previous study 120 
 
in which it was reported that although both sodium hypochlorite-stimulated oocysts and 
purified sporozoites were able to initiate infection in BS-C-1 cell lines, cultures inoculated 
with purified sporozoites were less efficient (Deng and Cliver, 1998). 
In the present study, several unusual developmental pathways, some of which have 
been previously observed in C. parvum cell-free culture (Hijjawi et al., 2004; Hijjawi, 
unpublished)  were  visualised  for  C.  hominis.  These  include  multiple  associations  and 
pairing between various developmental stages, the demonstration of two morphologically 
distinct meronts (I and II) and the formation Cryptosporidium stages inside the oocysts 
without excystation. Lateral pairing of two stages (intermediates between trophozoites and 
sporozoites) similar to syzygy (Figure 4.1b and 4.1f) similar to the process which occurs in 
gregarines was observed for C. hominis. Syzygy of various developmental stages early in 
development has previously been described for C. parvum and C. andersoni (Hijjawi et al., 
2002;  2004  and  unpublished).    Soon  after  excysting  from  oocysts,  some  sporozoites 
approached each other in multiple numbers and aggregated together end to end, but the 
majority transformed into oval / circular trophozoites which then developed into meronts 
of different sizes (Figure 4.1e).  
Another  interesting  finding  in  the  present  study  was  the  visualisation  of 
trophozoites and meronts developing inside the oocyst. A recent study has also reported 
that merozoites were released from oocysts directly during an incubation and excystation 
procedure  without  bleach  treatment  (Karanis  et  al.,  2008).  Why  this  occurs  is  not 
understood. It may be a protective process by which  Cryptosporidium can increase its 
proliferative  potential  while  it  is  still  protected  inside  the  oocyst.  Further  studies  are 
required to better understand this phenomenon.  
A  recent  study  reported  that  Nomarski  interference  microscopy  images  of  C. 121 
 
parvum stages cell-free culture in the publication by Hijjawi et al., (2004) were actually 
debris  and  contaminants  (Woods  and  Upton,  2007).  However,  the  use  of  the 
Cryptosporidium specific polyclonal antibody Sporo-Glo™, the Cry1 FISH probe which is 
specific for Cryptosporidium and the fact that the negative control bacterial FISH probe 
(EUB338) did not bind to any of the life cycle stages in the present study provides strong 
evidence that the stages observed are in fact Cryptosporidium life-cycle stages and not 
contaminants. In addition, amplification of DNA detected via a highly specific qPCR and 
the lack of DNA amplification or the presence of life cycle stages in heat-treated controls 
also confirms that the parasite is indeed undergoing development in cell-free culture.  
The description of the complete development for two species of Cryptosporidium 
(C. parvum and C. hominis) in cell free culture highlights new information and differences 
to earlier interpretations of the developmental biology and life cycle of this parasite. The 
present results support phylogenetic studies suggesting that Cryptosporidium spp. are more 
closely related to gregarines than to coccidia (Morrison and Ellis, 1997; Carreno et al., 
1999; Leander et al., 2003b; Barta and Thompson, 2006). Only a 5 to 6-fold amplification 
of parasite DNA was attained, indicating that parasite multiplication was far from optimal 
and future studies need to concentrate on improving the level of parasite multiplication. 
Further research using cell free culture may unveil the capability of this intriguing 
parasite  to  amplify  under  different  conditions  and  provide  more  information  on  its 
developmental biology.  By combining current and future developmental and phylogenetic 
studies of this parasite, a clearer understanding of its position within the Apicomplexa and 
its closeness to the gregarines species can be achieved. 
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CHAPTER 5: 
SURVIVAL AND AMPLIFICATION OF 
CRYPTOSPORIDIUM PARVUM LIFE CYCLE 
STAGES IN WATER 
 123 
 
5.1 INTRODUCTION 
 
Water-borne transmission of the enteric parasite Cryptosporidium is recognized as 
a public health issue world-wide (Rose, 1997; Carey et al., 2004). The oocyst stage is 
environmentally robust and many studies have shown that it can remain viable under cool, 
moist  conditions  for  many  months,  particularly  in  cooler  climates  where  the  water 
temperatures in lakes, rivers, ponds and dams remain low but above freezing (Slifko et al., 
2000; Wier et al., 2002; Carey et al., 2004; Fayer, 2004; Collinet-Adler and Ward, 2010). 
The oocyst stage is resistant to conventional disinfectants used by the water industry to 
disinfect water, including chlorination (Rose and Gerba, 1991; Robertson, 1992; Carpenter 
et al., 1999; Karanis et al., 2007; Collinet-Adler and Ward, 2010).  
  Cryptosporidium has a world-wide geographic distribution and has the ability to 
cause  infection  at  relatively  low  doses,  highlighting  its  potential  for  water-borne 
transmission  (Carey  et  al.,  2004;  Fayer  et  al.,  2000,  Fayer,  2004).    There  have  been 
numerous documented reports of water-borne outbreaks of cryptosporidiosis of varying 
size throughout the world. These outbreaks have been associated with the contamination of 
well  water,  filtered  and  unfiltered  drinking  waters,  recreational  waters  and  chlorinated 
swimming pools (MacKenzie et al., 1995; Rose, 1997; Smith, 1998; Slifko et al., 2000; 
Carey, et al., 2004; Karanis et al., 2007). 
  Recent developments in in vitro cultivation have revealed that Cryptosporidium can 
complete its life cycle in media devoid of host cells (Hijjawi et al, 2004; Hijjawi, 2010), 
which highlights the deficiency of our knowledge about the biology of this parasite. 
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As the oocyst is believed to be the only stage in the life cycle capable of surviving in the 
environment, current detection methods for Cryptosporidium within the water industry and 
studies  conducted  to  assess  the  survival  of  Cryptosporidium  under  environmental 
conditions have focused on the oocyst. Preliminary work in our laboratory, demonstrated 
the presence of Cryptosporidium life cycle stages appearing in samples, which had been 
stored in water for long periods of time. This present study was conducted to determine if 
C. parvum could complete its life cycle in water, as this will have an impact on the current 
understanding  of  the  ecology  of  this  organism  in  natural  water  bodies  and  will  have 
implications  for  the  drinking  water  industry.  In  Chapter  4,  it  was  noted  that  cultures 
inoculated with purified sporozoites lagged behind those inoculated with excysted oocysts. 
The reason for this is unclear. It was therefore decided that for experiments on water, that 
excysted oocysts and not purified sporozoites would be used for inoculation into water 
samples. The specific aims of the experiments reported in this chapter were to: 
1.  Determine if C. parvum life cycle stages can survive in different water types at 
various temperatures. 
2.  Investigate whether the parasite will continue through its life cycle under these 
conditions. 
3.  Determine any increase in the number of life cycle stages present over time (an 
increase in DNA mass over time).  
4.  Determine if the life cycle is completed (i.e. are new oocysts produced). 
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5.2 MATERIALS AND METHODS 
 
The  Cryptosporidium  isolate  used,  oocyst  purification,  oocyst  treatment,  media 
preparation, cell free cultivation in culture plates and microscopic techniques are described 
in the general materials and methods (Chapter 2).  Fluorescent staining methods described 
in Chapter 3 were utilised in this chapter. Specific techniques were also applied in this 
chapter and are outlined below. 
  Each well on a 48 well culture plate contained 1.0 mL of either filter-sterilised tap 
water or filter-sterilised rain water and were inoculated with 1,000 oocysts and incubated 
as described in section 2.4.4. Figure 5.1 represents a flow diagram outlining the experiment 
set-up.  Samples  were  removed  from  culture  wells  following  the  procedure  outlined  in 
section 2.4.6. For qPCR analysis, samples were removed after 0, 3, 6, 9 and 12 days post 
inoculation, samples were removed daily for microscopic imaging and every third day 
fluorescent staining techniques were applied. For oocyst counts, samples were removed at 
0, 3, 6, 9 and 12 days. Intact but heat inactivated oocysts (incubated at 70°C for 30 min) 
were used as a control and were subjected to all the same treatments as the test samples. 
 
5.2.1 DNA Extraction 
 
Samples  were  subjected  to  5  freeze  and  thaw  processes  in  liquid  nitrogen  (1 
minute) and boiling water (1 minute), followed by incubation in a boiling water bath for 30 
minutes. Finally samples were centrifuged briefly for 3-5 seconds to settle samples and 
then stored at -20°C until required. 126 
 
5.2.3 Quantitative PCR protocol (qPCR) 
 
The quantity of DNA present in each sample was determined using the primers 5'-
AAGAAGGCCGTGTTGGCTTA-3'  and  5'-GGGATTCAGCCCACCAGAAT-3' 
(MacDonald et al., 2002). The primers amplify an 85bp fragment of DNA, which codes for 
a  C-type  lectin  containing  protein  with  a  transmembrane  domain  and  mucin-like  rich 
regions,  which  appears  to  be  unique  to  Cryptosporidium  (cryptodb.com).  This  85bp 
fragment lies within the 680 bp diagnostic fragment identified by Morgan et al., (1996). 
Specificity  and  sensitivity  has  shown  these  primers  to  be  highly  specific  for 
Cryptosporidium with a detection limit of one oocyst (Morgan et al., 1996; MacDonald et 
al., 2002).  
  The  PCR  (25  µL)  was  performed  in  6.7  mM  Tris-HCl,  4.5  mM  MgCl2,  10 
picomole  of  each  primer,  1.25  picomole  Taqman
®  probe  (FAM/TAMRA;  5'-
TTCTGAGCTTTCTTGTGCAGTTTGTGGTACA-3'), 1 unit of Tth plus (Fisher-biotech, 
Western Australia) and 6.25 picomole of each dNTP with 5 µL of DNA template added. 
Samples were run on a RotorGene 3000 (Corbett Life Science, Sydney, Australia) using 
the following conditions; 1 cycle of 95°C for 2 minutes followed by 40 cycles of 94°C for 
20 seconds and 60°C for 1 minute. 
  Samples were compared against DNA standards extracted from known numbers of 
oocysts. A standard of serially diluted DNA extract was also included for each run as an 
internal PCR control. Five replicates of each sample were analysed.  
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5.2.5 Data analysis and statistics 
 
5.2.5.1 Oocyst counts 
The  total  number  of  oocysts  present  in  each  sample  was  estimated  using  a 
haemocytometer as described in section 2.3. Five replicate aliquots of each sample were 
counted. 
 
5.2.5.2 qPCR 
For the qPCR analysis, the threshold cycle (CT) data for experiments was analysed 
and  adjusted  to  experimental  controls  (counted  oocysts).  Samples  were  analysed,  and 
expressed as oocyst equivalents on plotted graphs. Standard error bars were calculated 
using 95% confidence limits from the five replicate samples. 
 
5.2.5.3 Statistical analysis 
The data were analysed by ANOVA using MINITAB statistical software (Minitab 
Inc., 2000,  U.S.A). Tukey’s  pairwise comparison was  used to  determine if there were 
differences between levels within a factor. 
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5.3 EXPERIMENTAL DESIGN 
 
5.3.1 Survival and amplification of Cryptosporidium parvum life cycle stages in tap 
and rain water at various temperatures 
 
Approximately  1,000  C.  parvum  oocysts  (pre-treated  with  0.25%  sodium 
hypochlorite followed by acidic water for excystation) were inoculated into each culture 
plate well containing filter sterilised tap or rain water and subsequently incubated at one of 
four temperatures; 4°C, 15°C, 24°C or 37°C. Oocyst numbers were quantified on days 0, 3, 
6,  9  and  12  by  counting  using  a  heamocytometer  and  C.  parvum  DNA  concentration 
(oocyst equivalents) was quantified by qPCR on days 0, 3, 6, 9, and 12. Oocysts inoculated 
into culture wells were checked daily using an inverted microscope at 400x magnification 
to observe life cycle development. Samples were also collected over the course of the 
experiment for morphological analysis at 1000x magnification on an upright microscope. 
Nomarski Interference contrast microscopy and fluorescent antibody staining techniques 
were used to identify and confirm the presence of life cycle stages. 
 
A  total  of  twenty-four  48-well  plates  were  analysed  (one  48-well  plate  per 
temperature and time point). For each media type, temperature and time point, there were 5 
wells (replicates) for qPCR analysis and 2 wells for microscopic examination (refer to 
Figure 5.1). Approximately 1,000 oocysts were inoculated into each well containing 1 ml 
of the appropriate medium type. 4°C plates were placed in the fridge, the 15°C samples 
were stored in a dedicated fridge kept at 15°C, the 24°C samples were maintained at room 129 
 
temperature  (temperatures  ranged  between  22°C  and  25°C),  and  the  37°C  plates  were 
placed in an incubator. At the appropriate time points, plates were taken and each well was 
checked under the microscope to monitor the development of the cultures and to assess any 
differences between water types and temperatures the samples were collected for qPCR 
analysis,  oocyst  counts  and  microscopic  examination  and  imaging  under  1000x 
magnification. 130 
 
Figure 5.1. Flow chart outlining experiment set-up to determine survival and amplification 
of Cryptosporidium parvum in purified tap and rain-water at various temperatures.  
 
 
 
Filter sterilised tap water                           
4°C        15°C        24°C        37°C 
Incubation temperatures: 
 
Samples monitored daily by 
microscopy for life cycle 
development 
Samples collected 
from 2 wells at 0, 3, 
6, 9 and 12 days   
 
Samples collected from 5 
wells at 0, 3, 6, 9 and12 
days 
 
DNA extraction 
qPCR analysis 
Oocysts counted using a 
haemocytometer. Each 
sample counted in triplicate  
Filter sterilised rain water                           
Samples removed from 
culture wells for 
fluorescent microscopy 
techniques daily 
~ 1000 purified and pre-treated oocysts inoculated into 
48 well plates with wells containing: 131 
 
5.4 RESULTS 
 
5.4.1 Survival and amplification of Cryptosporidium parvum life cycle stages in tap 
and rain water at various temperatures 
 
5.4.1.1 Examination of life cycle development by microscopy 
Observations by microscopy of C. parvum cultures in tap and rain water incubated 
at 4°C, 15°C, 24°C and 37°C, revealed that not only could this parasite survive for at least 
12 days, but also that sporozoites could excyst from oocysts and proceed through the life 
cycle  (Figure  5.2).  Life  cycle  stages  appeared  at  the  same  time  points  as  previously 
described  in  cell  and  cell  free  culture  systems  (Hijjawi  et  al.,  2002,  2004,  2010). 
Microscopically, differences were observed in the initial development of Cryptosporidium 
incubated at different temperatures as well as between water types. 
  Examination  of  C.  parvum  cultures  after  24  hours  in  both  water  types  and  all 
temperatures revealed excysted, excysting (Figure 5.2B) and un-excysted oocysts. Many 
excysted sporozoites (Figure 5.2C) had matured into motile trophozoites (1.9 x 1.3 µm), 
which would fuse together forming aggregates of two or more trophozoites (Figure 5.2D). 
  After 48 and 72 hours, oocysts were still observed excysting and more trophozoite 
aggregates  were  present,  with  some  undergoing  mitotic  division  and  developing  into 
meronts. The size of meronts ranged from 3.8 x 2.6 µm to 7.0 x 8.2 µm and sometimes 
larger, depending on the number of initially fused trophozoites. Consistent with previous 
observations (Hijjawi et al., 2001, 2002, 2004, Hijjawi, 2010), two different meront types 
were observed developing in the water. Meront type I stages (Figure 5.2E) appeared as 132 
 
early as 48 hours and released circular, actively motile merozoites (0.7 x 0.8 µm) (Figure 
5.2F). These merozoites would mature, and then clump together forming Type II meronts 
(Figure 5.2G), which would be present from 72 hours onwards. Type II meronts had a 
more irregular shape and appeared denser, the majority of merozoites released from type II 
meronts were round (1.0µm x 0.8µm), and a few were spindle shaped (1.9µm x 0.7µm) 
(Figure 5.2H).  
  As  with  previous  studies  (Hijjawi  et  al  2001,  2002  and  2004),  sexual  stages 
developed from type II merozoites. These stages, (micro and macrogamonts) were first 
visualised after 5-6 days.  Microgamonts appeared very dark and measured 5 x 5.6 µm 
(Figure  5.2I).  Developing  microgametes  were  visible  leaving  the  microgamonts  via  a 
suture and often clumps of microgametes were seen after full rupturing of the microgamete 
membrane.  Individual  microgametes  (Figure  5.2J)  were  also  visualised  moving  freely.  
Microgametes varied in size from 1.5 x 1.2 µm to 2.0 x 1.7 µm, depending on their stage 
of maturity. Macrogamonts were identified by their characteristic peripheral nuclei and 
measured 5 x 4 µm  (Figure 5.2K). Microgametes  on several  occasions were observed 
adhering to the surface of macrogamonts (Figure 5.2L) resulting in fertilisation and the 
formation of a zygote (Figure 5.2M), which matured into a new sporulated oocyst (Figure 
5.2A). 
  Due to the delay in excystation of some oocysts, a variety of stages were observed 
over the course of the experiment, including unsporulated and sporulated oocysts, meront 
I, meront II, merozoites, macrogamonts and microgamonts. Spontaneous excystation was 
regularly observed throughout the 12 days.  
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Figure 5.2. Cryptosporidium parvum life cycle stages observed developing in rain and tap 
water incubated at 4, 15, 24 and 37°C over a 12 day period. (Scale Bar= 5µm). 
 
 
5.4.1.2 Fluorescent microscopy 
The  fluorescent  antibody  staining  techniques  Crypto  Cel  and  Sporo-Glo™, 
described in chapter 3, were implemented in this experiment to provide further evidence of 
life  cycle  development  of  C.  parvum  in  water  at  various  temperatures.  Samples  were 
collected daily for examination using fluorescent antibody stains Crypto Cel and Sporo-
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Glo™. Many trophozoites, some of which were very active, meront I and II and excysting 
oocysts were observed. Some unsporulated oocysts were observed from day 9 onward, 
however, no micro- or macrogametes were observed during sampling when staining with 
these fluorescent antibodies (Figure 5.3). 
 
5.4.1.3 Oocyst counts 
Total oocyst numbers significantly increased from day 0 to day 9 (p< 0.05). After 
day 9 total oocysts numbers declined, however, they stayed well above the inactivated 
controls and initial inoculum (Figure 5.4). The greatest mean oocyst numbers were seen in 
rain water incubated at 15 and 24°C (Figure 5.4). No oocysts or other life cycle stages 
were detected in the heat-treated control samples (data not shown). 
 
 135 
 
Figure 5.3. Cryptosporidium parvum life cycle stages derived from tap and rain water 
stained  with  fluorescent  antibody  stains;  Sporo-Glo™  and  Crypto  Cel.
 
a = Nomaski (left) and Sporo-Glo
TM staining (middle) and Crypto Cel staining left; a = 
unexcysted and excysting oocysts; b = Nomaski (left) and Sporo-Glo
TM Crypto Cel overlay 
(right) b = excysting oocysts, c-e = Nomaski (left) and Sporo-Glo
TM staining (right) c = 
trophozoite clump d = meront, e = meront. Scale bar = 5 µm. 
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Figure 5.4. Mean number of Cryptosporidium parvum oocysts counted in tap and rain 
water incubated at 4, 15, 24 and 37°C over a 12 day period. Error bars represent standard 
error (n=5). 
 
 
5.4.1.4 Quantitative-PCR analysis 
Based on qPCR analysis, samples showed an approximately 3 fold increase in the 
number of life cycle stages from day 0 to day 9 (p<0.05) (Figure 5.5). The largest increase 
was seen in samples incubated in rain water at 15 and 24 °C, which agreed with oocyst 
counts  (Figure  5.5  compared  with  Figure  5.4).  After  9  days,  the  number  of  oocyst 
equivalents  declined,  however,  levels  were  still  significantly  greater  (p<0.05)  than  the 
initial inoculum and heat-treated controls in all samples (Figure 5.5). 
  Peak numbers of oocysts were reached at day 9 for both counts and qPCR, but 
DNA quantification indicated the presence of many more ‘oocyst equivalents’ than could 
be accounted for by oocyst counts in all the inoculated wells.  
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Figure 5.5. Quantitative PCR analysis of Cryptosporidium parvum incubated in tap and 
rain water at 4, 15, 24 and 37°C over a 12 day period. Error bars represent standard error (n 
= 5). 
 
 
5.5 DISCUSSION 
 
The present study has shown for the first time that C. parvum can complete its life 
cycle and multiply in water. This was demonstrated in tap water and rainwater by the 
presence of life cycle stages other than the oocyst as well as by an increase in oocyst 
numbers by microscopy and oocyst DNA equivalents by qPCR over time. These results 
confirm other studies showing that C. parvum can survive under a range of environmental 
conditions (Robertson et al., 1992; Fayer et al., 1998; Pokorny et al., 2002). Microscopic 
observations of inoculated tap and rainwater revealed the presence of all developmental 
phases including merogony, gametogony and sporogony as described by Hijjawi et al., 
(2002, 2004). All stages appeared at time-points consistent with cultured Cryptosporidium 
(Hijjawi et al., 2004). In addition, due to the delayed excystation of a proportion of the 
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oocysts, there were many different life cycle stages present at any one time. Spontaneous 
excystation was observed in all samples throughout the experiment demonstrating that no 
additional laboratory trigger was required for the release of sporozoites. An interesting 
observation noted on several occasions when oocysts were excysting at delayed times, was 
that the sporozoites had appeared to have already matured into trophozoites prior to their 
release into the external environment.  Among Cryptosporidium researchers, it is common 
belief that the sporozoites are quite sensitive to external conditions (unpublished data), 
therefore, perhaps the maturation of sporozoites to trophozoites within the oocysts prior to 
excystation is a response to external conditions and a survival mechanism to enable the 
continuation of the life cycle.   
Both direct microscopy counts and qPCR showed a peak in oocyst numbers on day 
9 in all samples but counts were lower for microscopy than qPCR. It is likely that the 
discrepancies between qPCR and microscopy counts was due to the fact that only oocysts 
were counted by microscopy, whereas qPCR detected the DNA from all life cycle stages 
present in the sample but expressed the results as oocyst equivalents (due to the nature of 
the DNA standard used), where as microscopy would have missed many of the smaller 
life-cycle stages as they are difficult to see. By qPCR there was an approximately 3 fold 
increase  in  parasite  DNA  compared  to  heat-treated  controls.  This  is  less  than  the 
approximately 6 fold increase that was seen using cell culture media, however this is to be 
expected as the media provided nutrients for the survival and maintenance of the parasite 
that would have been lacking in rain and tap water. 
  The source of energy that drives the development of the various Cryptosporidium 
life cycle stages  in  the environment  is  still  largely unknown.  Cryptosporidium  oocysts 
contain a residual body consisting of a large lipid body, a crystalline protein inclusion and 
numerous amylopectin granules which act as a source of energy for the maintenance of 139 
 
sporozoites during the transmission period in the environment or during storage (Fayer et 
al., 1998a; Harris et al., 2004; King et al., 2005). Cryptosporidium species possess both 
anaerobic  and  aerobic  metabolic  pathways  giving  them  environmental  flexibility 
(Abrahamsen et al., 2004; Xu et al., 2004; Barta and Thompson, 2006). Further, the greatly 
reduced biochemical repertoire of Cryptosporidium species, which lack either a functional 
mitochondrion  or  apicoplast,  means  the  life  cycle  stages  salvage  nutrients  for  their 
metabolic needs from the environment (Abrahamsen et al., 2004; Xu et al., 2004; Barta 
and Thompson, 2006). Whether this allows for some flexibility in the nutrient resources 
required  for  different  life  cycle  stages  is  not  known.  Certainly,  studies  assessing  the 
survival of Cryptosporidium oocysts incubated at various temperatures in natural waters 
demonstrated  a  direct  proportionate  increase  in  degradation/inactivation,  (or  decreased 
infectivity), with an increase in temperature (Fayer, 1994; Jenkins et al., 1997; Fayer et 
al.,1998; Olsen et al., 1999;Walker et al., 2001; King et al., 2005). In a recent study by 
King et al., (2005), the use of an oocyst ATP assay indicated that oocyst inactivation at 
higher temperatures was a function of increased oocyst metabolic activity, resulting in a 
depletion of energy stores (King et al., 2005). The relationship between the depletion of 
ATP in oocysts and the development of life cycle stages has yet to be established.  
  It is possible that in closed systems such as this experiment, energy stores released 
from degraded, broken and excysted oocysts as well as sporozoite energy stores may be 
utilised for differentiation of sporozoites, maintenance of cells and for growth producing 
new  infective  oocysts.  This  may  also  be  of  particular  significance  when  oocysts  are 
trapped  in  biofilms,  which  have  the  potential  to  be  an  environmental  reservoir  for 
Cryptosporidium and an additional source of nutrients (Keevil, 2003; Searcy et al., 2006).  
  In addition to the outcomes from the present study, there is growing evidence that 
Cryptosporidium may also survive or propagate in the environment by other means. Recent 140 
 
molecular and biological studies demonstrate that Cryptosporidium should be placed in a 
taxonomic group separate from coccidia and closer to the gregarines (reviewed in Barta 
and Thompson, 2006). Gregarine protozoa are ubiquitous parasites of invertebrates and 
lower vertebrates and thus are common in natural water sources. Given the similarities 
between the gregarines and Cryptosporidium, it is possible that Cryptosporidium can infect 
invertebrates, amplify further in the environment and thus may be more prevalent in water 
sources than currently thought.  
  Contrary  to  the  currently  held  belief  that  Cryptosporidium  needs  a  host  to 
propagate,  results  from  this  study  demonstrate  the  potential  for  Cryptosporidium  to 
amplify  its  life  cycle  stages,  including  the  infective  oocyst,  in  the  environment.  The 
possible growth of  Cryptosporidium  in  the environment  needs  to  be considered in  the 
assessment of risks to drinking water supplies, particularly in light of the fact that current 
detection methods used by the water industry only target oocysts.  Data on the survival of 
life cycle stages other than oocysts under the conditions they are exposed to in the natural 
environment are required to establish the risk posed by these stages. 
  While the propagation of Cryptosporidium in tap water was investigated in this 
study, no assessment of chlorine concentrations in samples was undertaken and hence it is 
not clear what effect chlorine has on the various life cycle stages. As a key barrier in 
drinking  water  supply,  the  ability  of  chlorine  and  chloramines,  as  well  as  other 
disinfectants used by the water industry, to disinfect the various Cryptosporidium life cycle 
stages needs to be determined in order to fully assess water quality risks.  
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CHAPTER 6: 
INFECTIVITY OF NON-OOCYST LIFE CYCLE 
STAGES OF CRYPTOSPORIDIUM PARVUM TO 
NEONATAL MICE 
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6.1 INTRODUCTION 
 
Animal  infectivity  models  are  the  most  direct  method  for  the  assessment  of 
viability and infectivity of Cryptosporidium oocysts.  This method is considered the ‘gold 
standard’ for determining Cryptosporidium oocyst infectivity and has been used in studies 
assessing oocyst survival under environmental conditions (Fayer, 1994; Fayer and Nerad, 
1996; Fayer et al., 1998a, b; Freire-Santos et al., 1999; Jenkins et al., 2003). Hijjawi et al., 
(2004), demonstrated the infectivity of oocysts collected from 46 day old cell free cultures 
to  neonatal  mice.  However,  no  studies  to  date  have  been  carried  out  assessing  the 
infectivity of life cycle stages other than oocysts. This reason behind this is because the 
oocyst is universally known as the ‘environmental’ or ‘infective’ stage (refer to section 
1.7.1.1.).  Oocysts  possesses  a  robust  cell  wall  capable  of  withstanding  adverse 
environmental pressures (Fayer and Unger, 1986; Fayer, 2008), however, once inside the 
host and exposed to conditions in the stomach, infective sporozoites are released which 
begins the endogenous phase of the life cycle. It is not known how ingested sporozoites, 
trophozoites or merozoites react to conditions in the stomach or whether they survive and 
are able to infect the host. Another possibility for the infectivity of other life cycle stages 
not being explored could be the difficulty in recognizing the life cycle stages due to their 
very small size and sometimes ambiguous shape. Experiments conducted in this chapter set 
out  to  explore  the  possibility  of  meront  and  merozoite  stages  derived  from  cultivated 
oocysts in rainwater being infective to neonatal mice. 
  Cryptosporidium  infections  tend  to  localise  to  particular  areas  of  the 
gastrointestinal tract and these areas differ depending on the species or strain. The primary 
site of infection with C. parvum is the small intestine, and in some animals such as mice, 143 
 
the favoured location is the ileum above the ceacal junction (Tzipori and Widmer, 2008). 
When looking for histological evidence of infection, it is important to know the specific 
site of infection to ensure the correct part of the intestinal tract is collected for processing 
and ultimately an answer is confidently determined. Part two of this chapter investigates 
the  site  of  infection  for  the  C.  parvum  cattle  genotype  (Swiss  cattle  C26)  used  in 
experimentations  throughout  this  study.  By  determining  the  site  of  infection,  this  will 
enable successful sampling for histological examination of infections. 
 
The specific aim of the experiments reported in part 1 of this chapter was to; 
1.  Determine  the  infectivity  of  non-oocyst  life  cycle  stages  derived  from  oocysts 
incubated in water to neonatal mice. 
 
The specific aim of the experiments reported in part 2 of this chapter was to; 
1.  Determine the specific site of infection of C. parvum oocysts in neonatal mice. 
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6.2 MATERIALS AND METHODS 
 
  The  Cryptosporidium  isolate  used  in  this  procedure,  oocyst  purification,  oocyst 
treatment, media preparation, cell free cultivation, intra-gastric inoculation of mice and 
microscopic techniques are described in the general materials and methods (Chapter 2). 
The  qPCR  method  used  in  this  chapter  was  described  in  section  5.2.3.2.  Specific 
techniques were also applied in this chapter and are outlined below. 
 
6.2.1 Cultivation and collection of C. parvum life cycle stage for inoculation into mice 
 
Pre-treated  oocysts  were  placed  into  rainwater  in  a  25  cm
2  culture  flask  and 
incubated at 24°C for 4 days for meronts and merozoites to develop. Contents were then 
removed from the flasks by mixing the contents up and down to lift any stages that may 
have stuck to the flask, and then placed into a 10 mL centrifuge tube. The tube(s) were 
then centrifuged at 2,000 x g for 8 minutes to concentrate life cycle stages. The supernatant 
was removed down to approximately 500 µl and the pellet was then resuspended in 5 mL 1 
x  PBS.  Oocysts  were  separated  from  other  life  cycle  stages  using  Dynal
®  anti-
Cryptosporidium  DynaBeads
®  following  the  manufacturer’s  instructions,  with  the 
exception that the supernatant was retained as this contained the C. parvum meronts and 
merozoites. The Cryptosporidium antibody attached to the DynaBeads
® is directed against 
the Cryptosporidium oocyst wall protein (COWP), which is not present on life cycle stages 
other than the oocyst. The DynaBeads
® supernatant suspension containing the C. parvum 
life cycle stages was further purified on a Ficoll
® density gradient to ensure no oocysts, or 
oocyst  walls  remained.  Section  2.2  describes  the  protocol  for  Ficoll
®  density  gradient 145 
 
separation; however, instead of taking the interphase at the 2 mL mark, the top 1.5 mL 
which contains the life cycle stages (and not oocysts) was removed and used to infect 
mice. The suspension was screened by microscopy at 400x magnification to ensure no 
oocysts were present. 
 
6.2.2  Inoculation  of  purified  meronts  and  merozoites  into  neonatal  mice  and 
processing of mice post-inoculation 
 
One litter of neonatal ARC/Swiss mice (4-5 days old) (n= 11) were inoculated 
intragastrically with the purified life cycle stages (approximately 25,000 stages per mouse). 
Two litters of neonatal ARC/Swiss mice were used as controls which were inoculated with 
either; sterile rain water (negative control) or oocysts only (positive control). 
 
6.2.3 Examination of mice for evidence of infection with C. parvum 
 
Mice were euthanised four days post-inoculation and gastrointestinal tracts were 
examined in a few different manners to search for evidence in infection. 
 
6.2.3.1 Collection of gastrointestinal tract tissue for histopathological analysis 
Five mice from each group were randomly selected and the small intestine from the 
duodenum  to  just  before  the  caecum  of  each  was  removed  and  sectioned  into  three 
sections. Approximately 1 – 1.5 cm of each these sections were randomly excised from 146 
 
each of the mice. The tissue sections were fixed in Bouins fixative for 5 hours, followed by 
3 x 1 hour washes in 70% ethanol. Tissues were then processed for histological sectioning, 
thin sections were cut and stained with heamotoxylin and eosin. 
 
Figure 6.1. Flow diagram of experimental design to determine infectivity of life cycle 
stages derived from oocysts. 
 
 
 
Oocysts isolated and removed from other life cycle stages using 
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6.2.3.2 Purification of C. parvum life cycle stages from mice 
The gastrointestinal tract from the remainder of the mice (n = 6) in each group was 
processed as described in section 2.2, with the exception that Dynal
® anti-Cryptosporidium 
Dynabeads replaced the Ficoll
 gradient to isolate any oocysts. Aliquots of the sample 
pellets and supernatants were analysed by microscopy to check for the presence of oocysts 
and other life cycle stages. An estimation of the number of oocysts recovered was made 
using a haemocytometer. Images of recovered oocysts and life cycle stages were taken and 
recorded. 
 
6.2.4 Determining the site of infection of C. parvum in neonatal mice 
 
Due  to  the  lack  of  histological  evidence  of  infection  with  C.  parvum,  a  new 
experiment was designed to determine the site of infection in neonatal ARC/Swiss mice (4-
5 days old) for this strain of Cryptosporidium. The mice were inoculated intragastrically 
with C. parvum oocysts. 
 
6.2.4.1 Sectioning of gastrointestinal tract 7 days post infection 
The inoculated mice were euthanised 7 days post inoculation with C. parvum (refer 
to section 2.2). Four mice were selected and their gastrointestinal tract from the duodenum 
to the rectum was carefully removed and straightened. Using the outside smooth edge of 
the  dissection  scissors,  the  contents  of  the  large  colon  were  carefully  pushed  out  by 
dragging the scissors along the outside of the colon whilst it was laying on a board. Then, 
using  a  10  mL  syringe  and  a  20  gauge  needle  covered  with  plastic  tubing,  the  entire 148 
 
gastrointestinal tract was carefully flushed with 1 x PBS to remove luminal contents. The 
gastrointestinal tract was then laid flat and dissected into 3 roughly equal sections (labeled 
1,  2  and  3).  These  sections  were  then  further  dissected  into  3  roughly  equal  sections 
(labeled a, b and c) (refer to Figure 6.2). Each of these sections measured approximately 3 
cm each. Gut sections were placed into clean 1.5 mL microcentrifuge tubes containing 0.5 
mL of 1 x PBS. 
 
Figure 6.2. Diagram demonstrating the dissection of the gastrointestinal tract. 
 
6.2.4.2 DNA extraction of mice gastrointestinal tract sections and qPCR analysis 
Gastrointestinal  sections  were  homogenised  in  the  tubes  using  a  tissue 
homogeniser,  thereafter,  they  were  subjected  to  DNA  extraction  using  the  Epichem 
MasterPure™ DNA purification kit following the manufacturer’s instructions for tissue 
samples. Samples were stored at -20°C until required for qPCR analysis. qPCR analysis 
was conducted as described in section 5.2.3. 
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6.2.4.3 Preparation of gastrointestinal tissue for histopathological examination 
The gastrointestinal tracts were carefully removed and straightened, and then the 
1.5 cm section of ileum directly before the caecum was removed and halved. This section 
of  gut  was  chosen  based  on  results  shown  in  section  6.3.2.  The  tissue  was  fixed  for 
histopathological examination (see section 6.2.2.1). 
 
6.2.4.4 Purification of C. parvum life cycle stages from mice 
The  remainder  of  the  gastrointestinal  tract  from  all  mice  in  each  group  was 
processed as described in section 2.2, with the exception that Dynal
® anti-Cryptosporidium 
Dynabeads replaced the Ficoll
 gradient to isolate any oocysts. The supernatant was also 
observed microscopically to determine the presence of other life cycle stages.  
 
6.3 RESULTS 
 
6.3.1 Infectivity of C. parvum life cycle stages to neonatal mice 
 
6.3.1.1 Presence of C. parvum life cycle stages in intestinal material 
The number of life cycle stages inoculated into each mouse was estimated to be 
approximately 25,000, although it is very difficult to enumerate these stages due to their 
small size. No oocysts were observed in the inocula. Mice were euthanised 4 days post 
infection  and  gastrointestinal  tracts  were  processed  to  examine  for  the  presence  of  C. 
parvum life cycle stages and oocysts. On microscopic inspection of purified material from 150 
 
6 mice infected with meronts and merozoites, 1.1 x 10
6 oocysts were recovered and other 
life cycle stages such as sporozoites and microgametes were observed (Fig. 6.3). 
  Mice  inoculated  with  oocysts  returned  life  cycle  stages  such  as  trophozoites, 
meronts, and merozoites at 4 days post infection, no oocysts were detected (Fig. 6.4). No 
Cryptosporidium  life  cycle  stages  were  seen  in  negative  control  mice  inoculated  with 
sterile rainwater. 
 
6.3.1.2 Histopathological examination of gastrointestinal tissue 
No evidence of infected intestinal epithelial cells was observed in any of the tissues 
collected using methodology described in section 6.2.3.1, including the positive controls. 151 
 
Figure  6.3.  Life  cycle  stages  recovered  from  neonatal  mice  inoculated  with 
Cryptosporidium parvum meronts and merozoites at 4 days post infection.  
 
a  =  microgamete,  b  and  c  =  sporulated  oocysts,  d  =  excysting  oocyst,  e  =  motile 
sporozoites and f = excysted oocyst with residual body still intact. Scale bars = 5 µm. 
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Figure 6.4. Life cycle stages recovered 4 days post infection from mice inoculated with 
Cryptosporidium parvum oocysts. 
 
 
 
 
 
 
 
a and e = merozoites, b, c and d = meronts. Scale bar = 5µm. 
 
6.3.2 Determination of site of infection of C. parvum in neonatal mice 
 
qPCR  analysis  of  gastrointestinal  sections  of  C.  parvum-infected  neonatal  mice 
determined the site of infection to be located in the ileum of all four mice. Figure 6.5 
demonstrates the detection of C. parvum throughout the gastrointestinal tract of neonatal 
mice. The first half of the small intestine (duodenum and jejunum) shows a low quantity of 
C. parvum DNA, the quantity of DNA detected increases toward and through the ileum 
and decreases again from the caecum through the large colon. 
  In order to identify the region of the ileum that contained the highest infection 
levels, another batch of mice were intragastrically inoculated with C. parvum oocysts. The 
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gastrointestinal tract of 4 mice was removed and washed as described in section 6.2.4.1, 
however, only the  caecum  and the 7 cm  of small  intestine (ileum) directly before the 
caecum were dissected. This portion of the gastrointestinal tract was cut into 1 cm sections 
with the last section being the caecum only (8 sections in total) (see Figure 6.6). 
 
Figure  6.5.  qPCR  analysis  of  Cryptosporidium  parvum  in  gastrointestinal  sections 
removed from neonatal mice inoculated with C. parvum oocysts.  
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Figure  6.6.  Diagram  demonstrating  the  area  of  the  gastrointestinal  tract  dissected  for 
further analysis of site of infection.  
 
Sections A – G represent 1 cm sections in length, H represents the caecum. 
 
Results from these 1 cm sections helped to pinpoint the exact area in which the 
highest concentration of C. parvum infection occurred. All four mice exhibited the highest 
DNA concentration in the 1cm section directly before the caecum, section G (see Figure 
6.7).  One  mouse,  however,  had  a  more  extensive  area  of  infection  foci,  with  high  C. 
parvum DNA concentrations detected in sections E, F, G and H (the caecum and the three 
cm of ileum preceding the caecum). 
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Figure 6.7. qPCR analysis of Cryptosporidium parvum in 7 x 1 cm ileum sections and the 
caecum  removed  from  neonatal  mice  inoculated  with  C.  parvum  oocysts. 
 
 
6.3.2.1 Histological examination of tissue 
In addition to qPCR analysis to determine the presence of infection, tissue was 
processed  for  histological  examination  and  images  were  recorded.  Figure  6.8a 
demonstrates infected ileum from mice inoculated with C. parvum oocysts and Figure 6.8b 
demonstrates non-infected ileum from negative control mice. 
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Figure 6.8. Histological sections of neonatal mice ileum inoculated with Cryptosporidium 
parvum oocysts (a) and lifecycle stages (b) 7 days post inoculation.  
 
 
 
 
 
 
Images were photographed at 400 x magnification. a = ileum of neonatal mouse infected 
with C. parvum oocysts. b = ileum of neonatal mouse infected with C. parvum life cycle 
stages (no oocysts). Scale bar = 10 µm. 
 
6.4 DISCUSSION 
 
6.4.1 Infectivity of purified life cycle stages from oocysts cultivated in rain water 
 
The aim of the experiments conducted for this chapter was to determine if meront 
and merozoite life cycle stages derived from C. parvum oocysts incubated in rain water at 
24°C were infective to neonatal ARC/Swiss mice. Previous experiments (see chapter 5) 
determined  that  C.  parvum  had  the  ability  to  proceed  through  its  life  cycle  in  filter 
sterilised rain and tap water at various temperatures. One way to determine whether these 
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life  cycle  stages  were  in  fact  ‘viable’  would  be  to  demonstrate  their  ability  to  cause 
infection in neonatal mice. The neonatal mouse model is particularly useful to answer this 
question, firstly because it is already recognised as the gold standard in determining the 
viability of Cryptosporidium oocysts, and secondly because neonatal mice do not produce 
gastric acids. It is yet to be determined how life cycle stages other than the oocyst react to 
such conditions and if they are capable of infecting an adult host, therefore, by using the 
neonate model this would bypass such conditions and act as a first step to determining the 
possibility of infectivity of these stages. 
  Cryptosporidium parvum requires at least 5 days to complete its life cycle from 
oocysts  (Hijjawi  et  al.,  2001),  therefore  when  mice  are  infected  with  meronts  and 
merozoites, which occur later in the Cryptosporidium life cycle, recovery of oocysts would 
be expected at three to four days post inoculation. Likewise, when infected with oocysts, 
by day four post infection, the life cycle would have only proceeded to the type II meront 
and merozoite and gamete formation phase. 
  This study provided some evidence that meront and merozoite life cycle stages are 
capable of causing infection in neonatal mice. Oocysts and other life cycle stages were 
found in the gastro-intestinal contents from mice 4 days post inoculation with meronts and 
merozoites. This is the first report of life cycle stages of Cryptosporidium other than the 
oocyst causing infection. Each mouse was inoculated with approximately 25,000 meronts 
and merozoites, meronts were counted as ‘1’ stage. An estimated 1.1 x10
6 oocysts were 
recovered from 6 mice, therefore on average of 183,333 oocysts per mouse was recovered. 
This represents a 7.3 fold increase from the number of stages, which were inoculated into 
the mice. Many other life cycle stages were also recovered making a true estimate of the 
infection very difficult as it is known that meronts contain multiple merozoites. 158 
 
  The  purified  meront  and  merozoite  stages  used  to  inoculate  the  mice  were 
cultivated from pre-treated oocysts which were incubated in filter sterilised rain water at 
24°C for 4 days. The resulting collection of oocysts from inoculated mice provides strong 
evidence  that  these  life  cycle  stages  are  capable  of  living  outside  of  a  host,  in  the 
environment, and still be capable of infection. Should the life cycle complete producing 
new oocysts, the results obtained here suggest  that these oocysts would be capable of 
infecting adult hosts. Hijjawi et al., (2004), successfully demonstrated the infectivity of 
oocysts collected from 46 day old cell free cultures to neonatal mice. These oocysts from 
cell free cultures  used to  inoculate mice are highly likely to  have been newly  formed 
oocysts from life cycle development over the 46 day old cell free cultures. 
  Although  purification  of  intestinal  tissue  and  contents  revealed  the  presence  of 
oocysts and other life cycle stages, no signs of infection were observed histologically in the 
intestinal epithelial cells of mice inoculated with meronts and merozoites, or in the control 
mice inoculated with oocysts. This is most likely due to the specific area where the foci of 
infection occurred not being sampled amongst the tissue collected. Further experiments 
were conducted to pinpoint the region of the gastrointestinal tract infected with this isolate 
of C. parvum. 
 
6.4.2 Determination of site of infection of Cryptosporidium parvum in neonatal mice 
 
Experiments revealed that the 1 cm section of ileum immediately preceding the 
caecum had the highest intensity of infection. This finding allowed successful sectioning of 
intestinal tissue for histological analysis of infection. The primary site of infection with C. 
parvum is the small intestine and Tzipori and Widmer, (2008), reported that the ileum 159 
 
above the ceacal junction was the favoured location in mice. In initial experiments (part 1) 
the intestinal tract was cut approximately 0.5 cm before the caecum, thereby removing a 
good portion of the potentially heavily infected area and further processing and random 
selection of the tissue used for histological analysis probably resulted in the correct areas 
not being sampled. 
  Ideally,  following  the  determination  of  the  site  of  infection  for  this 
Cryptosporidium  strain,  repeat  experiments  should  be  conducted  to  find  histological 
evidence of infectivity of life cycle stages (no oocysts) cultivated in rainwater to neonatal 
mice.  Unfortunately,  however,  due  to  time  constraints  no  new  experiments  were 
conducted.  
   160 
 
CHAPTER 7: 
GENERAL DISCUSSION 
 161 
 
7.1 INTRODUCTION 
 
  The  focus  of  this  thesis  was  the  characterization  and  validation  of  cell-free 
including the use of fluorescence microscopy techniques and qPCR for the identification of 
Cryptosporidium  life  cycle  stages  in  cell  free  culture,  complete  development  and 
amplification  of  C.  hominis  in  cell-free  culture,  novel  observations  of  life  cycle 
development and amplification of C. parvum in water under laboratory conditions and the 
infectivity of life cycle stages derived from water to neonatal mice. The findings presented 
in this thesis has provided more evidence for the extra-cellular nature of this parasite and 
has  made  important  contributions  regarding  improved  methodologies  for  detection  and 
cultivation of this parasite in cell-free media. 
 
7.2 FLUORESCENT STAINING METHODS 
 
Fluorescence microscopy techniques are widely and commonly utilised as research 
tools, in diagnostic laboratories as well as in water testing facillites and for many other 
applications. For Cryptosporidium research, diagnostics and environmental detection, the 
oocyst stage is the life cycle stage that everyone is most familiar with and fluorescent 
techniques  are  well  established  for  this  stage.  As  discussed  throughout  this  thesis, 
Cryptosporidium life cycle stages are very small, translucent and often difficult to identify 
from extraneous matter, the focus of chapter 3 was to find suitable fluorescent staining 
methods to enable the easier detection, observation and identification of other life cycle 162 
 
stages in an effort to make it more common place to identify other life cycle stages as well 
as oocysts in the laboratory. 
  Chapter  3  compared  three  specific  (FISH  and  two  commercially  available 
immunofluorescent antibody stains Crypto Cel and Sporo-Glo™) and three non-specific 
(Texas  red,  DAPI  and  CFSE)  fluorescent  staining  techniques  for  visualisation  of  C. 
parvum life-cycle stages in cell-free culture. Findings determined that using a combination 
of the specific antibody fluorescent stains Sporo-Glo™ and Crypto Cel, allowed the easiest 
and most reliable identification of life-cycle stages in cell-free culture, which will facilitate 
a better understanding of the life-cycle of Cryptosporidium. 
  The identification of all life-cycle stages using both antibody and RNA staining 
methods  that  are  specific  for  Cryptosporidium  provides  further  proof  of  the  ability  of 
Cryptosporidium to complete its life cycle in cell-free culture. The use of a combination of 
both Sporo-Glo™ and Crypto Cel should allow easier and more reliable identification of 
life-cycle stages in cell-free culture, which will facilitate a better understanding of the life-
cycle of Cryptosporidium.  
  One disadvantage of fluorescent stains is that internal structure is often difficult to 
see. Fluorescent staining could be combined with acid-fast staining and hematoxylin and 
eosin (H and E) staining to better visualise internal structure. Cell-free life cycle stages 
could be spun down, embedded in agar, sliced and then stained with H and E to provide a 
clearer view of internal structure. 
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7.3 COMPLETE DEVELOPMENT OF C. HOMINIS IN CELL FREE CULTURE 
 
Chapter 4 reported for the first time the completion of the life cycle of C. hominis 
in cell-free culture and multiplication of the parasite via qPCR. As the majority of human 
infections are caused by C. hominis (Xiao, 2010), this is an important advance. Differences 
in the development of the life cycle were noted when purified sporozoites were inoculated 
cultures  compared  with  excysted  oocysts  with  both  microscopy  and  qPCR  analysis 
indicated that cultures inoculated with purified sporozoites lagged behind those inoculated 
with  excysted  oocysts.  For  cultures  inoculated  with  excysted  oocysts,  sporozoites  and 
trophozoites  were  observed  spontaneously  excysting  from  oocysts  throughout  the  time 
course of the experiments, suggesting that this parasite may respond to the presence of life 
cycle stages in the immediate external environment and environmental conditions in an 
attempt to propogate and proceed with the life cycle. This assumption would explain why 
cultures  started  from  pure  populations  of  sporozoites  appeared  to  be  less  productive. 
Further studies assessing the behavior and survival of pure populations as well as mixed 
populations of life cycle stages in cell free media and environmental conditions would 
facilitate a greater understanding of the survival of these stages, their fate, their interactions 
with each other and any differences in the life cycle development when populations are 
manipulated. 
Several  unusual  developmental  pathways  including  multiple  associations  and 
pairing between various developmental stages, the demonstration of two morphologically 
distinct meronts (I and II) and the formation Cryptosporidium stages inside the oocysts 
without excystation were observed which warrant further investigation. 164 
 
A cell-free culture system for C. hominis is an important advance for the water 
industry  as  it  will  facilitate  disinfection  studies.  Depending  on  the  efficiency  of  the 
conventional water treatment plant, oocysts may pass through the treatment process and 
enter the distribution system. The oocysts may still be capable of causing infection, which 
is the critical health parameter. Currently C. parvum is the only species that can be easily 
propagated in the laboratory and therefore studies on oocyst disinfection and viability have 
concentrated  on  C.  parvum  and  little  is  known  about  survival  and  disinfection  of  C. 
hominis. To date only one study has been conducted examining UV inactivation of  C. 
hominis (Johnson et al., 2005). No studies have been conducted on the effect of chlorine or 
chloramine disinfection on C. hominis infectivity or the effect of water treatment processes 
on the infectivity of aged C. hominis oocysts. 
 
7.4 THE LIFE CYCLE OF C. PARVUM IN WATER AND INFECTIVITY OF LIFE 
CYCLE STAGES TO NEONATAL MICE 
 
Following the landmark description of the complete development of C.parvum in 
host cell free culture (Hijjawi et al., 2004) and the complete development of C. hominis in 
cell free culture in Chapter 4, Chapters 5 and 6 were designed to further investigate the 
ability of cell free life cycle stages to develop and survive in water and also to consider the 
infectivity of life cycle stages which developed in water. 
  Previous studies assessing the survival of Cryptosporidium under environmental 
conditions  have  focused  on  the  oocyst  and  no  attempt  has  been  made  to  identify  the 
presence of other life cycle stages. This thesis identified that the life cycle can still proceed 
in  water  with  limited  nutrients  and  no  external  trigger  is  necessarily  required  for  the 165 
 
excystation of sporozoites  from  oocysts. Regular microscopy monitoring of pre-treated 
oocysts placed into water revealed the development of the life cycle and the presence of all 
developmental  phases  including  merogony,  gametogony  and  sporogony  at  time-points 
consistent  to  those  described  by  Hijjawi  et  al.,  (2002,  2004).    It  was  noted  that  once 
oocysts were placed into water, those that excysted over the course of the experiment, 
would do so within the first two to three days, then gradually more would spontaneously 
excyst resulting in an unsynchronised culture and thus many different life cycle stages 
present  at  any  one  time,  particularly  after  9  days.  qPCR  analysis  also  confirmed  the 
multiplication of the parasite in water. 
While the propagation of Cryptosporidium in tap water was investigated in this 
study, no assessment of chlorine concentrations in samples was undertaken and hence it is 
not clear what effect chlorine has on the various life cycle stages. As a key barrier in 
drinking  water  supply,  the  ability  of  chlorine  and  chloramines,  as  well  as  other 
disinfectants used by the water industry, on the Cryptosporidium life cycle stages needs to 
be determined in order to fully assess water quality risks.  
Life  cycle  stages  other  than  the  oocyst  were  inoculated  into  neonatal  mice, 
producing signs of infection and hence raises the possibility that life cycle stages other 
than the oocyst can be infective. However, further experiments need to be conducted to 
support these results. Following the initial experiments, it was found the foci of infection 
in the mice with the utilized strain of C. parvum was very localised and this was the likely 
reason for no histological evidence of infection being found. Repeat experiments should be 
conducted and sections of gastrointestinal tract should be taken from the ileum directly 
before the caecum for histological analysis. 
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7.5 FUTURE STUDIES 
 
7.5.1 Development of micromanipulation as a tool for the isolation of Crytposporidium 
life cycle stages 
 
To  enable  the  investigation  of  biochemical  and  physiological  properties  of 
microorganisms,  the  isolation  and  management  of  pure  cultures  is  essential.  For 
Cryptosporidium, pure populations of each life cycle stage would facilitate the search for 
stage  specific  antigens  and  studies  on  host  cell  interaction,  survival,  infectivity, 
inactivation and more. 
Micromanipulation is a useful technique for the isolation of single cells and has 
been  applied  to  bacteria  (Bakos,  1970;  Hamilton,  1978),  cyanobacteria  (Bowyer  and 
Skerman, 1968), malarial parasites (Coulston and Manwell, 1941; Downs, 1947; Bishop, 
1958; Barnwell et al., 1983; Oduola et al., 1988; Beale et al., 1991) yeast (Sherman, 1973), 
water samples  and  activated sludge  (Sly and Arunpairojana 1987;  Hornsby  and Horan 
1994;  Bradford  et  al.,  1996)  and  dental  plaque  (Mouton  et  al.,  1977).  More  recently, 
micromanipulation techniques have been applied to Cryptosporidium oocysts (Sturbaum et 
al., 2001; Tanriverdi et al., 2002). 
  Micromanipulation  methodologies  could  be  applied  to  cell-free  culture  for  the 
isolation of Cryptosporidium life cycle stages to facilitate their further characterization, 
specifically to harvest life cycle stages, facilitating studies on the survival of these stages in 
the natural environment, ultrastructural studies, disinfectant susceptibility, infectivity to 
neonatal and adult animal models.  167 
 
Micromanipulation would also be particularly useful for characterization of newly 
described novel stages (Hijjawi et al., 2004) where molecular discrimination can be used to 
verify they are Cryptosporidium. It will also be useful to place these stages into culture to 
determine their fate in the life cycle. If enough of any of the life cycle stages can be 
isolated from the others, this may allow survival studies, infectivity studies, disinfection 
studies and protein work enabling identification of stage specific proteins. 
The limitations, however, of this technique include the expense of the equipment 
required, expertise required to perform micromanipulation and the fact that it is a labor-
intensive  process.  However,  once  the  correct  equipment  is  in  place  and  there  is  an 
experienced user to perform the technique, it is quite a routine procedure to follow and 
many life cycle stages could be collected in a short period of time. An advantage of using 
micromanipulation over other isolation techniques such as immunomagnetic separation, 
density gradient centrifugation, flocculation etc, is that it involves no chemicals or reagents 
to be added to the sample which may affect the performance in cell or cell free culture, 
there are also no centrifugation processes which may result in loss of life cycle stages. 
 
7.5.2 Scanning (SEM) and Transmission (TEM) Electron microscopy analysis of cell-
free life cycle stages 
 
Scanning (SEM) and transmission (TEM) electron microscopy should be applied to 
better characterize the morphology and structure of cell-free life cycle stages and novel 
stages. For example, how extracellular trophozoites and meronts progress in their life cycle 
without  cellular  invasion  is  still  not  understood.  Each  extracellular  trophozoite  might 
progress in a manner typical of an intracellular trophozoite, or each single trophozoite 168 
 
might transform into the next life-cycle stage. SEM and TEM could be applied to elucidate 
this. 
Recently, it has been observed that C. parvum also develops extracellularly, despite 
the presence of host cells (Borowski et al., 2010), which further supports the observations 
in this thesis and the proposal that Cryptosporidium has a close affinity with gregarines 
(Carreno et al. 1999; Barta and Thompson, 2006; Valigurova et al. 2007). In the study by 
Borowski et al., (2010), both SEM and TEM were used to demonstrate the possibility that 
C. parvum may undergo binary fission, i.e. the splitting of a parent cell into 2 daughter 
cells, other than during the course of merogony and shizogony and that C. parvum might 
employ syzygy. The C. parvum stages involved in syzygy in the study by Borowski et al., 
(2010),  were  identified  as  (most  likely)  microgametes.  In  that  study,  syzygy  was  first 
observed in culture, when sexual life-cycle stages occurred, suggesting that predominantly 
gamont stages employ syzygy (Borowski et al., 2010). This correlates with findings on 
gregarines and further supports the affinity of Cryptosporidium with these apicomplexans 
(Landers, 2001; Toso and Omoto, 2007b). 
 
7.5.3 Identification and analysis of stage specific proteins in cell-free culture 
 
The release of the complete genome sequences for C. parvum and C. hominis has 
facilitated comprehensive global transcriptome and proteome analysis of Cryptosporidium. 
To date proteome analysis in Cryptosporidium has been confined largely to oocysts and 
sprorozoites  due  to  the  difficulties  in  obtaining  sufficient  quantities  of  other  life-cycle 
stages (Snelling et al., 2007; Sanderson et al., 2008; Siddiki and Wastling, 2009; Wastling  
et al., 2009; Lee et al., 2011). Stage specific proteins have already been identified using 169 
 
transcriptome and proteome analysis, particularly for sporozoites (Jakobi and Petry, 2006; 
Snelling et al., 2007) but little information is available for other life-cycle stages. The 
ability to sort life-cycle stages generated from cell free culture, using micromanipulation 
would allow proteome  and transcriptome analysis of specific life  cycle stages  and the 
identification  of  stage  specific  surface  proteins  with  antigenic  properties.  This  in  turn 
would lead to the development of stage specific antibodies which could be used to follow 
the development of cell-free cultures more closely and to flow-sort life cycle stages for 
further analysis without the need for micromanipulation.  
Stage specific antibodies could be used by the water industry to identify if life 
cycle stages (in addition to oocysts) are present in raw and finished drinking water as this 
has important public health implications.  
Stage  specific  antibodies  could  also  lead  to  the  development  of  transmission 
blocking vaccines for Cryptosporidium. mRNA expression profiling could also be used to 
compare gene expression of cell-free versus HCT8-infected cultures to better understand if 
there are differences in gene expression between cell-free and host cell culture.  
Comparisons also need to be made between cell culture and cell free culture in 
media and water to determine differences in the multiplication and behavior of life cycle 
stages under different conditions. Studies need to be conducted to prove the sustainable life 
cycle production outside of a host cell and the reasons why and under which situations this 
occurs need to be explored.  
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7.6 CONCLUSIONS 
 
Overall  this  thesis  has  revealed  novel  insights  into  the  life  cycle  of 
Cryptosporidium and reports for the first time, contrary to the currently held belief that 
Cryptosporidium needs a host to propagate, the complete development and multiplication 
of C. hominis in cell-free culture and the ability of the parasite to complete its life cycle in 
water.  Furthermore,  it  was  shown  that  life  cycle  stages,  other  than  the  oocyst,  are 
potentially infectious to neonatal mice, although it is not clear if they are infectious to 
humans or other adult animals. 
These  two  factors,  growth  of  the  Cryptosporidium  in  the  environment  and 
infectivity of the various life cycle stages, need to be considered in the assessment of risks 
to drinking water supplies, particularly in light of the fact that current detection methods 
used by the water industry only target oocysts.  
 Data on the survival of life cycle stages other than oocysts under the conditions 
they are exposed to in the natural environment are required to establish the risk posed by 
these stages. Once the risk has been assessed, it may be necessary to review water-testing 
methodology, where only oocysts are targeted. 
Experiments conducted throughout this PhD have resulted in many more questions 
arising, which need to be answered, highlighting the complexity of this parasite and lack of 
knowledge of how it behaves outside of cell culture. Many standardised methodologies 
used for Cryptosporidium oocysts are not suitable for application to other life cycle stages 
and the development of suitable techniques and methodologies to study life-cycle stages is 
essential.  Results  obtained  in  this  PhD  serve  to  demonstrate  that  the  biology  of 
Cryptosporidium is much more complex than initially thought and further strengthen the 171 
 
relationship between Cryptosporidium and the gregarines. Given the present findings and 
similarities between Cryptosporidium and gregarines, it is possible that Cryptosporidium is 
able  to  continue  through  its  life  cycle  in  the  environment  and  possibly  parasitise 
invertebrates and thus may be more prevalent in water sources than currently thought. 
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